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Abstract 
Linear self-immolative polymers display a potential to address many of the limitations in the 
control over the degradation process in traditional biodegradable polymers. These materials 
are unique relative to most degradable polymers, in that they undergo end-to-end 
depolymerization in response to the cleavage of a stabilizing end-capping agent. Although 
one of their cited attributes is a dependence of their degradation time on chain length, no 
conclusive study has been conducted to demonstrate and study this effect. Using a previously 
reported linear self-immolative backbone derived from alternating 4-hydroxybenzyl alcohol 
and N,N’-dimethylethylenediamine spacers, this work offers the first conclusive study 
demonstrating the proportional relationship between chain length and degradation time. This 
is accomplished using a set of monodisperse oligomers synthesized through a new 
convergent iterative route and a series of polymers optimized to display varying molecular 
weights. This work also describes the development and validation of a new linear self-
immolative degradation model relating monomer kinetics to polymer degradation and shows 
its application in explaining oligomeric and polymeric degradation profiles. Collectively, this 
work provides the first quantitative evidence supporting the mixed pseudo zero- and first-
order degradation kinetics of linear self-immolative polymers and proves the utility of chain 
length as an alternate means to tune the degradation time in linear self-immolative polymers. 
In the second focus of this thesis, a series of modified linear self-immolative amphiphilic 
block copolymer designs are proposed and evaluated in an effort to develop functional self-
immolative nanoparticles for controlled release applications. Overall, the work presented in 
this thesis serves to expand the utility of linear self-immolative polymers for biomedical 
applications by demonstrating the flexibility of such systems through controlled design.  
 
Keywords 
Self-immolative polymers, self-immolative degradation, polymer degradation kinetics, 
cyclization kinetics, kinetic modelling, amphiphilic block copolymer, drug delivery vehicle.    
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Chapter 1  
1 Biodegradable Polymers for Biomedical Applications: 
From Polyesters to Self-Immolative Materials 
1.1 General Introduction 
Advances in the field of polymer science over the last 50 years have led to the 
development of biodegradable polymers for a wide variety of applications. Once limited 
to the domain of academic research, biodegradable polymers have now emerged as 
environmentally-friendly alternatives to commodity plastics and are finding widespread 
use in biomedical applications ranging from tissue engineering to drug delivery.1-6 In 
general, a biodegradable polymer can be defined as a polymeric system that is prone to a 
deleterious change in its chemical structure or physical properties under specific, 
practical environmental conditions.7 In addition, these polymers should be biologically 
inert and not generate any substances that are harmful to the environment during the 
degradation process.8  
Biodegradable polymers are typically comprised of systems with hydrolyzable bonds in 
the polymer backbone. Such polymers can be produced from natural materials such as 
polysaccharides, proteins, and bacterial polyesters or generated synthetically through the 
polymerization of polyamides, polyureas, polyurethanes, polyesters, polyethers, 
polyanhydrides, polypeptides and other corresponding copolymer systems (Figure 1.1).1,2 
Similar to the physical properties of polymeric materials, the degradation behaviour of 
biodegradable polymers is influenced by the chemical composition of the polymer 
backbone, molecular weight, polydispersity, and crystallinity.1 To this end, the proper 
design and application of biodegradable polymers relies on a thorough understanding of 
polymer properties and their effect on the degradation process.  
 
Figure 1.1. Conventional synthetic biodegradable polymers with hydrolyzable bonds 
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1.2 Biodegradable Polyesters 
Aliphatic polyesters have received the most attention for biomedical applications out of 
all the available biodegradable backbones due to their ease of synthesis, desirable 
mechanical properties, and high biocompatibility.9 Additionally, the degradation of these 
polymers is well tolerated in vivo, as the hydrolytic and/or enzymatic cleavage of 
backbone esters yields hydroxy-carboxylic acid species that can ultimately be 
metabolized.1 Popular synthetic polyesters such as poly(lactic acid) (PLA), poly(glycolic 
acid) (PGA), poly(lactic-co-glycolic acid) (PLGA), and poly(ε-caprolactone) (PCL) are 
widely used in the field of biomedicine as biodegradable stents and sutures10,11, tissue 
engineering scaffolds12,13, and drug delivery vehicles14-18 (Figure 1.2). 
 
Figure 1.2: Popular synthetic biodegradable polyesters for biomedical applications 
The synthesis of polyesters has evolved significantly since the initial method proposed 
and developed by Wallace Carothers in the 1930s.19 High molecular weight polyesters 
are now typically synthesized by means of a ring opening polymerization reaction 
involving coordinative catalysts or anionic, cationic, or nucleophilic initiators (Figure 
1.3).2,5 This strategy allows for a high degree of control over the polymerization process 
as well as the functionalization of polyesters through the homopolymerization or 
copolymerization of cyclic monomers bearing specific functional groups. Control over 
the polymer composition, molecular weight distribution, and stereochemistry has 
permitted a modulation of the time required for polyester degradation in the span of 
weeks to years under physiological conditions.9    
 
Figure 1.3: Ring opening polymerization of polyesters from (a) lactone or (b) cyclic 
dimer species.  
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1.2.1 Functional Designs 
In addition to the versatility offered through controlled polymerization, biodegradable 
polyesters can also be incorporated into a number of different functional designs for 
biomedical applications. One particularly important example of a functional polyester 
design is the 2,2-bis(hydroxymethyl)propionic acid (bisMPA)-based dendrimer scaffold 
(Figure 1.4).20-22 Dendrimers are highly branched, tree-like macromolecules comprised of 
a number of repeated branches emanating outward from a central core.23,24  Each 
concentric layer, referred to as a generation, gives rise to an exponential growth of 
peripheral groups, which can be used to conjugate other molecules.  Dendrimers are ideal 
candidates for biomedical applications due to their well-defined structures and 
monodispersity that come as a result of their stepwise synthesis. Prior to the development 
of the bisMPA scaffold, however, the biomedical utility of dendrimers was limited by 
their toxicity and poor aqueous solubility.25 Since the initial reports on the design and 
synthesis of bisMPA scaffolds,20-22 an extensive amount of promising work has been 
conducted on the use of bisMPA dendrimers in biomedical applications.25-30  
 
Figure 1.4: Example of a 4th generation dendritic polyester scaffold derived from 
2,2-bis(hydroxymethyl)propionic acid (bisMPA)  
Biodegradable polyesters have also been explored in the design of amphiphilic block 
copolymers capable of self-assembly into supramolecular structures. When incorporated 
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into a block copolymer architecture with a hydrophilic polymer such as poly(ethylene 
glycol) (PEG), polyesters can self-assemble in aqueous solution to form polymeric 
micelles31,32, vesicles33,34, and other nanoparticles.18 This phenomenon is attributed to two  
competing thermodynamic factors: (i) the enthalpic contribution from the interfacial 
energy between the two blocks and (ii) the entropic contribution due to chain stretching. 
In an attempt to minimize the interfacial energy between the two blocks and adopt the 
highest configurational entropy, block copolymers will self-assembly into the lowest 
energy conformation as dictated by the volume fractions of the blocks, the total degree of 
polymerization, and the Flory–Huggins parameter.35 In general, block copolymers will 
form vesicles if the volume fraction of the hydrophobic block is between 25 and 40%, or 
micelles if the volume fraction exceeds 50%.33  
 
Figure 1.5: Self-assembly of block copolymers into functional polymer assemblies: 
(a) spherical micelles and (b) polymer vesicles.  
PEG-polyester based micelles and vesicles are particularly important as drug delivery 
vehicles due to their ability to encapsulate and release hydrophobic and hydrophilic 
molecules, respectively.36 Spherical micelles are composed of a hydrophobic core 
surrounded by hydrophilic coronal chains (Figure 1.5a). The hydrophilic portion of these 
assemblies allows for aqueous solubility of the micelles, while the core can be used to 
encapsulate hydrophobic molecules. Polymer vesicles, on the other hand, are hollow 
spheres with a bilayer wall composed of a hydrophobic layer sandwiched between an 
internal and external hydrophilic corona (Figure 1.5b).35 When used as drug delivery 
vehicles, both of these assemblies have been demonstrated to increase the bioavailability 
of the encapsulated drug and enhance the efficacy of therapeutic treatment.36-41   
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1.2.2 Limitations in the Degradation of Polyesters 
Despite the proven utility of biodegradable polyesters, the degradation of these systems 
suffers from a lack of fine-control. The reliance of these materials on random hydrolytic 
cleavage of the ester linkages throughout the polymer backbone raises two concerns in 
the context of biomedicine: (i) the degradation process is not initiated by a specific 
stimulus and (ii) the cleavage of the polymer backbone is dictated by an uncontrolled 
process that can reduce the polymer molecular weight by up to 50% upon every cleavage 
event.42 In part, the overall rate of degradation can be influenced by pH and chain 
length43,44; however, there is no means to direct the degradation process along a specific 
pathway throughout the polymer backbone. Hence, many of the physical properties of 
polyesters are prone to unpredictable changes from the onset of degradation that can lead 
to the poor performance or failure of polyester-based biomedical devices in vivo. 43,45  
1.3 Stimuli-Responsive Degradable Polymers 
The issue of non-specific degradation in biodegradable polymer systems has been 
mediated through the development of stimuli-responsive degradable polymer backbones. 
Not to be confused with the general class of stimuli-responsive materials, these polymers 
undergo complete backbone degradation in response to specific environmental conditions 
or an applied stimulus.46-48 In general, there are 3 major classes of stimuli-responsive 
degradable polymers: (i) acid degradable polymers, (ii) reduction sensitive polymers, and 
(iii) photodegradable polymers. A small handful of other polymer systems have also been 
developed to degrade in response to biologically mediated events such as enzymatic 
cleavage49 or changes in chemical concentration.50,51 However, the biomedical 
applications of these materials will not be discussed in the following sections.  
1.3.1 Acid Degradable Polymers 
A large number of pH-sensitive linkers are available for the development of acid-
degradable polymers (Figure 1.6). Despite the structural diversity of these linkers, they 
all contain chemical linkages that are stable at neutral pH and prone to hydrolysis in 
acidic solution.52 This unique property has been exploited in the field of biomedicine to 
promote degradation of polymers derived from these units following an abrupt change in 
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environmental pH.48 To this end, acid-degradable polymers are commonly used to form 
drug delivery vehicles for the triggered release of therapeutics following intracellular 
uptake into mildly acidic endosomes or lysosomes or for the targeted delivery of drugs to 
cancerous tissues possessing a slightly acidic tumour environment.53-58  
 
Figure 1.6: Acid-sensitive linkers used in acid-degradable polymer backbones 
1.3.2 Reduction Sensitive Polymers 
Reduction sensitive polymers are a broad class of materials that incorporate disulfide 
linkages throughout the polymer backbone (Figure 1.7). The disulfide bond is a highly 
versatile linkage that can be cleaved and reformed under the appropriate conditions, but is 
stronger than most non-covalent interactions.59 This gives poly(disulfide) systems the 
ability to adapt, self-repair, and degrade in response to physical and/or chemical stimuli.59 
However, the use of poly(disulfide)s in applications requiring complete degradation relies 
on a total reduction of these bonds into their thiol constituents (Figure 1.7a).  Typically 
used in drug and gene delivery systems, disulfide-based carriers operate on a difference 
between the intracellular and extracellular redox potential. These systems are stable in the 
extracellular environment in which the glutathione concentration is on the order of 1 µM, 
but degrade upon cellular uptake where the glutathione concentration is on the order of 
several millimolar.60-64  
 
Figure 1.7: (a) General structure of a poly(disulfide) and its reduction to thiols. (b) 
An example of a poly(disulfide) synthesized from a linear disulfide monomer.  
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1.3.3 Photodegradable Polymers 
The third major class of stimuli-responsive degradable polymers involve polymer 
backbones that are susceptible to cleavage following exposure to ultraviolet (UV)/near 
infrared (NIR) light. These systems typically employ ortho-nitrobenzyl alcohol 
derivatives65 to promote cleavage by a single-photon process upon exposure to UV light 
(Figure 1.8).66-72 Due to the potential for photodamage caused by UV light, more recent 
investigations have focused on the use of 4-bromo 7-hydroxycoumarin derivatives73 to 
promote photolysis by the less efficient two-photon process using biologically benign 
NIR light.74-78 Although in the early stages of development, these materials display 
immense promise for the fabrication of drug delivery vehicles that release their payload 
in response to UV/NIR irradiation.  
 
Figure 1.8: Example of a photodegradable block copolymer incorporating a 
photolabile ortho-nitrobenzyl carbonyl group 
1.3.4 Limitations in the Degradation of Conventional Stimuli-
Responsive Degradable Polymers 
Stimuli-responsive degradable polymers circumvent the issues associated with the non-
specific degradation of polyesters. However, the degradation of these materials still relies 
on random chain scissions throughout the polymer backbone.  This reliance limits the 
overall control of the degradation process and prevents the reliable prediction of the 
degradation behavior in vivo.  Additionally, the complete degradation of these materials 
requires many environmentally-mediated cleavage events, thereby restricting their usage 
to applications in which triggering events are abundant 
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1.4 Self-Immolative Polymers 
Self-immolative polymers have been developed over the past 10 years as alternatives to 
conventional biodegradable polymers and address the limitations associated with the lack 
of fine-control over the degradation process. Self-immolative polymers are a general 
class of compounds that can undergo end-to-end depolymerization through a cascade of 
intramolecular reactions upon the selective removal of a stimuli-responsive, stabilizing 
end-cap (Figure 1.9).79-81 Inspired by and derived from their prodrug counterparts, self-
immolative polymers are typically comprised of a number self-immolative monomeric 
spacers covalently linked in an iterative fashion and terminated with a protective end-
capping agent. At the current stage in development, self-immolative polymers are limited 
to either a dendritic (Figure 1.9a) or linear architecture (Figure 1.9b).  
 
Figure 1.9: Self-immolative degradation in (a) dendritic and (b) linear polymeric 
systems 
Under the appropriate environmental conditions, self-immolative polymers are not 
susceptible to random backbone cleavage, thereby restricting their degradation to a well-
defined pathway that can only be triggered by end-cap removal. This controlled 
mechanism of self-immolative degradation allows for three main advantages over 
conventional biodegradable polymers. Firstly, the stimuli-responsiveness of self-
immolative polymers can be readily tuned and adjusted through the incorporation of 
different end-capping agents. Secondly, self-immolative degradation permits the 
amplification of a given stimulus in that only one triggering event is required to achieve 
End Cap
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complete degradation. Lastly, the degradation rate of self-immolative polymers is 
dictated by, and dependent on, the chemistry and architecture of the polymer backbone.  
As a result, self-immolative polymers can be engineered to degrade under a specific set 
of conditions with a degradation rate that is regulated by the composition and structure of 
the polymer backbone. 
1.4.1 Self-Immolative Spacers 
Self-immolative spacers were developed for prodrug systems as a means to overcome 
steric limitations by increasing the physical distance between the conjugated drug and 
active cleavage site.82 In the most basic prodrug design, the trigger group (also described 
as a protecting group) is attached directly to the drug molecule via a scissile bond (Figure 
1.10a).  While this strategy has proven useful for a large number of small molecule83,84 
and macromolecular prodrug systems85, it relies on an easily accessible linkage between 
the conjugated molecules. When the trigger and/or drug are sterically bulky, their spatial 
proximity can restrict enzymatic access to the linkage site, thereby preventing cleavage 
and release of the active drug molecule.86-88 Modification of this design to incorporate a 
self-immolative spacer between the trigger and drug moieties bypasses any steric 
restrictions and allows for the release of the drug molecule through an alternate 
pathway.89,90 In the self-immolative prodrug design, removal of the triggering group 
reveals an active terminus on the self-immolative spacer that initiates a spontaneous and 
irreversible intramolecular reaction to liberate the active drug molecule (Figure 
1.10b).91,92  
 
Figure 1.10: (a) Classic and (b) self-immolative prodrug strategies 
The basic process of self-immolation can be described as the spontaneous and irreversible 
disassembly of multi-component compounds into their constituent components through 
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an intramolecular reaction. This process is driven by an increase in entropy and by the 
irreversible formation of thermodynamically stable products (eg. CO2, cyclic species).79 
In general, self-immolative spacers can be grouped into three classes based on their 
mechanism of disassembly: (i) electronic cascade spacers; (ii) cyclization spacers; and 
(iii) hemiacetal spacers (Figure 1.11).  
  
Figure 1.11: General schematics for (a) electronic cascade spacers, (b) cyclization, 
and (c) hemiacetal spacers.   
1.4.1.1 Electronic Cascade Spacers 
The first class of self-immolative linkers, known as electronic cascade spacers, involve 
compounds capable of undergoing an elimination reaction caused by the shifting of 
electron pairs in a conjugated aromatic system (Figure 1.11a). The predominant majority 
of electronic cascade spacers are based on the initial 1,6-elimination spacer developed by 
Katzenellenbogen and coworkers in 1981.82 Often considered to be the first application of 
a self-immolative spacer in prodrug chemistry, this system involved a lysine 
functionalized 4-aminobenzyl alcohol spacer conjugated to a 4-nitroaniline reporter 
molecule through a carbamate linkage at the benzylic position. Following enzymatic 
cleavage of the lysine residue, the strongly electron-donating 4-aminobenzyl group 
initiates a 1,6-elimination reaction, followed by a spontaneous decarboxylation to release 
the 4-nitroaniline reporter.82  
This initial design has since been adapted to other polysubstituted electron-rich aromatic 
systems that feature a masked electron-donating group (hydroxyl93 or thiol94 moeities) 
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conjugated to a benzylic leaving group at either the ortho (1,4-elimination) or para  (1,6-
elimination) positions.95 Highly electron-donating substituents are required to lower the 
energy-barrier associated with dearomatisation to form the quinone, azaquinone or 
thioquinone methide intermediates, while benzylic carbonate and carbamate linkages are 
often employed to provide a thermodynamically favourable decarboxylation following 
elimination. Electronic cascade eliminations are typically quite rapid under the 
appropriate conditions and require proper modulation or masking of the electron-donating 
substituent using an appropriate triggering group to avoid premature elimination.79 
Despite the complexities associated with electronic cascade spacers, a number of 
homoaromatic49,86,87,90,96-108 and heteroaromatic109 systems have been developed for use 
in a variety of prodrug systems.   
1.4.1.2 Cyclization Spacers 
The second major class of self-immolative linkers, known as cyclization spacers, 
involves compounds capable of undergoing intramolecular cyclization reactions (Figure 
1.11b). These compounds most commonly involve activation of a latent nucleophile and 
subsequent nucleophilic attack on a carbonyl center to liberate an active drug molecule.79 
Although a large variety of cyclization spacers exist, the predominant majority of these 
compounds are based on either 4-amino or 4-hydroxybutanoyl esters or ethylenediamine 
species.110 The first reported self-immolative cyclization prodrugs were developed 
simultaneously by the Lane and Borchardt research groups and involved the use of 
hydroxyl amide lactonization reactions110 to release an active reporter molecule (Figure 
1.12a).111-114 This strategy was later applied to coumarin based prodrug systems by Wang 
and coworkers to take advantage of the relative non-toxicity of the released coumarin 
species and to increase the rate of lactonization (Figure 1.12b).115,116  
 
Figure 1.12: Self-immolative cyclization spacers derived from 4-hydroxybutanoyl 
esters. (a) Trimethyl lock lactonization and (b) Coumarin based prodrug design. 
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The other common class of cyclizaton spacers based on ethylenediamine compounds 
were first reported by Saari and coworkers in 1990 for a series of carbamate and ester 
prodrugs.117,118 In these systems, selective cleavage of a tert-butoxycarbonyl (Boc)-
protecting group reveals an active amine terminus, which then undergoes an 
intramolecular cyclization reaction to form the corresponding cyclic urea or amide 
species and liberate a reporter molecule (Figure 1.13). Varying the substituents on both 
the nucleophilic and electrophilic nitrogen atoms in the carbamate design allowed for 
tuning of the cyclization rate between 24 and 942 min in aqueous buffer maintained at pH 
7.4 and 37˚C, thereby demonstrating the inherent flexibility of such systems.117 Similar 
strategies have also been adopted using mercaptoethanol119, aminoethanol120-122, and 
cysteamine123 based spacers to further tune the rates of cyclization and expand the variety 
of chemical linkages permitted in self-immoaltive cyclization systems. In general, 
cyclization reactions are much slower than 1,4- and 1,6-eliminations and are often used to 
control the release kinetics in self-immolative prodrug systems.92,124-127 
 
Figure 1.13: Activation of carbamate prodrugs by intramolecular cyclization of the 
ethylenediamine pro-moiety117 
1.4.1.3 Hemiacetal Spacers 
A third minor class of self-immolative spacers based on hemiacetal systems does exist, 
but these spacers are not as widely employed in prodrug designs as electronic cascade or 
cyclization based spacers (Figure 1.11c). First introduced as potential spacers for amine 
prodrugs to address the relative instability of N-acyl groups, these spacers often involve 
N-acyloxyalkoxycarbonyl derivatized drug molecules. This strategy was first reported by 
Alexander and coworkers in 1987 and involved N-acyloxyalkoxycarbonyl derivatized 
model compounds terminated with an esterase sensitive trigger group.128-130 Following 
hydrolytic cleavage, the exposed hydroxyl group initiates a spontaneous 1,2-elimination 
followed by a decarboxylation reaction to decompose the (hydroxyalkoxy)carbonyl 
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derivative and liberate the active drug molecule. Similar prodrug strategies also exist for 
acyloxyalkyl and phosphoryloxyalkyl systems (Figure 1.14)131-135; however, the 
applicability of such systems is often limited by the generation of toxic aldehydes during 
degradation.136   
 
Figure 1.14: Other hemiacetal based self-immolative linkers based on acyloxyalkyl 
and phosphoryloxyalkyl systems 
1.4.2 Self-Immolative Oligomers 
The first extension of self-immolative spacers towards incorporation into oligomeric 
designs was introduced by Schereen and coworkers in 2001.137 It was hypothesized that 
the use of elongated and extended self-immolative spacers would enhance cleavage rates 
by further increasing the distance between the active trigger site and sterically bulky drug 
molecule. To this end, several biaromatic spacers based on napthyl (1,8-elimination) and 
biphenyl (1,10-elimination) moieties were prepared; however, these systems failed to 
undergo any electronic cascade reactions, which was attributed to the high cost of 
dearomatization required for the 1,8 and 1,10-elimination reactions, respectively. 
Conversely, the combination of multiple 1,6-elimination p-aminobenzyl oxycarbonyl 
(PABC) spacers into an elongated oligomeric design (Figure 1.15a) involving a plasmin 
sensitive trigger significantly enhanced the release rate of paclitaxel when compared to 
the analogous monomeric system. These PABC oligomers were subsequently modified 
with an additional N,N’-dimethylethylenediamine cyclization spacer to allow for the 
attachment of hydroxyl containing drugs using a carbamate linkage instead of the less-
stable carbonate linkage, available using the PABC spacers alone (Figure 1.15b). These 
combination 1,6-elimination and cyclization based oligomers displayed slower release 
kinetics compared to the purely 1,6-elimination systems, but demonstrated the potential 
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for fine control over the degradation process using cyclization linkers in conjunction with 
electronic cascade spacers.  
 
Figure 1.15: Oligomeric prodrugs based on (a) multiple 1,6-elimination spacers and 
(b) multiple 1,6-elimination spacers followed by a cyclization spacer in series (PG – 
protecting group, D – drug, n=1,2). 
While the first self-immolative oligomer system is important in the evolution of self-
immolative linkers from prodrugs to polymers, it failed to exploit the opportunity for 
chemical amplification in the design. The first self-immolative oligomer possessing 
chemical amplification was not developed until several years later in 2008 by Warnecke 
and Kratz.138 This system used a modified PABC linker design involving 2,4- 
bis(hydroxymethyl)aniline molecules capable of undergoing both 1,4 and 1,6-
eliminations (Figure 1.16). By using a “double release linker”, this system was able to 
concomitantly liberate reporter molecules through 1,4-eliminations during the linear 
degradation of the main chain through the faster 1,6-elimination pathway. Such a strategy 
allowed for an enhanced release rate compared to oligomeric prodrug systems in which 
drug molecules are simply conjugated at a single terminus. It was suggested that this 
oligomeric design would be highly versatile for the development of combination 
therapeutic strategies, particularly in cases in which steric hindrances could limit drug 
conjugation in dendrimer based systems. However, the complicated stepwise iterative 
synthesis required for such a system has limited any further development in the literature.  
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Figure 1.16: Linear self-eliminating prodrug design incorporating double-release 
linkers to achieve amplification in the amount of drug released   
Despite the potential of self-immolative oligomers, only a handful of systems have been 
developed over the past decade for drug delivery and sensing applications.121,139-141 The 
main limitation in the design of such systems is the lengthy stepwise iterative syntheses 
that typically only result in arithmetic growth.  As a result, an increased focus has been 
placed on the development of dendrimer systems that can be synthesized through iterative 
convergent methods and grown geometrically.80 More recently, however, self-immolative 
oligomers have emerged as useful models to investigate the mechanism and degradation 
kinetics of self-immolative polymers.101,102,142-144       
1.4.3 Self-Immolative Dendrimers 
The first incorporation of self-immolative spacers into a polymeric framework was 
reported almost simultaneously by three different groups in 2003.145-147  All three groups 
utilized dendritic architectures in their designs with variations on the triggering groups, 
self-immolative spacers, conjugated molecules, and potential applications. McGrath and 
coworkers described the synthesis of up to the 2nd generation “linear disassembling" 
benzyl(aryl ether) dendrimers derived from O-functionalized 3,4-dihydroxybenzyl 
alcohol and 4-hydroxybenzyl alcohol spacers (Figure 1.17).145 In this design, selective 
removal of a terminal allyl-ether group initiated a sequence of 1,6-eliminations to 
degrade the dendrimer backbone and ultimately release a single 4-nitrophenol reporter 
molecule. Interestingly, the time required to achieve complete degradation displayed no 
generational dependence in DMF, indicating that the cleavage of the allyl trigger group 
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under these conditions was strongly rate limiting. The degradation of these dendrimers 
was significantly slower in THF and allowed for the tracking of intermediate phenoxide 
species that supported the degradation through a 1,6-elimination pathway, rather than 
simple cleavage of the ether linkages.  
 
Figure 1.17: 2nd generation linear disassembling dendrimer that degrades through a 
1,6-elimination pathway upon cleavage of a terminal allyl-ether to release a single 4-
nitrophenol reporter molecule  
This work was succeeded in the same year by the same group with an alternate dendritic 
design derived from 2,4-bis(hydroxymethyl)phenol spacers that permitted an amplified 
release of reporter molecules.148 Upon cleavage of the terminal allyl-ether group at the 
dendrimer focal point, this system degraded through a combination of 1,4- and 1,6-
eliminations to fragment the polymer backbone and release 4-nitrophenol molecules from 
the dendrimer periphery (Figure 1.18). Unlike the previous example in which only a 
single reporter molecule was liberated, this system released 4-nitrophenol molecules 
geometrically according to the following relation: 
 Number of molecules released = 2n (1.1) 
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where n is the dendrimer generation. This system was also subsequently modified with a 
photolabile 2-nitrobenzyl alcohol based triggering group to allow for phototriggered 
dendrimer degradation.149   
 
Figure 1.18: 2nd generation geometric disassembling dendrimer that degrades 
through a 1,4 and 1,6-elimination pathway upon cleavage of a terminal allyl-ether to 
release a four molecules of 4-nitrophenol 
The first self-immolative dendrimer reported by Shabat and coworkers in 2003 utilized a 
stable polycarbamate backbone derived from alternating 2,6-bis(hydroxymethyl)-4-cresol 
elimination and N,N’-dimethylethylenediamine cyclization spacers (Figure 1.19).146 
Using this system, 1st and 2nd generation dendrimers were synthesized with a photolabile 
2-nitrobenzyl alcohol trigger and were shown to degrade through a cascade of 
cyclization, 1,4-elimination, and decarboxylation reactions to ultimately release 
aminomethylpyrene reporter molecules from the dendrimer periphery following exposure 
to UV light.  Exploiting the dendritic potential for chemical amplification, this system 
released a geometrically amplified amount of reporter molecules in response to a single 
triggering event according to the relation described in Eq. (1.1). Additionally, the 
incorporation of cyclization spacers into the polymeric design allowed for higher degree 
of control over the degradation process, as the overall kinetics of degradation were 
dictated by the rate limiting cyclization reactions. Tracking the evolution of degradation 
products over time by HPLC verified the proposed mechanism of degradation, but also 
revealed two important aspects pertaining to the degradation of self-immolative 
dendrimers: (i) the overall time for degradation is dependent on the generation of the 
dendrimer; and (ii) terminal self-immolative cyclization reactions are independent of the 
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polymer size.   This system was extended to a third generation dendrimer, however, a 
smaller 4-nitroaniline reporter molecule had to be used, as steric crowding prevented the 
attachment of 8 aminomethylpyrene molecules.  
 
Figure 1.19: 2nd generation self-immolative polycarbamate dendrimer that degrades 
through a cascade of cyclization, 1,4-elimination, and decarboxylation reactions to 
release aminomethylpyrene upon exposure to UV light 
The 2003 report on self-immolative dendrimers by de Groot and coworkers was the first 
system to explicitly demonstrate the amplified release of actual drug molecules from a 
self-immolative dendritic device.147 Using a polycarbamate system derived from 
branched 2-(4-aminobenzylidene)propane-1,3-diol spacers, de Groot and coworkers were 
able to construct dendrimers up to the 2nd generation with an oxidized aniline trigger and 
releasable units of the anticancer drug paclitaxel on the dendrimer periphery (Figure 
1.20). Since each branched monomer unit was designed to undergo two 1,8-eliminations, 
the entire dendrimer backbone was degraded through a cascade of 1,8-elimination and 
decarboxylation reactions to release 4 molecules of paclitaxel following reduction of the 
terminal nitro-group. Kinetic evaluation of these devices was rather limited, but indicated 
a complete release of paclitaxel after 30 minutes in organic solution. Subsequent 
cytotoxicity testing of the 2-(4-aminobenzylidene)propane-1,3-diol degradation product 
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using human cell lines also revealed that the dendrimer backbone displayed negligible 
adverse effects following degradation. Hence, this dendritic prodrug system was shown 
to be an effective and viable means of amplified paclitaxel release.  
 
Figure 1.20: 2nd generation polycarbamate dendrimer derived from branched 2-(4-
aminobenzylidene)propane-1,3-diol spacers and designed to degrade through a 
cascade of 1,8-elimination reactions 
Most of the work in the field of self-immolative dendrimers following the seminal reports 
has focused on expanding the utility of these systems by improving the initial designs. 
McGrath and coworkers have since reported an improved synthesis for their initial linear 
diassembling dendrimer design that enables the synthesis of 1st, 2nd, and 3rd generation 
dendrimers on a multigram scale.150 They have also reported a convergent synthesis of 
their geometrically disassembling dendrimer through a copper-mediated coupling 
reaction that avoids exposure of an active phenol and prevents issues associated with 
premature degradation during the synthetic procedure.151  
Shabat and coworkers have been monumental in the development and expansion of self-
immolative dendrimers for a wide variety of different drug delivery126,141,152-158 and 
sensing159-166 applications. In the field of drug delivery, the Shabat group has developed 
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self-immolative dendrimer systems incorporating PGA and catalytic antibody (Ab) 38C2 
sensitive triggers for both mono126,152,155,156,158 and combination153 therapeutic strategies. In 
the field of signal amplification, the Shabat group has developed probes for the detection 
of enzymes167, hydrogen peroxide161-163, triacetyl triperoxide160, fluoride anions165, and 
sulfhydryl compounds.164 The predominant majority of these systems are based on simple 
variants of the initial dendrimer backbones discussed above but arranged into one of three 
design categories: the simple amplifier, the molecular OR logic trigger, or the receiver 
amplifier design (Figure 1.21).  
 
Figure 1.21: Schematic representation of all currently available dendrimer designs. 
(a) Basic amplifier in which one triggering event leads to release of multiple 
reporter molecules. (b) Molecular OR logic trigger in which cleavage of one of two 
different triggers leads to the release of multiple reporter molecules. (c) Receiver-
amplifier design with high sensitivity and gain whereby a low-level signal can be 
detected and amplified through the release of multiple reporter molecules. Adapted 
with permission from Wong et al.80 Copyright 2012 Elsevier.  
The most promising strategy developed by the Shabat group involves a series of 
dendrimer-based probes capable of exponential signal amplification through a semi-
autocatalytic effect referred to as the “dendritic chain reaction (DCR)”.161-164,166 The first 
reported system to exploit this effect was derived from a 1st generation dendrimer with 
two bound molecules of choline, a single 4-nitroaniline reporter molecule and a H2O2 
sensitive phenylboronic acid triggering group (Figure 1.22). Exposure of this system to 
low levels of H2O2 triggered the degradation of a portion of these dendrimers, resulting in 
the release of 4-nitroaniline and two molecules of choline. In turn, the released choline 
molecules reacted with choline oxidase in situ to generate 4 molecules of H2O2 capable of 
activating an additional 4 dendrimer molecules.  In theory, a single molecule of H2O2 
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could initiate the dendritic chain reaction and ultimately catalyze the release of all the 
bound reporter groups in solution. However, this system only resulted in a 53–fold 
increase in signal amplification through the dendritic chain reaction. This potentially 
exponential amplification has been further improved through a slight modification to use 
releasable molecules of methanol in conjunction with alcohol oxidase to improve the 
stability of carbonate linkages in the dendritic design and reduce background signal 
amplification.166 Upon further improvements to reduce background signal generation, it is 
presumable that this dendritic chain reaction will offer a practical means for diagnostic 
signal amplification comparable to that of the immuno-polymerase chain reaction. 
 
Figure 1.22: Dendrimer system capable of exponential signal amplification through 
the dendritic chain reaction. Cleavage of the phenylboronic acid triggering group by 
H2O2 leads to the liberation of a 4-nitroaniline reporter and two molecules of 
choline, which in turn generate four additional molecules of H2O2 upon reaction 
with choline oxidase.  
1.4.4 Linear Self-Immolative Polymers 
Self-immolative oligomeric and dendritic frameworks lend themselves well towards 
simple adaptations of existing prodrug chemistries. The main issue associated with these 
designs, however, is the lengthy stepwise iterative procedures required to generate high 
molecular weight species. Consequently, the next logical step in the evolution of self-
immolative materials was to adapt self-immolative chemistry to allow for polymerization 
of simple monomeric units.  Although linear self-immolative polymers are no longer 
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monodisperse, they can be synthesized in a single step and allow for a practical and 
scalable means of generating self-immolative polymers. Additionally, these polymers 
possess an inherent capability for a higher degree of signal amplification compared to 
oligomeric or dendritic designs since they can incorporate more spacers while bypassing 
any steric constraints. Such linear systems also display a potential to generate self-
immolative drug delivery vehicles through the generation of micelles, vesicles, and 
nanoparticles.  
 
Figure 1.23: Linear self-immolative polymer that degrades through a cascade of 1,6-
elimination/decarboxylation reactions in the presence of BSA to release fluorescent 
monomer units and a terminal 4-nitroaniline reporter molecule (n=16).  
The first linear self-immolative polymer system was reported by Shabat and coworkers in 
2008.168 This system was derived from monomeric units of 4-aminobenzylalcohol 
derivatives terminated with a blocked isocyanate, phenyl carbamate moiety.  
Polymerization of this monomer was carried out at elevated temperatures in the presence 
of catalytic dibutyltin dilaurate (DBTL) to promote nucleophilic attack of the benzylic 
alcohol on the terminal blocked isocyanate. Addition of 4-nitrophenyl isocyanate during 
polymerization and a BSA sensitive trigger-alcohol complex following polymerization 
allowed for the incorporation of a terminal reporter and end-cap into the polymer 
framework (Figure 1.23). Following cleavage of the end-cap in the presence of BSA, this 
polymer was shown to degrade through a cascade of 1,6-elimination/decarboxylation 
reactions to release fluorescent monomer units and liberate a 4-nitroaniline reporter 
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molecule. With an average chain length of 16 units, this polymer displayed the promising 
potential of linear self-immolative polymers for heightened signal amplification. This 
same polymer backbone was later used by the same group for activity-linked labeling of 
enzymes169, while subsequent modifications allowed for the development of a water 
soluble variant capable of releasing pendent 4-nitroaniline reporters through an additional  
1,6-elimination-decarboxylation reaction at vinylogous 2-benzyl positions (Figure 
1.24).170  
 
Figure 1.24: Linear self-immolative polymer that degrades through 1,6-
elimination/decarboxylation reactions in the presence of PGA in aqueous solution. 
Liberation of 4-nitroaniline molecules occurs following main chain degradation via 
a 1,6-elimination/decarboxylation reaction at a vinylogous 2-benzyl position on a 
released monomer unit.  
This basic polycarbamate backbone was further developed in 2010 by Moore and 
coworkers to allow for the generation of self-immolative microcapsules.171 Fabrication of 
these microcapsules was accomplished using a 4-aminobenzyl alcohol derivative that 
permitted crosslinking of the linear polymers through an interfacial polymerization 
method. Selective removal of Boc or fluorenylmethyloxycarbonyl (Fmoc) end-capping 
agents triggered the degradation of the polymer backbone and promoted the release of the 
microcapsule contents through ruptures in the capsule shell wall (Figure 1.25). Due to 
aqueous insolubility of the polymer backbone, it was suggested that these microcapsules 
may be useful for self-healing autonomous repair systems, rather than for drug delivery 
applications.  
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Figure 1.25: Design of self-immolative microcapsules for self-healing autonomous 
repair systems. Selective removal of Boc and Fmoc end-caps triggers the 
degradation of the polycarbamate backbone through a cascade of 1,6-
elimination/decarboxylation reactions to promote the release of the microcapsule 
contents through ruptures in the shell wall. Adapted with permission from Esser-
Kahn et al.171 Copyright 2010 American Chemical Society. 
In recent years, poly(phthaldehyde) (PPA) based systems have also been developed for a 
variety of self-immolative applications. These linear self-immolative systems are 
fundamentally different than those based on 4-aminobenzyl alcohol derivatives as they 
rely on the low ceiling temperature (temperature at which polymerization and 
depolymerization are in equilibrium) of polyaldehydes to achieve depolymerization 
through hemiacetal decompositions.172 Through careful design, however, these systems 
can be end-capped with a stimuli-responsive agent that stabilizes the polymer above its 
ceiling temperature and permits triggered degradation through a self-immolative pathway 
involving a cascade of 1,2-hemiacetal eliminations. The first reported self-immolative 
PPA system was designed by Phillips and coworkers in 2010.173 Using allyloxycarbonyl 
(Alloc) and tert-butyldimethylsilyl (TBS) end-capped PPAs, they were able to create 
stimuli-responsive plastics that were sensitive to Pd(0) and F-, respectively (Figure 
25 
 
1.26a). Similar to the 4-aminobenzyl alcohol polymers, these PPAs displayed rapid 
solution phase degradation kinetics.  Exposure of the Alloc end-capped polymer to 0.40 
equivalents of Pd(0) resulted in complete depolymerization within 5 minutes, while 
exposure of the TBS end-capped polymer to 0.5 equivalents of F- caused complete 
depolymerization within 1 minute. With a clever application of these polymers, Phillips 
and coworkers were able to fabricate patterned plastics that changed their physical 
structure in response to an applied stimulus by depositing a non-degradable PPA around a 
stimuli-responsive one in a plastic sheet (Figure 1.26b). In a subsequent report, Phillips 
and coworkers were also able generate self-powered microscale pumps by depositing a 
thin-film of the TBS end-capped PPA on a microscale slide.173 
 
Figure 1.26: (a) First reported self-immolative poly(phthaldehyde)s that 
depolymerize through a cascade of 1,2-hemiacetal eliminations following end-cap 
removal. (b) Fabrication of a patterned plastic using a self-immolative 
poly(phthaldehyde).  
Since the initial reports, the focus in the development of self-immolative PPAs has 
shifted towards improving the design and synthesis of these polymers. Kaitz and Moore 
addressed the lack of functional monomer diversity through a copolymerization of ortho-
phthalaldehyde with substituted benzaldehydes (Figure 1.27a).174 In addition to 
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overcoming the thermodynamic barriers required for copolymerization, this revised 
synthesis reduced the polymerization time from 72 h to 4-6 h and allowed for the 
formation of functionalized PPAs through post-polymerization modifications. Phillips 
and coworkers have also further improved their initial design by developing a generalized 
procedure for the synthesis of PPAs that is: (i) reproducible and scalable; (ii) requires 4 h 
to complete; (iii) allows for end-caps to be appended to either side of the polymer; and 
(iv) provides a high-degree of control over the molecular weight (Figure 1.27b).175 
Phillips and coworkers subsequently expanded the utility of these polymers by 
fabricating stimuli-responsive core-shell PPA microcapsules using a flow-focusing 
microfluidics technique.176  
 
Figure 1.27: Recent improvements to the design and synthesis of self-immolative 
poly(phthaldehyde)s. (a) Copolymerization of ortho-phthalaldehyde with 
substituted benzaldehydes to allow for the formation of functionalized PPAs. (b) 
Generalized procedure for the synthesis of PPAs with two stimuli-responsive end-
caps appended to both ends of the polymer.  
Despite the proven utility of linear self-immolative polymers derived from PABC and 
PPA systems, the rapid degradation kinetics associated with 1,2 and 1,6-eliminations 
restricts the use of such polymers for applications involving controlled degradation at a 
slower rate. In general, PABC and PPA based systems display rapid solution phase 
degradation kinetics and depolymerize over the span of several minutes. Gillies and 
coworkers have addressed this limitation in degradation kinetics over the past 5 years 
through the design and synthesis of new linear self-immolative polymer backbones 
involving cyclization spacers. In 2009, DeWit and Gillies reported the first of such 
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designs with a linear self-immolative polymer backbone derived from alternating 1,6-
elimination and cyclization spacers.177 This system was based on a monomer comprised 
of 4-hydroxybenzyl alcohol and N,N’-dimethylethylenediamine units and was 
synthesized through a step-growth polycondensation reaction.  Selective removal of a 
Boc end-cap initiated a cascade of cyclization, 1,6-elimination, and decarboxylation 
reactions that ultimately led to complete depolymerization of the polymer over 7 days in 
a 3:2 pH 7.4 buffer:acetone mixture at 37˚C (Figure 1.28a). Subsequent modifications to 
the nucleophilic and electrophilic sites in the cyclization spacer enabled tuning of the 
degradation rate in this system to reduce the time required to achieve complete 
depolymerization.120 Enhancing the electrophilic character of the active carbonyl using a 
N-methylaminoethanol spacer reduced the degradation time to 4 hours (Figure 1.28b), 
while further enhancing the strength of the nucleophile using a 2-mercaptoethanol spacer 
reduced the degradation time to 2 hours (Figure 1.28c).  
 
Figure 1.28: Linear self-immolative polymer backbones derived from alternating 1,6 
elimination and cyclization spacers and their degradation kinetics in 3:2 pH 7.4 
phosphate buffer:acetone at 37˚C. Reprinted with permission from Chen et al. 
Copyright 2012 American Chemical Society.  
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Using different cyclization polymer frameworks, the degradation rate of linear self-
immolative polymers can also be further tuned in either direction. In 2010, Gillies and 
coworkers reported the design of a reduction sensitive, purely cyclization based polymer 
derived from alternating 2-mercaptoethanol and N,N’-dimethylethylenediamine spacers 
(Figure 1.29). Selective cleavage of the terminal thiopyridyl end-cap under reducing 
conditions initiated a cascade of cyclization reactions that ultimately led to 
depolymerization of the polymer over 2 weeks in a 3:2 pH 7.4 buffer:acetone mixture at 
37˚C. 178 The design of a purely cyclization based polymer was motivated by the 
potential toxicity of the quinone methide species released during the degradation of 1,6-
elimination based systems. However, the major limitation of this design was the tendency 
of the system to form cyclic oligomers during polymerization that were not prone to 
degradation under reducing conditions.  
 
Figure 1.29: Reduction sensitive linear self-immolative polymer derived from 
alternating 2-mercaptoethanol and N,N’-dimethylethylenediamine cyclization 
spacers.  
In an attempt to further bridge the gap between elimination and cyclization based 
polymers, DeWit and Gillies have also designed a series of 4-aminobutyric acid spacers 
that display rapid cyclization kinetics.179 It was demonstrated that the kinetics of these 4-
aminobutyric acid compounds display a remarkable substituent dependency, with 
cyclization half-lives varying between 2 and 39 s at physiological temperature and pH 
(Figure 1.30a). The incorporation of these spacers into polymer frameworks based on 
alternating cyclization/elimination or pure cyclization systems has been investigated, but 
the polymerization conditions required have yet to be optimized (Figure 1.30b-c).180 
Upon successful optimization of these systems, it is expected that a linear self-
immolative system involving cyclization spacers can be used in applications requiring 
depolymerization times on the order of several minutes to several weeks.  
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Figure 1.30: (a) 4-aminobutyric acid spacers that display rapid cyclization kinetics 
and their subsequent incorporation into linear self-immolative polymer frameworks 
based on (b) alternating cyclization/elimination reactions and (c) alternating 
cyclization reactions. 
Due to their longer timescales of degradation, linear self-immolative polymers involving 
cyclization spacers are ideal candidates for controlled release applications. DeWit and 
Gillies have explored this potential using their initial system derived from 4-
hydroxybenzyl alcohol and N,N’-dimethylethylenediamine to design a self-immolative 
amphiphilic block copolymer (Figure 1.31).177 This polymeric system was synthesized 
with a modified PEG end-cap possessing a hydrolytically sensitive ester linkage between 
the hydrophilic PEG block and hydrophobic polycarbamate backbone. When subjected to 
aqueous conditions, this system self-assembled into micelles capable of encapsulating 
hydrophobic molecules. As a proof of concept, this system was able to provide a 
controlled release of a model hydrophobic drug, nile red, over a period of approximately 
15 days in aqueous solution. Almutairi and coworkers have recently adopted an alternate 
approach to generate nanoparticles using the same self-immolative polycarbamate 
backbone with UV and NIR sensitive end-caps.181 Using an emulsion method, they were 
able to generate hydrophobic nanoparticles capable of encapsulating nile red. However, 
when exposed to UV/NIR light, these nanoparticles displayed a burst release profile that 
is unsuited for prolonged release applications. Subsequent cytotoxicity testing of this 
system and its degradation products revealed that is equally as well tolerated as 
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poly(lactic-co-glycolic acid), which is currently approved by the FDA for biomedical 
applications.181 As such, this polymer system displays immense promise for the 
fabrication of functional drug delivery vehicles, despite the limited work conducted in the 
field.  
 
Figure 1.31: Design of a self-immolative block copolymer micellular drug delivery 
vehicle. (a) General structure of the self-immolative polymer backbone based on 
alternating 1,6-elimination and cyclization spacers and the hydrolytically sensitive 
PEG end-cap. (b) Structure and the degradation of micellular drug delivery vehicle.  
1.5 Scope of the Thesis 
The work described in this thesis focuses on two currently underexplored areas in the 
field of linear self-immolative polymers: degradation kinetics and functional designs. 
Chapter 2 of this thesis offers a theoretical and experimental evaluation of the kinetics of 
self-immolative degradation in a linear polymeric system. This section is geared towards 
developing and validating a theoretical model to explain the observed degradation 
behaviour in systems involving cyclization spacers. Overall, the goal of this section is to 
prove the proportional relationship between chain length and the degradation time while 
demonstrating chain length as a functional means to control the depolymerization time in 
linear self-immolative systems.     
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Chapter 3 focuses on the controlled design of linear self-immolative block copolymer 
nanoparticles for drug delivery applications. Expanding on the initial work conducted by 
DeWit and Gillies in 2009, this section first explores the potential to form alternate self-
assemblies by varying the fraction of the hydrophilic PEG chain in the previously 
reported PEG-self-immolative copolymer system.177 This chapter also describes the 
design and synthesis of a redox sensitive PEG-self-immolative block copolymer using a 
new modular approach to conjugate the PEG and self-immolative blocks. Preliminary 
evaluation of the degradation kinetics and self-assembly characteristics associated with 
this copolymer are also presented throughout this chapter.  
The work described in this thesis involves the use of the previously reported linear self-
immolative polymer system derived from alternating 4-hydroxybenzyl alcohol and N,N’-
dimethylethylenediamine spacers. Practical considerations associated with the 
reproducibility, scale-up, and purification of this system are presented throughout with a 
focus on improving the utility of this system for further development and future 
applications.  
1.6 References 
(1) Tschan, M. J. L.; Brulé, E.; Haquette, P.; Thomas, C. M. Polym. Chem. 2012, 3, 
836. 
(2) Tian, H.; Tang, Z.; Zhuang, X.; Chen, X.; Jing, X. Prog. Polym. Sci. 2012, 37, 
237. 
(3) Amass, W.; Amass, A.; Tighe, B. Polym. Int. 1998, 47, 89. 
(4) Gross, R. A.; Kalra, B. Science 2002, 297, 803. 
(5) Gupta, A. P.; Kumar, V. Eur. Polym. J. 2007, 43, 4053. 
(6) Nair, L. S.; Laurencin, C. T. Prog. Polym. Sci. 2007, 32, 762. 
(7) Shi, B.; Topolkaraev, V.; Wang, J. In Renewable and Sustainable Polymers; 
Payne, G. F., Smith, P. B., Eds.; Amer Chemical Soc: Washington, 2011; Vol. 1063, p 
117. 
(8) Mecking, S. Angew. Chem. Int. Ed. 2004, 43, 1078. 
32 
 
(9) Sisson, A. L.; Schroeter, M.; Lendlein, A. In Handbook of Biodegradable 
Polymers; Wiley-VCH Verlag GmbH & Co. KGaA: 2011, p 1. 
(10) Gilding, D. K.; Reed, A. M. Polymer 1979, 20. 
(11) Reed, A. M.; Gilding, D. K. Polymer 1981, 22, 494. 
(12) Li, Y.; Thouas, G. A.; Chen, Q.-Z. RSC Advances 2012, 2, 8229. 
(13) Langer, R.; Vacanti, J. Science 1993, 260, 920. 
(14) Jeong, B.; Bae, Y. H.; Lee, D. S.; Kim, S. W. Nature 1997, 388. 
(15) Uhrich, K. E.; Cannizzaro, S. M.; Langer, R. S.; Shakesheff, K. M. Chemical 
Reviews 1999, 99, 3181. 
(16) Kataoka, K.; Harada, A.; Nagasaki, Y. Adv. Drug Delivery Rev. 2001, 47, 113. 
(17) Yih, T. C.; Al-Fandi, M. J. Cell. Biochem. 2006, 97, 1184. 
(18) Kumari, A.; Yadav, S. K.; Yadav, S. C. Colloids and Surfaces B: Biointerfaces 
2010, 75, 1. 
(19) Carothers, W. H.; Dorough, G. L.; Van Natta, F. J. J. Am. Chem. Soc. 1932, 54, 
761. 
(20) Ihre, H.; Hult, A.; Soderlind, E. J. Am. Chem. Soc. 1996, 118, 6388. 
(21) Ihre, H.; Hult, A.; Fréchet, J. M. J.; Gitsov, I. Macromolecules 1998, 31, 4061. 
(22) Ihre, H.; Padilla De Jesús, O. L.; Fréchet, J. M. J. J. Am. Chem. Soc. 2001, 123, 
5908. 
(23) Vögtle, F.; Richardt, G.; Werner, N. In Dendrimer Chemistry; Wiley-VCH Verlag 
GmbH & Co. KGaA: 2009, p 1. 
(24) Tomalia, D. A.; Fréchet, J. M. J. In Dendrimers and Other Dendritic Polymers; 
John Wiley & Sons, Ltd: 2002, p 1. 
(25) Gillies, E. R.; Fréchet, J. M. J. J. Am. Chem. Soc. 2002, 124, 14137. 
(26) Ihre, H. R.; Padilla De Jesús, O. L.; Szoka, F. C.; Fréchet, J. M. J. Bioconjugate 
Chem. 2002, 13, 443. 
(27) Padilla De Jesús, O. L.; Ihre, H. R.; Gagne, L.; Fréchet, J. M. J.; Szoka, F. C. 
Bioconjugate Chem. 2002, 13, 453. 
(28) Gillies, E. R.; Jonsson, T. B.; Fréchet, J. M. J. J. Am. Chem. Soc. 2004, 126, 
11936. 
33 
 
(29) Gillies, E. R.; Fréchet, J. M. J. Drug Discovery Today 2005, 10, 35. 
(30) Carlmark, A.; Malmström, E.; Malkoch, M. Chem. Soc. Rev. 2013. 
(31) Mikhail, A. S.; Allen, C. J. Controlled Release 2009, 138, 214. 
(32) Kataoka, K.; Harada, A.; Nagasaki, Y. Adv. Drug Delivery Rev. 2012, 64, 37. 
(33) Christian, D. A.; Cai, S.; Bowen, D. M.; Kim, Y.; Pajerowski, J. D.; Discher, D. 
E. European Journal of Pharmaceutics and Biopharmaceutics 2009, 71, 463. 
(34) Tanner, P.; Baumann, P.; Enea, R.; Onaca, O.; Palivan, C.; Meier, W. Acc. Chem. 
Res. 2011, 44, 1039. 
(35) Mai, Y.; Eisenberg, A. Chem. Soc. Rev. 2012, 41, 5969. 
(36) Saltzman, W. M. Drug Delivery : Engineering Principles for Drug Therapy: 
Engineering Principles for Drug Therapy; Oxford University Press, 2001. 
(37) Jain, R.; Shah, N. H.; Malick, A. W.; Rhodes, C. T. Drug Dev. Ind. Pharm. 1998, 
48, 703. 
(38) Aliabadi, H. M.; Lavasanifar, A. Expert Opinion on Drug Delivery 2006, 3, 139. 
(39) Zhang, J.; Li, S.; Li, X. Recent Pat. Nanotechnol. 2009, 3, 225. 
(40) Li, G.; Liu, J.; Pang, Y.; Wang, R.; Mao, L.; Yan, D.; Zhu, X.; Sun, J. 
Biomacromolecules 2011, 12, 2016. 
(41) Miyata, K.; Christie, R. J.; Kataoka, K. Reactive and Functional Polymers 2011, 
71, 227. 
(42) Vert, M. Biomacromolecules 2005, 6, 538. 
(43) Hofmann, D.; Entrialgo-Castaño, M.; Kratz, K.; Lendlein, A. Advanced Materials 
2009, 21, 3237. 
(44) Rahman, M. In Degradation of Polyesters in Medical Applications; Saleh, H. E.-
D., Ed. 2012. 
(45) Van Damme, H.; Deprez, M.; Creemers, E.; Limet, R. Acta chirurgica Belgica 
2005, 105, 249. 
(46) Esser-Kahn, A. P.; Odom, S. A.; Sottos, N. R.; White, S. R.; Moore, J. S. 
Macromolecules 2011, 44, 5539. 
(47) Morachis, J. M.; Mahmoud, E. A.; Almutairi, A. Pharmacological Reviews 2012, 
64, 505. 
34 
 
(48) Wei, H.; Zhuo, R.-X.; Zhang, X.-Z. Prog. Polym. Sci. 2012, 38, 503. 
(49) Karton-Lifshin, N.; Vogel, U.; Sella, E.; Seeberger, P. H.; Shabat, D.; Lepenies, 
B. Org. Biomol. Chem. 2013, 11, 2903. 
(50) Wu, Q.; Wang, L.; Yu, H.; Wang, J.; Chen, Z. Chemical Reviews 2011, 111, 
7855. 
(51) de Gracia Lux, C.; Joshi-Barr, S.; Nguyen, T.; Mahmoud, E.; Schopf, E.; Fomina, 
N.; Almutairi, A. J. Am. Chem. Soc. 2012, 134, 15758. 
(52) Binauld, S.; Stenzel, M. H. Chem. Commun. 2013, 49, 2082. 
(53) Zhao, C.; Nie, S.; Tang, M.; Sun, S. Prog. Polym. Sci. 2011, 36, 1499. 
(54) Park, I.-K.; Singha, K.; Arote, R. B.; Choi, Y.-J.; Kim, W. J.; Cho, C.-S. 
Macromol. Rapid Commun. 2010, 31, 1122. 
(55) Gao, W.; Chan, J. M.; Farokhzad, O. C. Mol. Pharm. 2010, 7, 1913. 
(56) Dai, S.; Ravi, P.; Tam, K. C. Soft Matter 2008, 4, 435. 
(57) Jain, R.; Standley, S. M.; Fréchet, J. M. J. Macromolecules 2007, 40, 452. 
(58) Heffernan, M. J.; Murthy, N. Bioconjugate Chem. 2005, 16, 1340. 
(59) Bang, E.-K.; Lista, M.; Sforazzini, G.; Sakai, N.; Matile, S. Chem. Sci. 2012, 3, 
1752. 
(60) Ko, N. R.; Yao, K.; Tang, C.; Oh, J. K. J. Polym. Sci. A Polym. Chem. 2012, n/a. 
(61) Bauhuber, S.; Hozsa, C.; Breunig, M.; Göpferich, A. Advanced Materials 2009, 
21, 3286. 
(62) Emilitri, E.; Ranucci, E.; Ferruti, P. J. Polym. Sci. A Polym. Chem. 2005, 43, 
1404. 
(63) Meng, F.; Hennink, W. E.; Zhong, Z. Biomaterials 2009, 30, 2180. 
(64) Wang, Y.-J. P. Y.-Y. C. D.-R. W. C. W. J. G. D.-R. L. C.-C. C. C.-C.; Chen, Y.-
Y.; Wang, D.-R.; Wei, C.; Guo, J.; Lu, D.-R.; Chu, C.-C.; Wang, C.-C. Biomaterials 
2012, 33, 6570. 
(65) Zhao, H.; Sterner, E. S.; Coughlin, E. B.; Theato, P. Macromolecules 2012, 45, 
1723. 
(66) Fomina, N.; Sankaranarayanan, J.; Almutairi, A. Adv. Drug Delivery Rev. 2012, 
64, 1005. 
35 
 
(67) Griffin, D. R.; Schlosser, J. L.; Lam, S. F.; Nguyen, T. H.; Maynard, H. D.; 
Kasko, A. M. Biomacromolecules 2013, 14, 1199. 
(68) Han, D.; Tong, X.; Zhao, Y. Macromolecules 2011, 44, 437. 
(69) Johnson, J. A.; Finn, M. G.; Koberstein, J. T.; Turro, N. J. Macromolecules 2007, 
40, 3589. 
(70) Lv, C.; Wang, Z.; Wang, P.; Tang, X. International Journal of Molecular 
Sciences 2012, 13, 16387. 
(71) Nazemi, A.; Schon, T. B.; Gillies, E. R. Org. Lett. 2013, 15, 1830. 
(72) Pasparakis, G.; Manouras, T.; Argitis, P.; Vamvakaki, M. Macromol. Rapid 
Commun. 2011, 33, 183. 
(73) Furuta, T.; Wang, S. S.; Dantzker, J. L.; Dore, T. M.; Bybee, W. J.; Callaway, E. 
M.; Denk, W.; Tsien, R. Y. Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 1193. 
(74) Fomina, N.; McFearin, C. L.; Almutairi, A. Chem. Commun. 2012, 48, 9138. 
(75) Goodwin, A. P.; Mynar, J. L.; Ma, Y.; Fleming, G. R.; Fréchet, J. M. J. J. Am. 
Chem. Soc. 2005, 127, 9952. 
(76) Hagen, V.; Kilic, F.; Schaal, J.; Dekowski, B.; Schmidt, R.; Kotzur, N. J. Org. 
Chem. 2010, 75, 2790. 
(77) Mynar, J. L.; Goodwin, A. P.; Cohen, J. A.; Ma, Y.; Fleming, G. R.; Fr chet, J. M. 
J. Chem. Commun. 2007, 2081. 
(78) Sun, L.; Yang, Y.; Dong, C.-M.; Wei, Y. Small 2010, 7, 401. 
(79) Blencowe, C. A.; Russell, A. T.; Greco, F.; Hayes, W.; Thornthwaite, D. W. 
Polym. Chem. 2011, 2, 773. 
(80) Wong, A. D.; DeWit, M. A.; Gillies, E. R. Adv. Drug Delivery Rev. 2012, 64, 
1031. 
(81) Peterson, G. I.; Larsen, M. B.; Boydston, A. J. Macromolecules 2012, 45, 7317. 
(82) Carl, P. L.; Chakravarty, P. K.; Katzenellenbogen, J. A. J. Med. Chem. 1981, 24, 
479. 
(83) Skwarczynski, M.; Hayashi, Y.; Kiso, Y. J. Med. Chem. 2006, 49, 7253. 
(84) Rautio, J.; Kumpulainen, H.; Heimbach, T.; Oliyai, R.; Oh, D.; Järvinen, T.; 
Savolainen, J. Nat. Rev. Drug Discovery 2008, 7, 255. 
(85) Duncan, R. Nat. Rev. Cancer 2006, 6, 688. 
36 
 
(86) Madec-Lougerstay, R.; Florent, J.-C.; Monneret, C. J. Chem. Soc., Perkin Trans. 
1 1999, 1369. 
(87) Leenders, R. G.; Damen, E. W.; Bijsterveld, E. J.; Scheeren, H. W.; Houba, P. H.; 
van der Meulen-Muileman, I. H.; Boven, E.; Haisma, H. J. Bioorg. Med. Chem. 1999, 7, 
1597. 
(88) Dubowchik, G. M.; Firestone, R. A. Bioorg. Med. Chem. Lett. 1998, 8, 3341. 
(89) Chakravarty, P. K.; Carl, P. L.; Weber, M. J.; Katzenellenbogen, J. A. J. Med. 
Chem. 1983, 26, 638. 
(90) de Groot, F. M. H.; de Bart, A. C. W.; Verheijen, J. H.; Scheeren, H. W. J. Med. 
Chem. 1999, 42, 5277. 
(91) Tranoy-Opalinski, I.; Fernandes, A.; Thomas, M.; Gesson, J. P.; Papot, S. Anti-
Cancer Agents Med. Chem. 2008, 8, 618. 
(92) Kratz, F.; Müller, I. A.; Ryppa, C.; Warnecke, A. ChemMedChem 2008, 3, 20. 
(93) Corre, G. E.; Guibe-Jampel, E.; Wakselman, M. Tetrahedron 1978, 34, 3105. 
(94) Senter, P. D.; Pearce, W. E.; Greenfield, R. S. J. Org. Chem. 1990, 55, 2975. 
(95) Wakselman, M. Nouv. J. Chem. 1983, 7, 439. 
(96) Andrianomenjanahary, S.; Dong, X.; Florent, J. C.; Gaudel, G.; Gesson, J. P.; 
Jacquesy, J. C.; Koch, M.; Michel, S.; Mondon, M.; Monneret, C.; Petit, P.; Renoux, B.; 
Tillequin, F. Bioorg. Med. Chem. Lett. 1992, 2, 1093. 
(97) Ghosh, A. K.; Khan, S.; Farquhar, D. Chem. Commun. 1999, 2527. 
(98) Jobron, L.; Hindsgaul, O. J. Am. Chem. Soc. 1999, 121, 5835. 
(99) Niculescu-Duvaz, D.; Niculescu-Duvaz, I.; Friedlos, F.; Martin, J.; Lehouritis, P.; 
Marais, R.; Springer, C. J. J. Med. Chem. 2003, 46, 1690. 
(100) Rivault, F. Bioorg. Med. Chem. 2004, 12, 675. 
(101) Erez, R.; Shabat, D. Org. Biomol. Chem. 2008, 6, 2669. 
(102) Perry-Feigenbaum, R.; Baran, P. S.; Shabat, D. Org. Biomol. Chem. 2009, 7, 
4825. 
(103) Jourden, J. L. M.; Daniel, K. B.; Cohen, S. M. Chem. Commun. 2011, 47, 7968. 
(104) Renoux, B.; Legigan, T.; Bensalma, S.; Chadéneau, C.; Muller, J.-M.; Papot, S. 
Org. Biomol. Chem. 2011, 9, 8459. 
37 
 
(105) Broaders, K. E.; Grandhe, S.; Fréchet, J. M. J. J. Am. Chem. Soc. 2011, 133, 756. 
(106) Nuñez, S. A.; Yeung, K.; Fox, N. S.; Phillips, S. T. J. Org. Chem. 2011, 76, 
10099. 
(107) Schmid, K. M.; Jensen, L.; Phillips, S. T. J. Org. Chem. 2012, 77, 4363. 
(108) Labruère, R.; Alouane, A.; Le Saux, T.; Aujard, I.; Pelupessy, P.; Gautier, A.; 
Dubruille, S.; Schmidt, F.; Jullien, L. Angew. Chem. Int. Ed. 2012, 51, 9344. 
(109) Hay, M. P.; Anderson, R. F.; Ferry, D. M.; Wilson, W. R.; Denny, W. A. J. Med. 
Chem. 2003, 46, 5533. 
(110) Cain, B. F. J. Org. Chem. 1976, 41, 2029. 
(111) Johnson, C. D.; Lane, S. J. Org. Chem. 1988, 53, 5130. 
(112) Amsberry, K. L.; Gerstenberger, A. E.; Borchardt, R. T. Pharm. Res. 1991, 8, 
455. 
(113) Amsberry, K. L.; Borchardt, R. T. Pharm. Res. 1991, 8, 323. 
(114) Amsberry, K. L.; Borchardt, R. T. J. Org. Chem. 1990, 55, 5867. 
(115) Wang, B.; Zhang, H.; Zheng, A.; Wang, W. Bioorg. Med. Chem. 1998, 6, 417. 
(116) Wang, B.; Zhang, H.; Wang, W. Bioorg. Med. Chem. Lett. 1996, 6, 945. 
(117) Saari, W. S.; Schwering, J. E.; Lyle, P. A.; Smith, S. J.; Engelhardt, E. L. J. Med. 
Chem. 1990, 33, 97. 
(118) Saari, W. S.; Schwering, J. E.; Lyle, P. A.; Smith, S. J.; Engelhardt, E. L. J. Med. 
Chem. 1990, 33, 2590. 
(119) Meyer, Y.; Richard, J.-A.; Massonneau, M.; Renard, P.-Y.; Romieu, A. Org. Lett. 
2008, 10, 1517. 
(120) Chen, E. K. Y.; McBride, R. A.; Gillies, E. R. Macromolecules 2012, 45, 7364. 
(121) Schuster, H. J.; Krewer, B.; von Hof, J. M.; Schmuck, K.; Schuberth, I.; Alves, F.; 
Tietze, L. F. Org. Biomol. Chem. 2010, 8, 1833. 
(122) El Alaoui, A.; Schmidt, F.; Monneret, C.; Florent, J.-C. J. Org. Chem. 2006, 71, 
9628. 
(123) El Alaoui, A.; Schmidt, F.; Amessou, M.; Sarr, M.; Decaudin, D.; Florent, J.-C.; 
Johannes, L. Angew. Chem. Int. Ed. 2007, 46, 6469. 
38 
 
(124) Shabat, D.; Lode, H. N.; Pertl, U.; Reisfeld, R. A.; Rader, C.; Lerner, R. A.; 
Barbas III, C. F. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 7528. 
(125) Pessah, N.; Reznik, M.; Shamis, M.; Yantiri, F.; Xin, H.; Bowdish, K.; Shomron, 
N.; Ast, G.; Shabat, D. Bioorg. Med. Chem. 2004, 12, 1859. 
(126) Amir, R. J.; Popkov, M.; Lerner, R. A.; Barbas, C. F.; Shabat, D. Angew. Chem. 
Int. Ed. 2005, 44, 4378. 
(127) Thorn-Seshold, O.; Vargas-Sanchez, M.; McKeon, S.; Hasserodt, J. Chem. 
Commun. 2012, 48, 6253. 
(128) Gogate, U. S.; Repta, A. J.; Alexander, J. Int. J. Pharm. 1987, 40, 235  
(129) Gogate, U. S.; Repta, A. J. Int. J. Pharm. 1987, 40, 249. 
(130) Alexander, J.; Cargill, R.; Michelson, S. R.; Schwam, H. J. Med. Chem. 1988, 31, 
318. 
(131) Varia, S. A.; Schuller, S.; Sloan, K. B.; Stella, V. J. J. Pharm. Sci. 1984, 73, 1068. 
(132) Fechner, J.; Schwilden, H.; Schüttler, J. Handbook of experimental pharmacology 
2008, 253. 
(133) Takahashi, K.; Tamagawa, S.; Haginaka, J.; Yasuda, H.; Katagi, T.; Mizuno, N. J. 
Pharm. Sci. 1992, 81, 226. 
(134) Tang, X.; Xian, M.; Trikha, M.; Honn, K. V.; Wang, P. G. Tetrahedron Lett. 
2001, 42, 2625. 
(135) Lavis, L. D.; Chao, T.-Y.; Raines, R. T. Chem. Sci. 2011, 2, 521. 
(136) Simplicio, A. L.; Clancy, J. M.; Gilmer, J. F. Molecules 2008, 13. 
(137) de Groot, F. M. H.; Loos, W. J.; Koekkoek, R.; van Berkom, L. W. A.; Busscher, 
G. F.; Seelen, A. E.; Albrecht, C.; de Bruijn, P.; Scheeren, H. W. J. Org. Chem. 2001, 66, 
8815. 
(138) Warnecke, A.; Kratz, F. J. Org. Chem. 2008, 73, 1546. 
(139) Devy, L. FASEB J. 2004. 
(140) Meyer, Y.; Richard, J.-A.; Delest, B.; Noack, P.; Renard, P.-Y.; Romieu, A. Org. 
Biomol. Chem. 2010, 8, 1777. 
(141) Haba, K.; Popkov, M.; Shamis, M.; Lerner, R. A.; Barbas, C. F.; Shabat, D. 
Angew. Chem. Int. Ed. 2005, 44, 716. 
(142) Lee, H. Y.; Jiang, X.; Lee, D. Org. Lett. 2009, 11, 2065. 
39 
 
(143) Kevwitch, R. M.; Shanahan, C. S.; McGrath, D. V. New J. Chem. 2012, 36, 492. 
(144) Robbins, J. S.; Schmid, K. M.; Phillips, S. T. J. Org. Chem. 2013, 
130222154949002. 
(145) Li, S.; Szalai, M. L.; Kevwitch, R. M.; McGrath, D. V. J. Am. Chem. Soc. 2003, 
125, 10516. 
(146) Amir, R. J.; Pessah, N.; Shamis, M.; Shabat, D. Angew. Chem. Int. Ed. 2003, 42, 
4494. 
(147) de Groot, F. M. H.; Albrecht, C.; Koekkoek, R.; Beusker, P. H.; Scheeren, H. W. 
Angew. Chem. Int. Ed. 2003, 42, 4490. 
(148) Szalai, M. L.; Kevwitch, R. M.; McGrath, D. V. J. Am. Chem. Soc. 2003, 125, 
15688. 
(149) Kevwitch, R. M.; McGrath, D. V. New J. Chem. 2007, 31, 1332. 
(150) Ortiz, A.; Shanahan, C. S.; Sisk, D. T.; Perera, S. C.; Rao, P.; McGrath, D. V. J. 
Org. Chem. 2010, 75, 6154. 
(151) Polaske, N. W.; Szalai, M. L.; Shanahan, C. S.; McGrath, D. V. Org. Lett. 2010, 
12, 4944. 
(152) Amir, R. J.; Shabat, D. Chem. Commun. 2004, 1614. 
(153) Shamis, M.; Lode, H. N.; Shabat, D. J. Am. Chem. Soc. 2004, 126, 1726. 
(154) Perry, R.; Amir, R. J.; Shabat, D. New J. Chem. 2007, 31, 1307. 
(155) Sagi, A.; Segal, E.; Satchi-Fainaro, R.; Shabat, D. Bioorg. Med. Chem. 2007, 15, 
3720. 
(156) Gopin, A.; Ebner, S.; Attali, B.; Shabat, D. Bioconjugate Chem. 2006, 17, 1432. 
(157) Shamis, M.; Shabat, D. Chem. Eur. J. 2007, 13, 4523. 
(158) Erez, R.; Segal, E.; Miller, K.; Satchi-Fainaro, R.; Shabat, D. Bioorg. Med. Chem. 
2009, 17, 4327. 
(159) Amir, R. J.; Danieli, E.; Shabat, D. Chem. Eur. J. 2007, 13, 812. 
(160) Sella, E.; Shabat, D. Chem. Commun. 2008, 5701. 
(161) Sella, E.; Shabat, D. J. Am. Chem. Soc. 2009, 131, 9934. 
(162) Avital-Shmilovici, M.; Shabat, D. Bioorg. Med. Chem. 2010, 18, 3643. 
40 
 
(163) Sella, E.; Lubelski, A.; Klafter, J.; Shabat, D. J. Am. Chem. Soc. 2010, 132, 3945. 
(164) Sella, E.; Weinstain, R.; Erez, R.; Burns, N. Z.; Baran, P. S.; Shabat, D. Chem. 
Commun. 2010, 46, 6575. 
(165) Perry-Feigenbaum, R.; Sella, E.; Shabat, D. Chem. Eur. J. 2011, 17, 12123. 
(166) Karton-Lifshin, N.; Shabat, D. New J. Chem. 2012, 36, 386. 
(167) Danieli, E.; Shabat, D. Bioorg. Med. Chem. 2007, 15, 7318. 
(168) Sagi, A.; Weinstain, R.; Karton, N.; Shabat, D. J. Am. Chem. Soc. 2008, 130, 
5434. 
(169) Weinstain, R.; Baran, P. S.; Shabat, D. Bioconjugate Chem. 2009, 20, 1783. 
(170) Weinstain, R.; Sagi, A.; Karton, N.; Shabat, D. Chem. Eur. J. 2008, 14, 6857. 
(171) Esser-Kahn, A. P.; Sottos, N. R.; White, S. R.; Moore, J. S. J. Am. Chem. Soc. 
2010, 132, 10266. 
(172) Köstler, S. Polym. Int. 2012, 61, 1221. 
(173) Seo, W.; Phillips, S. T. J. Am. Chem. Soc. 2010, 132, 9234. 
(174) Kaitz, J. A.; Moore, J. S. Macromolecules 2013, 46, 608. 
(175) DiLauro, A. M.; Robbins, J. S.; Phillips, S. T. Macromolecules 2013, 46, 2963. 
(176) DiLauro, A. M.; Abbaspourrad, A.; Weitz, D. A.; Phillips, S. T. Macromolecules 
2013, 46, 3309. 
(177) DeWit, M. A.; Gillies, E. R. J. Am. Chem. Soc. 2009, 131, 18327. 
(178) DeWit, M. A.; Beaton, A.; Gillies, E. R. J. Polym. Sci. A Polym. Chem. 2010, 48, 
3977. 
(179) DeWit, M. A.; Gillies, E. R. Org. Biomol. Chem. 2011, 9, 1846. 
(180) DeWit, M., The University of Western Ontario, 2012. 
(181) de Gracia Lux, C.; McFearin, C. L.; Joshi-Barr, S.; Sankaranarayanan, J.; Fomina, 
N.; Almutairi, A. ACS Macro Lett. 2012, 1, 922. 
 
 
 41 
†This chapter contains work that has been published: McBride, R. A.; Gillies, E. R. G. Macromolecules 
2013, doi: 10.1021/ma4009753. Copyright 2013 American Chemical Society.  
  
Chapter 2  
2 Kinetics of Self-Immolative Degradation in a Linear 
Polymeric System: Demonstrating the Effect of Chain 
Length† 
2.1 Introduction 
Recent advances in the field of polymer science have contributed to a paradigmatic shift 
in the use of biodegradable polymers as environmentally-friendly substitutes for 
traditional commodity plastics and in biomedical applications ranging from drug delivery 
to tissue engineering. While there exists a large variety of different biodegradable 
polymer backbones, the predominant majority of such systems are polyester-based. 
Despite the proven utility of popular synthetic polyesters such as poly(caprolactone), 
poly(lactic acid), and poly(glycolic acid), the degradation of polyesters suffers from a 
lack of fine control, as it initiated by a non-specific triggering event and relies on random 
hydrolytic cleavage of ester bonds throughout the polymer backbone.1-3 In part, the 
limited control over the degradation of polyesters has been addressed through the 
development of stimuli-responsive, biodegradable polymers in which polymer 
degradation is triggered4 by specific environmental conditions such as changes in pH5-7 or 
redox potential,8-10 biologically mediated events including enzymatic cleavage11 and 
changes in chemical concentration,12,13 or by an applied external stimulus such as 
UV/NIR light.14-17 Such systems are an improvement over basic polyesters in that they 
circumvent the issue of non-specific degradation. However, these systems still require 
many environmentally-mediated cleavage events to ensure complete degradation, thereby 
restricting their usage to applications in which triggering events are abundant. 
Self-immolative polymers have been developed over the past decade as an alternative to 
traditional biodegradable polymers and offer new levels of control and amplification to 
the degradation process. Self-immolative polymers undergo end-to-end depolymerization 
through a cascade of intramolecular reactions upon the removal of a stimuli-responsive, 
stabilizing end-cap (Figure 2.1a).18-20 This particular mechanism of degradation possesses 
three main advantages over the degradation of traditional biodegradable polymers: (i) it 
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permits the amplification of a given stimulus, in that only one triggering event is required 
to achieve complete degradation of the polymer backbone; (ii) the stimuli-responsive 
degradation of a given polymer can be readily adjusted and tuned through the 
incorporation of different end-capping agents; and (iii) the degradation kinetics of these 
polymers are dictated and controlled by the chemical composition of the polymer 
backbone. 
 
Figure 2.1: Illustration of linear self-immolative degradation. (a) Generic overview 
depicting the end-to-end depolymerization of the polymer backbone following the 
removal of the stabilizing end-cap. (b) Previously reported linear self-immolative 
polymer derived from alternating cyclization and 1,6-elimination spacers and its 
mechanism of degradation.  
Following the seminal reports on the design and synthesis of self-immolative 
dendrimers,21-23 a number of different self-immolative polymer backbones and 
architectures have been designed for signal amplification,24-27 drug delivery,28-31 
microfluidics,32 protein labeling,33 self-healing,34 and shape-memory applications.35 Our 
group, along with several others, have focused predominantly on the design and synthesis 
of linear self-immolative polymers with a special consideration towards fine-tuning the 
degradation rate.26,33-41 Despite being no longer monodisperse, linear self-immolative 
polymers provide a high-degree of amplification in a limited number of synthetic steps 
while bypassing any restrictions associated with steric constraints. 
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The first reported linear self-immolative polymer was derived entirely from monomers 
that underwent 1,6-elimination reactions to degrade the polymer into fluorescent 
monomer units.36 Our group subsequently developed linear polymer backbones that were 
comprised of alternating cyclization and 1,6-elimination spacers or purely cyclization 
spacers and showed that the degradation kinetics of such polymers could be significantly 
slowed through the incorporation of cyclization spacers.37,38 More recently, we have 
shown that the degradation rate of such polymers can be effectively tuned by exploiting 
the structure-property relationships of the monomer cyclization spacers.39,41 A similar 
approach has also been utilized by Phillips and coworkers for linear self- immolative 
oligomers derived from 1,6-elimination spacers.42,43 While this approach is a proven 
means to induce large changes to the depolymerization rate, it should be possible to 
effectively tune the depolymerization rate by simply changing the length of the polymer. 
In particular, since the depolymerization of linear self-immolative polymers involves a 
cascade of reactions across a defined architecture, the degradation rate of these polymers 
should be inversely proportional to chain length. In the absence of more complicated 
effects arising from alternative reaction pathways or electronic communication between 
adjacent monomer units, the relative depolymerization rates of linear self-immolative 
oligomers and polymers should be inversely proportional to chain length. While several 
studies have been performed to investigate the effect of chain length on the degradation 
rate of short self-immolative oligomers, with varying results,44-47 the length dependence 
of self-immolative polymer degradation has not yet been demonstrated, and no 
comprehensive model has been developed to describe their behaviour. 
Using our previously reported linear polycarbamate backbone derived from alternating 
1,6-elimination and cyclization spacers (Figure 2.1b) 37 we herein report the first 
conclusive study demonstrating the effect of chain length on the kinetics of linear self-
immolative degradation. This is accomplished using a set of monodisperse oligomers 
synthesized through a new convergent iterative route and a series of polymers optimized 
to display varying molecular weights. We also report the development and validation of a 
new linear self-immolative degradation model relating monomer kinetics to polymer 
degradation and show its application in explaining oligomeric and polymeric degradation 
profiles. Collectively, this work offers the first quantitative evidence supporting the 
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mixed pseudo zero- and first-order degradation kinetics of linear self-immolative 
polymers and proves the utility of chain length as an alternate means to tune the 
degradation time in linear self-immolative polymers. 
2.2 Experimental 
2.2.1 General Procedures and Materials 
All reagents were purchased from commercial suppliers and used without further 
purification unless otherwise noted. Anhydrous toluene was obtained from a solvent 
purification system using aluminum oxide columns. Dichloromethane (CH2Cl2), pyridine, 
triethylamine (NEt3), and N,N- diisopropylethylamine (DIPEA) were distilled from CaH2 
immediately prior to use. Unless otherwise stated, all reactions were performed under an 
Ar atmosphere using flame-dried glassware. Column chromatography was performed 
using silica gel (0.040 – 0.063 mm particle size, 230 – 430 mesh). Thin layer 
chromatography (TLC) was carried out using EMD silica gel 60 F254 plates (20 cm × 20 
cm, 250 µm). Deionized water was purified using a Millipore purification system. 
Dialyses were performed using Spectra/Por® regenerated cellulose membranes with 
either a 6000-8000 g/mol or 25000 g/mol molecular weight cutoff (MWCO). 
1H NMR spectra were obtained at 400 MHz or 600 MHz using a Varian INOVA 
spectrometer, while 13C NMR spectra were obtained at 100 MHz using a Varian INOVA 
spectrometer. Chemical shifts are reported in ppm versus tetramethylsilane and 
referenced to residual solvent signals of CDCl3 (δ 7.26, 77.2), (CD3)2CO (δ 2.05), or D2O 
(δ 4.79). Coupling constants are expressed in Hz. High resolution mass spectrometry 
(HRMS) was performed on either a Finnigan MAT 8400 or a PE-Sciex API 365 mass 
spectrometer using electron impact (EI) or electrospray (ESI) ionization, respectively. 
Fourier transform infrared spectra were obtained using a Bruker Tensor 27 from CH2Cl2 
films on KBr plates. Size exclusion chromatography (SEC) was carried out at a flow rate 
of 1 mL/min in N,N- dimethylformamide (DMF) with 10 mM LiBr and 1% (v/v) NEt3 at 
85˚C using a Waters 2695 separations module equipped with a Waters 2414 differential 
refractometer and two PLgel 5 µm mixed-D (300 mm × 7.5 mm) columns from Polymer 
Laboratories connected in series. SEC calibrations were performed using poly(methyl 
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methacrylate) (PMMA) standards. Reverse phase high pressure liquid chromatography 
(RP-HPLC) was performed at a flow rate of 1 mL/min on a Waters 2695 separations 
module equipped with a Waters 2998 photodiode array detector at a wavelength of 225 
nm and a Nova-Pak® C-18 analytical column (3.9 mm × 150 mm, 4 µm). The HPLC 
gradient was linear from 40/60 MeCN/H2O to 100/0 MeCN/H2O over 15 min. Solvent 
mixtures for all chromatographic analyses contained 0.1% TFA. 
2.2.2 Synthesis 
Synthesis of Compound 2.1a. Unactivated monomer 2.1b37 (1.34 g, 4.0 mmol, 1.0 equiv) 
was dissolved in 20 mL of anhydrous CH2Cl2. Acetyl chloride (0.42 mL, 5.9 mmol, 1.5 
equiv), pyridine (1.0 mL, 12.0 mmol, 3 equiv) and 4-(dimethylamino)pyridine (DMAP) 
(0.05 g, 0.4 mmol, 0.1 equiv) were successively added to the reaction flask and the 
solution was stirred at room temperature until completion (∼ 1.25 h) as determined by 
TLC. The reaction mixture was then diluted with CH2Cl2 and washed with 1 M HCl. The 
organic layer was dried over MgSO4, filtered, and concentrated in vacuo. The resulting 
oil was purified by silica gel flash chromatography (1:19 EtOAc:CH2Cl2, gradient to 3:7 
EtOAc:CH2Cl2) to afford 1a as a pale yellow oil (1.31 g, 87%). 1H NMR (CDCl3, 400 
MHz):δ 7.31 (m, 2H), 7.11–7.03 (m, 2H), 5.04 (s, 2H), 3.61–3.49 & 3.48–3.37 (2 m, 4H 
total, rotamers), 3.09 & 3.00 (2 s, 3H total, rotamers), 2.93–2.82 (m, 3H, rotamers), 2.05 
(s, 3H), 1.48–1.39 (m, 9H, rotamers). 13C NMR (CDCl3, 150 MHz): δ 170.7, (155.9, 
155.7 & 155.5, rotamers ), (154.7, 154.5, & 154.4, rotamers), (151.4 & 151.2, rotamers), 
(133.0 & 132.9, rotamers), 129.4, (122.0 & 121.8, rotamers), (79.8, 79.7, 79.6, & 79.4, 
rotamers), 69.7, (47.3, 47.1, 46.9, 46.7, 46.5, 46.4, & 45.6, methylenes, rotamers), (35.4, 
35.2, 35.1, 34.7, & 34.5, methyls, rotamers), 28.4, 21.0. FT-IR (νmax/cm−1): 2976, 2934, 
1724, 1693, 1515. HRMS: calcd [M]+ (C19H28N2O6): 380.1947. Found (EI) 380.1948. 
RP-HPLC: tR=3.8 min (purity, >99%). 
Synthesis of Compound 2.2a. Acetylated monomer 2.1a (1.12 g, 2.9 mmol, 1.2 equiv) 
was dissolved in 6 mL of 1:1 TFA:CH2Cl2 and stirred at room temperature for 2 h. The 
reaction mixture was then diluted with CH2Cl2 and the solvent was removed under 
reduced pressure. This dilution/evaporation cycle was repeated an additional three times 
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to remove residual TFA, yielding the deprotected-acetylated monomer 2.1d. 4-
Nitrophenyl-activated activated monomer 2.1c37 (1.25 g, 2.5 mmol, 1.0 equiv) was then 
added and the resulting mixture was dissolved in anhydrous toluene and cooled to 0˚C. 
DIPEA (1.3 mL, 7.4 mmol, 3.0 equiv) and DMAP (35 mg, 0.29 mmol, 0.12 equiv) were 
sequentially added and the solution was stirred at 0˚C for 8 h. The reaction was allowed 
to warm to room temperature and stirred an additional 8 h. The reaction mixture was then 
diluted with CH2Cl2 and washed with 1 M HCl followed by 1 M Na2CO3. The organic 
layer was dried over MgSO4, filtered, and concentrated in vacuo. The resulting oil was 
then purified by silica gel flash chromatography (1:4 EtOAc:CH2Cl2, gradient to 3:2 
EtOAc:CH2Cl2) to afford 2.2a as a colourless oil (1.34 g, 84%). 1H NMR (CDCl3, 400 
MHz): δ 7.38–7.27 (m, 4H), 7.11–7.00 (m, 4H), 5.13–5.01 (m, 4H), 3.64–3.36 (m, 8H), 
3.12–2.82 (m, 12H), 2.06 (s, 3H), 1.52–1.37 (m, 9H, rotamers). FT-IR (νmax/cm−1): 2932, 
1722, 1699, 1512. HRMS: calcd [M+Na]+ (C32H44N4O10Na): 667.2955. Found (ESI): 
667.2929. RP-HPLC: tR=5.1 min (purity, >99%). SEC: Mn=875 g/mol, PDI=1.03 
(PMMA standards). 
Synthesis of Compound 2.2b. Acetylated dimer 2.2a (0.64 g, 1.0 mmol, 1.0 equiv) and 
LiOH·H2O (59 mg, 1.4 mmol, 1.4 equiv) were dissolved in 15 mL of 3:2 THF:H2O and 
stirred at room temperature for 16 h. Upon completion of the reaction, the solvent 
mixture was poured over 1 M HCl and the product was extracted with CH2Cl2. The 
combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo to 
yield compound 2.2b (0.55 g, 92%) as a white solid. 1H NMR (CDCl3, 400 MHz): δ 
7.38–7.17 (m, 4H), 7.10–6.89 (m, 4H), 5.13–5.03 (m, 2H, rotamers), 4.58 (d, J=5.4, 2H, 
rotamers), 3.67–3.37 (m, 8H), 3.16–2.78 (m, 12H), 1.48–1.37 (m, 9H, rotamers). FT-IR 
(νmax/cm−1): 3468, 2928, 2872, 2856, 1718, 1701, 1510. HRMS: calcd [M+Na]+ 
(C30H42N4O9Na): 625.2850. Found (ESI) 625.2858. RP-HPLC: tR=3.4 min (purity, 
>99%). 
Synthesis of Compound 2.2c. Unactivated dimer 2.2b (0.50 g, 0.84 mmol, 1.0 equiv) and 
pyridine (20 µL, 2.5 mmol, 3.0 equiv) were dissolved in 6 mL of anhydrous CH2Cl2. 4-
Nitrophenyl chloroformate (0.34 g, 1.7 mmol, 2.0 equiv) was added slowly to the 
reaction flask and the solution was stirred at room temperature until completion (∼ 3 h) as 
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determined by TLC. The reaction mixture was then diluted with CH2Cl2 and washed with 
1 M HCl followed by saturated NaHCO3. The organic layer was dried over MgSO4, 
filtered, and concentrated in vacuo. The resulting oil was purified by silica gel flash 
chromatography (1:4 EtOAc:CH2Cl2, then 2:3 EtOAc:CH2Cl2) to afford 2.2c as a white 
solid (0.51 g, 79%). 1H NMR (CDCl3, 400 MHz): δ 8.23 (d, J=9.0, 2H), 7.46–7.27 (m, 
6H), 7.14–7.01 (m, 4H), 5.24 (s, 2H), 5.13–5.03 (m, 2H), 3.66–3.35 (m, 8H), 3.15– 2.82 
(m, 8H), 1.50–1.37 (m, 9H, rotamers). FT-IR (νmax/cm−1): 2972, 2934, 1767, 1720, 
1697, 1614, 1593, 1526. HRMS: calcd [M+Na]+ (C37H45N5O13Na): 790.2912. Found 
(ESI) 790.2898. RP-HPLC:tR=7.2 min (purity, 99%). 
Synthesis of Compound 2.3a. Acetylated tetramer 2.3a was prepared using similar 
conditions to those described for compound 2.2a. The quantities of reagents used were 
2.2a (0.55 g, 0.86 mmol, 1.4 equiv), 2.2c (0.48 g, 0.63 mmol, 1.0 equiv), DIPEA (0.33 
mL, 1.8 mmol, 3.0 equiv), and DMAP (13 mg, 0.11 mmol, 0.17 equiv). The product was 
purified by silica gel flash chromatography (4:1 EtOAc:CH2Cl2, gradient to EtOAc) to 
afford 2.3a as a white solid (0.65 g, 88%). 1H NMR (CDCl3, 400 MHz): δ 7.40–7.28 (m, 
8H), 7.12–7.00 (m, 8H), 5.15–5.03 (m, 8H), 3.64–3.39 (m, 16H), 3.16–2.84 (m, 24H), 
2.07 (s, 3H), 1.50–1.38 (m, 9H, rotamers). FT-IR (νmax/cm−1): 2934, 1720, 1701, 1510. 
HRMS: calcd [M+Na]+ (C58H76N8O18Na): 1195.5176. Found (ESI) 1195.5133. RP-
HPLC: tR=6.8 min (purity, 97%). SEC: Mn=1940 g/mol, PDI=1.02 (PMMA standards). 
Synthesis of Compound 2.3b. Deprotected tetramer 2.3b was prepared using similar 
conditions to those described for compound 2.2b. The quantities of reagents used were 
2.3a (0.27 g, 0.23 mmol, 1.0 equiv) and LiOH·H2O (19 mg, 0.46 mmol, 2.0 equiv). The 
product alcohol was purified by silica gel flash chromatography (1:24 MeOH:CH2Cl2) to 
afford 2.3b as a white solid (0.19 g, 73%). 1H NMR (CDCl3, 400 MHz): δ 7.39–7.18 (m, 
8H), 7.11–6.91 (m, 8H), 5.14–4.99 (m, 6H), 4.59 (d, J=4.4, 2H), 3.66–3.36 (m, 16H), 
3.14–2.84 (m, 24H), 1.51–1.39 (m, 9H, rotamers). FT-IR (νmax/cm−1): 3479, 2934, 1718, 
1703, 1510. HRMS: calcd [M+Na]+ (C56H74N8O17Na): 1153.5070. Found (ESI) 
1153.5031. RP-HPLC: tR=5.5 min (purity, >99%). 
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Synthesis of Compound 2.3c. 4-Nitrophenyl-activated tetramer 2.3c was prepared using 
similar conditions to those described for compound 2.2c. The quantities of reagents used 
were 2.3b (0.12 g, 0.11 mmol, 1 equiv), pyridine (30 µL, 0.3 mmol, 3 equiv), and 4-
nitrophenyl chloroformate (60 mg, 0.30 mmol, 2.7 equiv). The product was purified by 
silica gel flash chromatography (EtOAc, then 1:24 MeOH:EtOAc) to afford 2.3c as a 
white solid (0.1 g, 70%). 1H NMR (CDCl3, 400 MHz): δ 8.22 (m, 2H), 7.44–7.26 (m, 
10H), 7.13–6.97 (m, 8H), 5.23 (s, 2H), 5.13–5.01 (m, 2H), 3.63–3.34 (m, 16H), 3.15–
2.80 (m, 24H), 1.48–1.38 (m, 9H, rotamers). FT-IR (νmax/cm−1): 2930, 2856, 1767, 1720, 
1701, 1614, 1593, 1525, 1512. HRMS: calcd [M+Na]+ (C63H77N9O21Na): 1318.5132. 
Found (ESI) 1318.5132. RP-HPLC: tR=8.4 min (purity, 96%). 
Synthesis of Compound 2.4a. Acetylated octamer 2.4a was prepared using similar 
conditions to those described for compound 2.2a. The quantities of reagents used were 
2.3a (0.14 g, 0.12 mmol, 1.6 equiv), 2.3c (0.09 g, 0.07 mmol, 1 equiv), DIPEA (60 µL, 
0.4 mmol, 5 equiv) and DMAP (1 mg, 0.007 mmol, 0.1 equiv). The product was purified 
by silica gel flash chromatography (1:49 MeOH:CH2Cl2, then 3:47 MeOH:CH2Cl2) to 
afford 2.4a as a white solid (0.14 g, 74%). 1H NMR (CDCl3, 400 MHz): δ 7.40 –7.28 (m, 
16H), 17.12–6.99 (m, 16H), 5.14–5.05 (m, 16H), 3.65–3.39 (m, 32H), 3.19–2.86 (m, 
48H), 2.08 (s, 3H), 1.50–1.41 (m, 9H, rotamers). FT-IR (νmax/cm−1): 2936, 1718, 1701, 
1512. HRMS: calcd [M+Na]+ (C110H140N16O34Na): 2251.9610. Found (ESI) 2251.9593. 
RP-HPLC: tR =8.9 min (purity, 96%). SEC: Mn =3660 g/mol, PDI=1.03 (PMMA 
standards). 
Synthesis of Polymer 2.6. Activated monomer 2.1c37 (0.28 g,0.55 mmol, 1 equiv) was 
dissolved in 3 mL of 1:1 TFA:CH2Cl2 and stirred at room temperature for 2 h. The 
solvent was then removed under a stream of nitrogen in the fume hood prior to subjecting 
the reaction mixture three times to a repeat cycle of dilution with CH2Cl2 followed by 
concentration under reduced pressure to remove residual TFA and provide the 
deprotected monomer 2.5.37 End-cap 2.1c37 (0.014 g, 0.027 mmol, 0.05 equiv) was added 
and the resulting mixture was dissolved in 3 mL of anhydrous toluene. DIPEA (0.48 mL, 
2.75 mmol, 5.0 equiv) and DMAP (0.016 g, 0.13 mmol, 0.24 equiv) were sequentially 
added and the solution was stirred at room temperature for 6 h. The solvent was then 
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evaporated under reduced pressure and the crude polymer was dissolved in 2 mL of DMF 
and dialyzed against DMF for 24 h (200, mL, 1 solvent change) using a regenerated 
cellulose membrane (6000-8000 g/mol MWCO). The contents of the dialysis membrane 
were then concentrated in vacuo and lyophilized to afford polymer 2.6 (0.063 g, 42%). 1H 
NMR indicated a degree of polymerization of ∼ 25 by integrating the benzylic peak 
against the Boc end-cap. 1H NMR (CDCl3, 600 MHz): δ 7.46–7.26 (m, 51H), 7.18–6.95 
(m, 44H), 5.18–4.97 (m, 50H), 3.70–3.37 (m, 103H), 3.25–2.80 (m, 158H), 1.50–1.41 
(m, 9H, rotamers). SEC: Mn=5250 g/mol, Mw=7730 g/mol, PDI=1.47 (PMMA 
standards). 
Synthesis of Polymer 2.7. Activated monomer 2.1c37 (1.25 g, 2.49 mmol, 1 equiv) was 
dissolved in 6 mL of 1:1 TFA:CH2Cl2 and stirred at room temperature for 2 h. The 
solvent was then removed under a stream of nitrogen in the fume hood prior to subjecting 
the reaction mixture three times to a repeat cycle of dilution with CH2Cl2 followed by 
concentration under reduced pressure to remove residual TFA and provide the 
deprotected monomer. End-cap 2.1c37 (0.013 g, 0.025 mmol, 0.01 equiv) was added and 
the resulting mixture was dissolved in 12 mL of anhydrous toluene and cooled to 0˚C. 
NEt3 (1.73 mL, 12.43 mmol, 5 equiv) and DMAP (0.066 g, 0.54 mmol, 0.22 equiv) were 
sequentially added and the solution was stirred at 0˚C for 24 h. The reaction mixture was 
then diluted with CH2Cl2 and washed with 1M HCl followed by 1 M Na2CO3. The 
organic layer was dried over MgSO4, filtered, and concentrated in vacuo to provide the 
crude polymer (0.60 g, 92%). The crude polymer was then dissolved in 5 mL of DMF 
and dialyzed against DMF for 24 h (500, mL, 1 solvent change) using a regenerated 
cellulose membrane (25000 g/mol MWCO). The contents of the dialysis membrane were 
then concentrated in vacuo and lyophilized to afford polymer 2.7 (0.25 g, 37%). 1H NMR 
indicated a degree of polymerization of ∼ 101 by integrating the benzylic peak against the 
Boc end-cap. 1H NMR (CDCl3, 600 MHz): δ 7.39–7.29 (m, 181H), 7.12–6.99 (m, 178H), 
5.17–5.02 (m, 203H), 3.70–3.36 (m, 409H), 3.21–2.79 (m, DMF, 700H), 1.49–1.42 (m, 
9H, rotamers). SEC: Mn=13600 g/mol, Mw=21500 g/mol kDa, PDI=1.58 (PMMA 
standards). 
50 
 
2.2.3 Simulation Studies 
Lognormal polymer distributions were simulated using the Statistics Toolbox in 
MATLAB® (R2012 A). Solutions to the set of differential equations (Eqs. (2.2), (2.3) 
and (2.5)) were solved numerically in MATLAB using a non-stiff ordinary differential 
equation solver (ode45) using simulated lognormal weight-fraction distributions for the 
initial concentrations of each polymeric species. 
2.2.4 Degradation Studies 
Degradation of oligomers 2.1d–2.4d. Acetylated oligomers 2.1a-2.4a were Boc-
deprotected using the same procedures described above to yield compounds 2.1d-2.4d. 
Deprotected oligomer (10 mg) was dissolved in CH2Cl2 and washed with a 1:1 mixture of 
brine:1 M citric acid. The product was then re-extracted from the aqueous layer 5 times 
with CH2Cl2. The combined organic layers were dried over MgSO4, filtered, and 
concentrated in vacuo. The product was then taken up in 1 mL of 0.1 M phosphate buffer 
(D2O):acetone-d6 (3:2) preheated to 37˚C and filtered through a Promax® PTFE 
membrane (0.22 µm). The filtered solution was then incubated at 37˚C using an INOVA 
variable temperature controller calibrated using ethylene glycol. 1H NMR spectra were 
recorded at 3 min intervals over a period of 4 hours. Following depolymerization, the pH 
of the solution was tested to ensure that the sample did not fall outside of the buffer 
region during the degradation process. The extent of depolymerization was quantified by 
integrating the methyl peak of the N,N’-dimethylimidazolidinone degradation product 
relative to the (CHD2)(CD3)CO in the sample. The plateau region corresponding to 100% 
degradation was defined as the region in which the mean fluctuation between successive 
integral values was less than or equal to 2%. Oligomer degradation data was treated by 
non-linear regression and fit to the appropriate form of Eq. (8) to assess the degradation 
kinetics. 
Degradation of polymers 2.6 and 2.7. Polymer (10 mg) was dissolved in 1 mL of 1:1 
TFA:CH2Cl2 and stirred at room temperature for 2 h. The solvent was blown off and the 
product was taken up in CH2Cl2 and washed with a 1:1 mixture of brine:1 M citric acid. 
The deprotected polymer was then re-extracted from the aqueous layer 5 times with 
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CH2Cl2. The combined organic layers were dried over MgSO4, filtered, and concentrated 
in vacuo. The product was then taken up in 1 mL of 0.1 M phosphate buffer 
(D2O):acetone-d6 (3:2) preheated to 37˚C and filtered through a Promax® PTFE 
membrane (0.22 µm). The filtered solution was then incubated at 37˚C using an INOVA 
variable temperature controller calibrated using ethylene glycol. 1H NMR spectra were 
recorded at 5 min intervals over a period of 8 hours. Following depolymerization, the pH 
of the solution was tested to ensure that the sample did not fall outside of the buffer 
region during the degradation process. The extent of depolymerization was quantified by 
integrating the methyl peak of the N,N’- dimethylimidazolidinone degradation product 
relative to the (CHD2)(CD3)CO in the sample. The plateau region corresponding to 100% 
degradation was defined as the region in which the mean fluctuation between successive 
integral values was less than or equal to 5%. Polymer degradation data was treated by 
non-linear regression and fit to the self-immolative degradation model (Eqs. (2), (3) and 
(5)) to assess the degradation kinetics. 
2.2.5 Statistics 
Nonlinear least-squares regression was performed using a Gauss-Newton algorithm 
contained within the R stats package. Unless otherwise noted, the presented data 
represent the average plus or minus the standard deviation determined through triplicate 
measurement. 
2.3 Results and Discussion 
2.3.1 Choice of Model System 
The chemical structure of our previously reported linear self-immolative polycarbamate 
derived from alternating N,N’-dimethylethylenediamine and 4-hydroxybenzyl alcohol-
based spacers is shown in Figure 2.1a.37 Selective removal of the N-tert-butoxycarbonyl 
(Boc) end-cap reveals a terminal amine that cyclizes to form N,N’-
dimethylimidazolidinone, exposing a phenol, which then spontaneously undergoes 1,6-
elimination followed by a decarboxylation to regenerate an amine on the polymer 
terminus. This cascade of alternating cyclization, 1,6-elimination, and decarboxylation 
reactions is repeated along the length of the polymer backbone until complete 
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depolymerization of the polymer into N,N’-dimethylimidazolidinone, 4-hydroxybenzyl 
alcohol, and CO2 occurs. This linear polymeric framework was selected as the model 
system for the kinetic study as the cyclization of N,N’-dimethylethylenediamine spacers 
is well studied and occurs over a moderate time frame under physiological conditions.48 
Additionally, the polymer is sufficiently stable as a trifluoroacetic acid (TFA)-salt 
following end-cap removal. As a result, end-cap removal can be effectively decoupled 
from the degradation of the polymer backbone, allowing the kinetics of self-immolation 
to be studied independent from the end-cap removal. 
2.3.2 Oligomer Synthesis 
In order to test the effect of chain length on the kinetics of linear self-immolative 
degradation, a series of monodisperse oligomers were synthesized using a convergent 
iterative scheme (Scheme 2.1). The use of monodisperse oligomers was driven by the fact 
that chain length and polydispersity are inherently difficult to control in the previously 
reported polycondensation of the model polymer. The use of a monodisperse sample set 
also eliminates any competing effects of polydispersity on the overall degradation 
kinetics, thereby allowing for a more accurate assessment of the influence of chain length 
on self-immolative degradation. A monomer and three oligomers, dimer, tetramer, and 
octamer, were prepared using a modified route used to synthesize the model polymer.37 
As in the previously reported monomer synthesis,37 a Boc group was selected as a 
protecting group and end-cap for the amine termini of the oligomers. An acetyl protecting 
group was chosen for the hydroxyl termini of the oligomers because it can be selectively 
removed in the presence of carbamates and can tolerate TFA deprotections of the Boc 
group.41 As shown in Scheme 2.1, the previously reported unactivated monomer (2.1b)37 
was reacted with acetyl chloride to provide the acetyl-protected monomer (2.1a). The 
Boc group of 2.1a was then removed by treatment with 1:1 TFA:CH2Cl2 to provide 
monomer 2.1d. The monomer 2.1d was then reacted with the 4-nitrophenyl carbonate-
activated monomer (2.1c)37 to afford the acetyl-protected dimer (2.2a). From here a 
convergent, iterative strategy was employed in which the acetyl-protected oligomers 
(2.2a,2.3a) were treated with LiOH·H2O in 3:2 THF:H2O to hydrolyze the acetate and 
provide the unactivated alcohol species (2.2b,2.3b). These compounds were then 
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activated with 4-nitrophenyl chloroformate to afford the activated carbonate species 
(2.2c,2.3c), which were subsequently reacted with the Boc-deprotected acetyl compounds 
(2.2d,2.3d) in the presence of DIPEA and DMAP to produce the acetyl-protected 
oligomers (2.3a,2.4a). For example, the tetramer 2.3a was obtained from the reaction of 
dimer 2.2c with dimer 2.2d, while the octamer 2.4a was obtained from tetramer 2.3c and 
2.3d. 
 
Scheme 2.1: Iterative convergent synthesis of monodisperse oligomers 
The oligomers were characterized by NMR spectroscopy, IR spectroscopy, SEC, and 
HPLC. Notably, the absence of N,N’-dimethylimidazolidinone that would be formed 
from the competing intramolecular cyclization reaction during each coupling step was 
assessed using 1H NMR spectroscopy. NMR spectra for the acetylated compounds 2.1a-
2.4a showing the evolution of oligomeric peaks relative to the Boc-terminus as well as 
the absence of N,N’-dimethylimidazolidinone are shown in Figure 2.3. Due to the 
presence of many carbamate rotameric centres, standard 13C NMR analysis could not be 
used to assess purity in each of the oligomer samples above the monomer generation. 
Therefore, the absence of different oligomeric species from each sample was assessed 
2.1a
2.1c
2.1d
2.1b
2.2a: n=1 (from 2.1d + 2.1c)
2.3a: n=3 (from 2.2d + 2.2c)
2.4a: n=7 (from 2.3d + 2.3c)
HO
O N
O
N
O
O
O
O
N
NBoc
n
OO
O
O2N
O N
O
N
O
O
O
O
N
NBoc
n
O
O
O N
O
N
O
O
O
O
N
NBoc
n
O
O
O N
O
N
O
O
O
O
N
NH2
n
TFA
O
O
Cl
O2N
DIPEA, DMAP
Toluene, 0˚C
OO
O
O N
O
NBoc
O
O
O N
O
NBoc
HO
O N
O
NBoc
O
Cl
O
O
O N
O
NH2 TFA
O2N
2.2d: n=1 (from 2.2a)
2.3d: n=3 (from 2.3a)
2.2c: n=1 (from 2.2b)
2.3c: n=3 (from 2.3b)
2.2b: n=1 (from 2.2a)
2.3b: n=3 (from 2.3a)
1:1
TFA:CH2Cl2
1:1
TFA:CH2Cl2
CH2Cl2, NEt3
DIPEA, DMAP
Toluene, 0˚C
Pyridine, CH2Cl2
LiOH.H2O
3:2 THF:H2O
54 
 
using reverse phase HPLC analysis and it was demonstrated that the purity of each 
oligomer was > 95% (Appendix B). Ensuring the absence of both cyclic urea and 
unwanted oligomer contaminants was crucial to allow proper experimental model 
validation, as the presence of cyclic urea would result in an overestimation of the 
degradation rate and the presence different oligomer species would invalidate the 
assumption of monodispersity in the subsequent model development and validation. As 
shown in Figure 2.2a, SEC traces for 2.2a, 2.3a, and 2.4a exhibited monomodal 
distributions and very narrow polydispersities ranging from 1.02-1.03. The number 
average molecular weights for 2.2a, 2.3a, and 2.4a were 875, 1940, and 3660 g/mol 
relative to PMMA standards, in comparison with the theoretical molecular weights of 
644, 1173, and 2230 g/mol, respectively. 
 
Figure 2.2: Size exclusion chromatograms of compounds 2.2a (- . -), 2.3a (- - -), and 
2.4a (—) prior to the removal of the Boc-protecting group (black) and after 
complete degradation (grey). (b) Size exclusion chromatograms of polymers 2.6  
(- - -) and 2.7 (—) before (black) and after degradation (grey). All chromatograms 
acquired at a sample concentration of 5 mg/mL and calibrated using PMMA 
standards. 
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Figure 2.3: 1H NMR spectra of monodisperse oligomers 2.1a-2.4a showing the 
evolution of oligomeric peaks relative to the Boc-terminus and the absence of N,N’-
dimethylimidazolidinone during the iterative convergent synthesis (600 MHz, 
CDCl3)  
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2.3.3 Polymer Synthesis 
In addition to the oligomers that possessed exact molecular weights, it was also a goal of 
this work to demonstrate the dependence of the depolymerization time on chain length in 
longer polymeric systems. As shown in Scheme 2.2, the polycarbamate can be 
synthesized from the activated carbonate 2.5,37 along with 2.1c as an end-cap in the 
presence of a tertiary amine base. In order to obtain a reference set of polymers 
displaying varying chain lengths, a two-level, four factor designed experiment was 
conducted to investigate the effects of end-cap ratio, temperature, reaction duration, and 
the nucleophilicity of the amine base on the degree of polymerization in the previously 
reported polycondensation of the model polymer (Scheme 2.2).37 The results of this study 
(Appendix D) were used to select adequate polymerization conditions to synthesize both 
a low and high molecular weight polymer. Polymer 2.6 was synthesized using the 
previously reported polymerization conditions37 and purified by dialyses in DMF against 
a 6000-8000 g/mol molecular weight cutoff (MWCO) membrane to yield a polymer with 
a Mn of 5250 g/mol and a PDI of 1.47 (Figure 2.2b). Analysis by 1H NMR spectroscopy 
revealed a monomer to end-cap ratio of 25:1, which was similar to the monomer feed 
ratio of 20:1. Polymer 2.7 was synthesized using similar conditions to those previously 
reported except that a lower end-cap ratio was used (0.01 equiv), NEt3 was used instead 
of DIPEA, and the polymerization was carried out at 0˚C for a longer period of time. 
Polymer 2.7 was purified by dialyses in DMF against a 25000 g/mol MWCO membrane 
to yield a polymer with a Mn of 13600 g/mol and a PDI of 1.58 (Figure 2.2b). Analysis by 
1H NMR spectroscopy revealed a monomer to end-cap ratio of 101:1, which was similar 
to the monomer feed ratio of 100:1. 
 
Scheme 2.2: Synthesis of Polymers 2.6 and 2.7 
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2.3.4 Linear Self-Immolative Degradation Model 
As part of this work, we aimed to probe the kinetics of linear self-immolative degradation 
using computational simulations. Despite the growing popularity of self-immolative 
polymers, there has been very little work conducted into developing models that describe 
the self-immolative degradation process. It has long been inferred that the degradation 
kinetics of self-immolative polymers are dictated by the kinetics of the monomer repeat 
units, yet no conclusive study has been conducted to relate the two on a theoretical and 
quantitative basis. The kinetics of linear self-immolative degradation have been 
previously explored on a number of oligomers based on 1,4 and 1,6-elimnation spacers 
and on elongated cyclization spacers, however, analysis of the degradation kinetics has 
either been qualitative or limited to the fitting of higher order models.44,46,47 The Shabat 
group have shown that the kinetics between successive dendrimer generations in systems 
derived from cyclization and elimination spacers approximately follows first-order 
cyclization kinetics and used this observation to derive theoretical release models for 
second generation dendrons.21,30 In this work we also sought to build off the promising 
results observed for dendrimer systems and derive a theoretical model for the degradation 
of linear self-immolative polymers that relates monomer kinetics to the overall kinetics of 
polymer degradation and use this model to predict and explain experimental degradation 
trends. 
The linear self-immolative degradation of the model polymer may be described as a 
sequence of elementary reactions proceeding from the chain terminus. Such a model is 
mechanistically similar to the end-wise depolymerization models that have been 
developed for linear protein systems to describe microtubulin disassembly.49,50 Assuming 
that the rate of cyclization is significantly slower than the rate of 1,6-elimination, the 
degradation of the model polymer can be treated as a series of first-order intramolecular 
cyclization reactions between successive chain lengths as follows: 
Pn -­‐Mkn Pn-­‐1 -­‐Mkn-­‐1…   -­‐Mk2 P1 -­‐Mk1M (2.1) 
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where Pi is the polymer chain of length i, M is the released monomer unit, and ki is the 
rate of intramolecular cyclization for a terminal cyclization spacer on a polymer chain of 
length i. This assumption is valid, as the rate of 1,6-elimination is generally much faster 
than the rate of intramolecular cyclization, especially when followed by a 
thermodynamically favourable carbamate decarboxylation reaction.46,51 1,6-eliminations 
in hydroxybenzyl alcohol-based system are typically quite rapid with complete 
conversion to the quinone methide occurring in several seconds,46 while the cyclization 
of N,N’-dimethylethylenediamine in aqueous systems is much slower with a previously 
reported half-life of 36.3 min at pH 7.4.48 In the simplest case, the intramolecular 
cyclization rate constant is independent of chain length and Eq. (2.1) can be reduced to 
the following set of linear ordinary differential equations: d[Pn]dt =-­‐k[Pn]   (2.2) d Pidt =k Pi+1 -­‐ Pi         ∀  i≤n-­‐1 (2.3) 
where [Pi] is the concentration of polymer chains of length i and t is the time elapsed in 
the degradation process. This assumption has been previously shown to hold true for 
dendritic systems21 and is later validated through our experimental systems. Using an 
integrating factor, Eqs. (2.2) and (2.3) can be solved for all chain lengths and generalized 
into the following form: 
[Pn-­‐i]=e-­‐kt kt i-­‐ji-­‐j !ij=0 [Pn-­‐j]0 (2.4) 
Since N,N’-dimethylimidazolidone and 4-hydroxybenzyl alcohol are ultimately released 
upon every cyclization, the concentration of either released monomer unit can be used as 
a measure of polymer degradation as follows: 
d Mdt =k   Pini=1  (2.5) 
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D t =M(t)M∞ = M(t)i[Pi]0ni=1  (2.6) 
where D(t) is the relative degradation of the self-immolative polymers at time t. Although 
not a true measure of molecular weight, the trend in the appearance of degradation 
byproducts is inversely related to the number average molecular weight. Tracking the 
degradation in this manner also allows for a more robust method of practical 
measurement in that small changes in the concentration of degradation products can be 
measured with a higher degree of accuracy compared to small changes in Mn or Mw. 
In the case of initial monodispersity, Eqs. (2.2), (2.3) and (2.5) can be solved 
algebraically to yield the following expression for the evolution of degradation products 
during the linear self-immolative process: 
M t =[Pn]0 n-­‐e-­‐kt (kt)j-­‐1j-­‐1 !ij=1ni=1  (2.7) 
Where n is the chain length of the initial monodisperse polymer species. Substituting into 
Eq. (2.6): 
D t = M tn[Pn]0=[Pn]0 1-­‐e-­‐ktn-­‐1 (kt)j-­‐1j-­‐1 !ij=1ni=1  (2.8) 
2.3.5 Mixed-Mode Degradation Kinetics 
Analysis of the system of differentials describing the linear self-immolative degradation 
process reveals a mixed-mode kinetic phenomenon unique to linear self-immolative 
polymers. Unlike traditional biodegradable polyesters that display pseudo first-order 
degradation kinetics, linear self-immolative polymers exhibit mixed-mode kinetics in 
which the degradation displays an initial pseudo zero-order phase followed by a gradual 
transition towards first-order behavior over the course of degradation. This theoretical 
behavior is consistent with our previous experimental findings for the degradation of 
linear self-immolative polymer systems that required fitting of a modified first-order 
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model to account for the sharp rise in the initial pseudo zero-order domain.39 Such 
behavior can be explained by considering that the concentration of polymer chains is not 
affected until complete degradation of a given chain into monomer units occurs (Figure 
2.4). This causes the concentration of polymer chains to remain relatively constant during 
the initial stages of degradation, thereby imparting pseudo zero-order characteristics to 
Eq. (2.5). The length and duration of the apparent zero-order phase is dependent on PDI, 
but also on the length of polymer chains, as the resistance to first-order behavior 
(polynomial term in Eq. (2.4)) is enhanced by the presence of high molecular weight 
species.   
 
Figure 2.4: Mixed-mode degradation profile for the degradation of linear self-
immolative polymers involving an initial pesudo zero-order domain followed by a 
gradual transition towards first-order behaviour 
2.3.6 Simulation Studies 
Prior to the experimental investigation of the degradation kinetics for the oligomer and 
polymer samples, computational studies were conducted to investigate the effects of 
degree of polymerization (rn) and PDI on the kinetics of self-immolative degradation. A 
series of artificial polymer distributions with varying number average chain lengths 
(Figure 2.5a) and polydispersities (Figure 2.5c) were simulated on a lognormal basis 
according to the following probability density function: 
n r = 12π 12 1σn exp -­‐(r-­‐rn)22σn2  (2.9) 
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σn=rn(PDI-­‐1)12 (2.10) 
where r is chain length, n(r) is the number fraction of chains of length r, rn is the number 
average chain length, σn is the standard deviation, and PDI is the polydispersity index. 
The set of linear differentials describing the self-immolation process (Eqs. (2.2), (2.3) and 
(2.5)) were solved numerically on the artificial polymer distributions using the 
experimentally determined rate constant for intramolecular cyclization of 1.61×10−1 
min−1 (Figure 2.5). Using the times required to reach 50% (t50) and 95% (t95) degradation, 
the computational simulations suggest that the overall degradation time is proportional to 
rn at a fixed PDI. Analysis of the effect of PDI, however, is slightly more complicated. 
The mixed-mode degradation kinetics are most pronounced for monodisperse samples 
and become skewed as PDI is increased (Figure 2.5d). This can be explained by 
considering that the fraction of both low and high molecular weight species increases as 
PDI is raised at a fixed rn. Consequently, the degradation kinetics become more heavily 
weighted towards both small and large chain lengths, which results in a minor increase to 
the relative rate of degradation early in the process and a substantial reduction to the rate 
during the latter stages. This trend is evidenced in Figure 2.5 and Table 2.1, as increases 
to the PDI resulted in a minor increase to the time required to reach 50% degradation and 
a substantial increase to the time required to reach complete degradation.  
Table 2.1: Summary of simulation studies investigating the effect of rn and PDI on 
the kinetics linear self-immolative degradation 
rn PDI t50 (min)a t95 (min)b 
10 - 37.1 161.5 
20 - 71.6 309.5 
30 - 106.1 458.3 
40 - 140.8 608.5 
20 1.00 62.3 137.2 
- 1.25 65.4 211.7 
- 1.50 69.8 281.7 
- 1.75 74.2 351.4 
- 2.00 78.7 422.5 
a – time required to reach 50% degradation 
b – time required to reach 95% degradation 
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Figure 2.5: Calculated influence of chain length (a and b) and polydispersity index 
(c-d) on the rate of self-immolative degradation. Initial weight fraction (wi) 
distributions are shown in (a and c) and the resultant degradation plots are shown 
in (b and d). (a and b): PDI=1.6, rn =10 (—), 20 (- - -), 30(···), 40(– · –). (c and d): 
rn=10, PDI=1(—), 1.25(- - -), 1.5(···), 1.75 (– · –), 2(––). All distribution and kinetic 
plots were derived from numerical solutions to Eqs. (2.2), (2.3) and (2.5) with k=1.61 
× 10−1 min−1. 
  
2.3.7 Oligomer Degradation Kinetics 
Based on the promising results of the simulation studies, the degradation kinetics for the 
oligomer samples were investigated and compared to the expected theoretical behaviour. 
The solution degradation kinetics for compounds 2.1d-2.4d were studied by 1H NMR 
spectroscopy in 3:2 0.1 M pH 7.4 phosphate buffer (D2O):acetone-d6 at 37˚C (Scheme 
2.3). The Boc protecting groups of compounds 2.1a-2.4a were cleaved by treatment with 
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TFA/CH2Cl2 and the solvent was removed to afford compounds 2.1d-2.4d. The 
oligomer-TFA salts were then washed with 1 M citric acid/brine and concentrated under 
reduced pressure to remove any residual TFA immediately prior to dissolving the 
resulting oligomers in 1 mL of buffer:acetone. Incorporation of the wash step was 
necessary to ensure the pH was maintained at 7.4 during the degradation process. Citric 
acid was selected as its pKa (3.15) was sufficiently high to remove the residual TFA, but 
also acidic enough to ensure no premature degradation occurred during the wash step 
(Figures C1-C2). The relative degradation of the oligomeric species was quantified and 
assessed by integrating the methyl peak of N,N’-dimethylimidazolidinone relative to 
residual solvent peaks in the samples. The complete degradation of all oligomer species 
except the monomer was assessed by SEC before and after the degradation studies. 
Model validation and kinetic analysis were carried out by fitting the degradation model to 
the oligomeric degradation profiles. As stated beforehand, application of the linear self-
immolative degradation model to a monodisperse sample set allows for an algebraic 
solution to the system of differentials (Eq. (2.8)) and requires no approximations in 
determining the initial polymer distribution relative to chain length. This is particularly 
important in comparing the fitted monomer cyclization rate constant between oligomer 
samples of different lengths, as any approximations in the calculation of chain length 
would alter the form of the nonlinear degradation model and introduce an artificial 
dampening or inflation to the rate constant. 
 
Scheme 2.3: Degradation of compounds 2.1-2.4d to form dimethylimidazolidinone 
and 4-hydroxybenzyl alcohol 
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As shown in Table 2.2 and Figure 2.6, the relative rate of degradation was inversely 
proportional to the length of the oligomer species, with longer oligomers requiring more 
time to degrade than shorter ones. This trend was quantified using the time to reach 50% 
degradation (t50), which was found to be proportional to the size of the oligomer species 
within experimental error (Tabe 2.2). Fitting the degradation data for each oligomer 
species to the respective solutions to Eq. (2.8) using non-linear regression provided 
reasonable fits to all of the experimental data with significant parameter estimations 
(P<0.001) and low residual standard errors (<5%) (Appendix E). Additionally, the fitting 
of all oligomeric species past the monomer stage to Eq. (2.8) offered better fits to the 
experimental data than the standard first-order degradation model (Eq. (2.8), n=1), 
evaluated based on the Akaike information criterion (AIC) and Bayesian information 
criterion (BIC) (Appendix E). More importantly, however, the monomer cyclization rate 
constants determined through non-linear regression (Table 2.2) displayed no significant 
difference based on a one-way ANOVA test (P=0.82), thereby validating the linear self-
immolative degradation model relating monomer kinetics to polymer degradation.  
Table 2.2: Kinetic parameters for the degradation of oligomers 2.1d-2.4d 
Compound k ×101 (min-1) t50 (min)a 
2.1d 1.61 ± 0.37 4.5 ± 0.9 
2.2d 1.48 ± 0.10 8.1 ± 0.9 
2.3d 1.60 ± 0.38 13.2 ± 1.7 
2.4d 1.73 ± 0.34 23.9 ± 4.3 
a – time to reach 50% degradation 
Complete degradation of the starting oligomers to the intended degradation byproducts 
was observed by 1H NMR spectroscopy (Figures C3-C6) and verified by SEC analysis 
(Figure 2.2a). The half-life for monomer cyclization of 4.5 min determined in this study 
was significantly shorter than the previously reported half-life of 35 min.37 The large 
discrepancy in the cyclization kinetics can likely be attributed to insufficient buffering of 
residual TFA from the Boc deprotection step in the previously reported case, as we found 
that the half-life was significantly longer and pH values of the solution measured using a 
microelectrode were lower when the citric acid wash was not performed. Use of the citric 
acid wash led to reproducible data for all oligomers, as demonstrated in triplicate 
experiments (Appendix E). 
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Figure 2.6: Degradation kinetics of compounds 2.1d-2.4d, as measured by 1H NMR 
spectroscopy in 0.1 M phosphate buffer (D2O):acetone-d6 (3:2) at 37˚C. 
Representative samples from triplicate runs of 2.1d (), 2.2d (¡), 2.3d (p), 2.4d (®). 
Solid lines correspond to the regressed fits of Eq. (2.8) to each generation of 
oligomer (n=1,2,4,8). (b) Degradation kinetics of polymers 2.6 (p) and 2.7 (¡), as 
measured by 1H NMR spectroscopy in 0.1 M phosphate buffer (D2O):acetone-d6 
(3:2) at 37˚C. Overlayed lines correspond to the self-immolative model fits for both 
polymers. 
2.3.8 Polymer Degradation Kinetics 
The solution degradation kinetics of polymers 2.6 and 2.7 were investigated under the 
same conditions used for compounds 2.1d-2.4d (Figure 2.1b). 1H NMR spectroscopy 
supported complete degradation of the polymers into the expected degradation products 
(Figures C7-C8), however, SEC analysis revealed the presence of a small fraction of 
0 10 20 30 40 50 60
0
20
40
60
80
100
Time (min)
Pe
rc
en
t D
eg
ra
da
tio
n 
(%
)
a)
0 30 60 90 120 150 180
0
20
40
60
80
100
Time (min)
Po
lym
er
 D
eg
ra
da
tio
n 
(%
)
b)
66 
 
polymers 2.6 (Mn=2020 g/mol, PDI=1.26) and 2.7 (Mn=8000 g/mol, PDI=1.07) 
remaining after degradation (Figure 2.2b). Similar to other studies involving linear self-
immolative polymers, this non-degraded fraction is likely related to the presence of non-
end-capped cyclic oligomers that are formed during polymerization.38-40 These peaks 
were neglected in the treatment of the degradation data as fractional analysis revealed 
that they were present at less than 3 wt% in the initial distributions. 
As shown in Figure 2.6b, the polymer degradation times were proportional to Mn, with 
polymer 2.6 reaching 50% degradation by 17.4 min and complete degradation by 150 
min, while polymer 2.7 reached 50% degradation by 41.5 min and complete degradation 
by 200 min. These trends are in agreement with the differences in Mn and follow the 
trends depicted in Figure 2.5b, as polymer 2 displayed a 2.6-fold difference in Mn and 
required 2.4 times longer to reach 50% degradation. Based on the simulation results 
shown in Figure 2.5, the slight discrepancy between the relative differences in Mn and t50 
can be attributed to the low molecular weight tailing observed for polymer 2.6, which 
leads to an increased rate of degradation in the early stages of the self-immolation 
process. Although this slight tailing would have a minor influence on the degradation 
time, the determining factor in these studies was the large difference in Mn. 
Consequently, the results of this study indicate that altering the chain length is an 
effective means to tune the rate of degradation in linear self-immolative polymers 
involving cyclization spacers. 
The degradation profile for polymers 2.6 and 2.7 were also fit to the self-immolative 
model using a modified non-linear regression algorithm in which the numerical solution 
to Eqs. (2.2), (2.3) and (2.5) was applied to the SEC chromatograms for both polymers. 
As shown in Figure 2.6b, the linear self-immolative model offered reasonable fits to the 
degradation data with standard errors of 6.6% and 4.7% and coefficients of determination 
(R2) of 0.94 and 0.98 for polymers 2.6 and 2.7, respectively (Figures E7-E8). The 
regressed monomer cyclization rate constants of 5.26 × 10−1 min−1 and 4.79 × 10−1 min−1 
for polymers 2.6 and 2.7 were higher than expected based on the oligomer data but were 
within experimental error based on the spread of rate constants determined for the 
oligomer samples (Table 2.2). Hence, the self-immolative degradation model was an 
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adequate predictor of polymer degradation and offered quantitative evidence supporting 
the influence of chain length on the degradation time. Despite the promising results 
observed in this study, further investigation into the application of the linear self-
immolative degradation model to polymeric profiles is necessary, as the degradation 
studies for polymer 2.6 and 2.7 were not performed in triplicate. In the absence of error 
measurements, no conclusive comments can be made on the potential influence of 
diffusive effects during self-immolative polymer degradation, which may limit the 
quality of the model fit available for higher molecular weight samples.   
The one major limitation of the linear self-immolative degradation model developed in 
this work is the requirement for an a priori knowledge of the chain fraction distribution 
for a given polymer sample. Absolute molecular weight data could not be obtained for 
these polymers, thereby necessitating the use of relative molecular weight data in the 
fitting of the self-immolative degradation model. Although molecular weight data relative 
to PMMA offered a more reasonable approximation compared to polystyrene in DMF, 
the molecular weights reported in this study were still overestimated by a factor of at 
least 1.6 based on the limited SEC data obtained for the monodisperse oligomers. 
Therefore, the rapid monomer cyclization rate constants determined through non-linear 
regression on the polymeric data were subject to an artificial inflation due to the use of 
relative molecular weight data. Work in our group is currently underway to extend the 
results and improve the fitting of the polymer degradation model to different systems to 
further broaden the applicability of the self-immolative degradation model as a means of 
predicting and explaining experimental degradation profiles.  
2.4 Conclusions 
In conclusion, chain length was shown as an alternate means to tune the rate of 
degradation in linear self-immolative polymers. In this work we presented a new 
convergent iterative synthesis of a set of monodisperse oligomers based on the previously 
reported linear self-immolative polymer backbone derived from alternating 4-
hydroxybenzyl alcohol and N,N’-dimethylethylenediamine spacers. The degradation time 
of these oligomers in 0.1 M pH 7.4 phosphate buffered (D2O):acetone-d6 (3:2) was 
shown to be proportional to chain length within experimental error. This finding was then 
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extended to the polydisperse case using a set of polymers synthesized to display varying 
molecular weights. A theoretical model describing linear self-immolative degradation 
was also proposed and fit to the experimental degradation profiles to provide quantitative 
evidence supporting the influence of chain length on the rate of degradation. This model 
offers new insight to the kinetics of linear self-immolative degradation in systems 
involving cyclization spacers and provides a means of relating monomer kinetics to the 
relative rate of polymer degradation. In conjunction with rational monomer design, the 
controlled use of chain length should allow for two-dimensional tuning of the 
depolymerization times in linear self-immolative polymers and thus significantly expand 
the usefulness of these materials for diverse applications such as sensing and 
programmable release. 
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Chapter 3  
3 Progress Towards a Redox-Sensitive Self-Immolative 
Block Copolymer 
3.1 Introduction 
Self-immolative polymers have emerged as promising alternatives to traditional 
biodegradable polymers and offer new levels of control to the degradation process.1-5 In 
contrast to traditional biodegradable materials, self-immolative polymers undergo end-to-
end depolymerization through a cascade of intramolecular reactions upon response to a 
specific trigger (Figure 3.1a). This mechanism of degradation possesses several key 
advantages over the random hydrolytic cleavage of conventional biodegradable polymers 
as it permits stimuli-responsive degradation, allows for an amplified response to a 
triggering agent, and is regulated by the composition and architecture of the polymer 
backbone. To exploit these effects, a wide variety of self-immolative polymer backbones 
and architectures have been designed for signal amplification,6-12 shape-memory,13 
protein labeling,14 self-healing,15 microfluidics,16 and drug delivery applications17-20 
following their initial development in dendritic systems.21-23 
Our group,19,24-26 along with several others,13-16,27-31 have focused on the design and 
synthesis of linear self-immolative polymers for biomedical applications. Although no 
longer monodisperse, linear self-immolative polymers can be synthesized in a single step 
and allow for a practical and scalable means of preparing self-immolative materials. At 
the current stage of development, these polymers can be grouped into four general classes 
based on the their mechanism of degradation and include those that degrade through: (i) 
1,6-eliminations,14,15,27,28 (ii) cyclization reactions,24 (iii) alternating 1,6-eliminations and 
cyclizations,19,20,26 or (iv) hemiacetal decompositions.13,16,29-31 The predominant focus of 
our group over the last several years has been to develop linear self-immolative polymer 
backbones incorporating different cyclization spacers to control and tune the rate of self-
immolative degradation. Compared to the systems that depolymerize through 1,6-
eliminations and hemiacetal decompositions, cyclization based systems display slower 
degradation kinetics, making them ideal candidates for controlled release applications.  
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Figure 3.1: Linear self-immolative block copolymers synthesized using a 
poly(ethylene glycol) (PEG) end cap. (a) Generic diagram depicting the basic 
structure and mechanism of degradation. (b) Previously reported linear self-
immolative block copolymer synthesized using a PEG acid end cap. (c) Diagram 
showing the self-assembly of amphiphilic linear self-immolative block copolymers in 
aqueous solution to form micelles for the encapsulation of hydrophobic drug 
molecules.  
The investigation of self-immolative polymers incorporating cyclization spacers for 
controlled release applications is limited to two different and fundamentally distinct 
studies. Our group was the first to explore this potential using our initial polycarbamate 
backbone derived from alternating 4-hydroxybenzyl alcohol and N,N’-
dimethylethylenediamine spacers.19 Utilizing a poly(ethylene glycol) end-cap we were 
able to generate an amphiphilic self-immolative block copolymer that self-assembled in 
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aqueous solution to form micelles. Hydrolytic cleavage of the PEG end-cap following 
incubation in a pH 7.4 phosphate buffer at 37˚C initiated a cascade of alternating 1,6-
elimination, decarboxylation, and cyclization reactions to degrade the polymer backbone 
over a period of approximately 30 days (Figure 3.1b). These block copolymer micelles 
were also demonstrated to encapsulate a model hydrophobic drug, nile red, and provide a 
controlled release throughout a 15 day period (Figure 3.1c). The major design flaw of this 
block copolymer system, however, was the incorporation of the PEG end-cap through a 
hydrolytically sensitive ester linkage. As a result, this design relied on a non-specific 
triggering factor to initiate degradation, and thus, failed to exploit the potential for 
stimuli-responsive degradation in self-immolative systems. 
Using the same polycarbamate backbone, Almutairi and coworkers have recently 
generated hydrophobic nanoparticles incorporating UV and NIR sensitive end-caps 
through an emulsification method.20 These nanoparticles were capable of encapsulating 
nile red, but demonstrated a significant burst release profile following exposure to 
UV/NIR light due to the poor aqueous solubility of the polymer backbone. Nevertheless, 
this system and its degradation products were well tolerated in vitro and displayed 
comparable non-toxicity to the FDA approved poly(lactic acid-co-glycolic acid) (PLGA). 
The results of these two studies have laid a promising groundwork for the use self-
immolative polymers incorporating cyclization spacers for controlled release 
applications. However, additional development of functional self-immolative 
nanoparticles is necessary before this system can be effectively applied for the controlled 
release of hydrophobic molecules.  
We herein report a follow-up study to our self-immolative block copolymer system to 
address the limitations of our initial design19 (Figure 3.1). We first develop an alternative 
pathway to synthesize a low-cost alternative to our initial design using a PEG-succinic 
acid end cap and use this system to investigate the potential for self-assembly into 
different block copolymer morphologies. Furthermore, we propose and develop a 
reduction sensitive PEG-self-immolative block copolymer using a new modular approach 
in which backbone polymerization and PEG incorporation are decoupled from one 
another. This is accomplished using a N-methylaminoethanethiol end-cap during 
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polymerization and subsequently modifying this polymer with a PEG thiol derivative to 
produce a PEG-self-immolative block copolymer incorporating a disulfide linkage 
between both blocks. This strategy should offer more control over the synthesis of such 
block copolymer systems as it minimizes the steps required to incorporate the PEG end 
cap and permits a higher degree of control over the length of either block. Lastly, the 
degradation kinetics and self-assembly characteristics of this reduction sensitive block 
copolymer system are investigated under physiological conditions. This reduction 
sensitive PEG-self-immolative block copolymer system displays promise for the 
controlled release of hydrophobic drugs in mildly reducing environments. Such 
conditions are typically encountered in hypoxic tumour tissues, in which the 
concentration of the reducing agent glutathione is 4-fold higher than in healthy tissues,32 
or intracellularly where the concentration of glutathione is 0.5-1.0 mM compared to 2-20 
µM in the extracellular environment.33,34 
3.2 Experimental 
3.2.1 General Procedures and Materials 
All reagents were purchased from commercial suppliers and used without further 
purification unless otherwise noted. Anhydrous toluene was obtained from a solvent 
purification system using aluminum oxide columns. Dichloromethane (CH2Cl2), pyridine, 
triethylamine (NEt3), and N,N-diisopropylethylamine (DIPEA) were distilled from CaH2 
immediately prior to use. Unless otherwise stated, all reactions were performed under an 
Ar atmosphere using flame-dried glassware. Column chromatography was performed 
using silica gel (0.040 – 0.063 mm particle size, 230 – 430 mesh). Thin layer 
chromatography (TLC) was carried out using EMD silica gel 60 F254 plates (20 cm × 20 
cm, 250 µm). Deionized water was purified using a Millipore purification system. 
Dialyses were performed using Spectra/Por® regenerated cellulose membranes with 
either a 6000-8000 g/mol or 25000 g/mol molecular weight cutoff (MWCO). 
1H NMR spectra were obtained at 400 MHz or 600 MHz using a Varian INOVA 
spectrometer, while 13C NMR spectra were obtained at 100 MHz using a Varian INOVA 
spectrometer. Chemical shifts are reported in ppm versus tetramethylsilane and 
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referenced to residual solvent signals of CDCl3 (δ 7.26, 77.2), (CD3)2CO (δ 2.05), or D2O 
(δ 4.79). Coupling constants are expressed in Hz. High resolution mass spectrometry 
(HRMS) was performed on either a Finnigan MAT 8400 or a PE-Sciex API 365 mass 
spectrometer using electron impact (EI) or electrospray (ESI) ionization, respectively. 
Fourier transform infrared spectra were obtained using a Bruker Tensor 27 from CH2Cl2 
films on KBr plates. Size exclusion chromatography (SEC) was carried out at a flow rate 
of 1 mL/min in N,N- dimethylformamide (DMF) with 10 mM LiBr and 1% (v/v) NEt3 at 
85˚C using a Waters 2695 separations module equipped with a Waters 2414 differential 
refractometer and two PLgel 5 µm mixed-D (300 mm × 7.5 mm) columns from Polymer 
Laboratories connected in series. SEC calibrations were performed using either 
poly(methyl methacrylate) (PMMA) or poly(ethylene glycol) (PEG) standards. Dynamic 
light scattering (DLS) data was obtained using a Zetasizer Nano ZS instrument from 
Malvern Instruments. 
3.2.2 Synthesis 
Synthesis of Compound 3.1a. Poly(ethylene glycol) monomethylether  (PEGMME) (2000 
g/mol) (5.00 g, 2.5 mmol, 1.0 equiv) and succinic anhydride (2.50 g, 25 mmol, 10 equiv) 
were dissolved in 50 mL of dry CH2Cl2 and stirred at room temperature for 5 min. NEt3 
(7.0 mL, 50 mml, 20 equiv) and DMAP (0.32 g, 2.5 mmol, 1 equiv) were added and the 
solution was refluxed at 45˚C for 24 h. The reaction mixture was diluted with CH2Cl2 and 
poured over 1:1 1M HCl:brine. The product was re-extracted from the aqueous layer 5 
times using CH2Cl2. The combined organic layers were dried over MgSO4, filtered, and 
concentrated in vacuo. The crude product was then dissolved in 10 mL of DMF and 
dialyzed against DMF for 24 h (1 L, 1 solvent change) using a regenerated cellulose 
membrane (3500 g/mol MWCO). The contents of the dialysis membrane were then 
concentrated in vacuo and lyophilized to afford compound 3.1a (4.12 g, 78%). 1H NMR 
(CDCl3, 600 MHz): δ 4.28-4.23 (m, 2H), 3.89-3.43 (m, 170H), 3.37 (s, 3H), 2.68-2.58 
(m, 6H).  
Synthesis of Compound 3.1b. Compound 3.1b was synthesized using an identical 
procedure to 3.1a except that 5000 g/mol molecular weight PEGMME was used in place 
of 2000 g/mol molecular weight PEGMME. The quantities of reagents used were 
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PEGMME (5000 g/mol) (4.99 g, 1.0 mmol, 1.0 equiv), succinic anhydride (1.00 g, 10 
mmol, 10 equiv), NEt3 (2.0 mL, 20 mmol, 20 equiv), and DMAP (0.13 g, 1 mmol, equiv). 
The crude product was purified through dialysis against DMF using a regenerated 
cellulose membrane (3500 g/mol MWCO) and lyophilized to afford compound 3.1a (4.34 
g, 85%). 1H NMR (CDCl3, 600 MHz): δ 4.25-4.22 (m, 2H), 3.81-3.44 (m, 574H), 3.36 (s, 
3H), 2.66-2.58 (m, 6H). 
Synthesis of Compound 3.2a. Compound 3.1a (2.96 g, 1.41 mmol, 1.0 equiv) was 
dissolved in 30 mL of dry CH2Cl2. Pyridine (3.10 mL, 28.2 mmol, 20 equiv) and 4-
nitrophenyl chloroformate (2.85 g, 14.2 mmol, 10 equiv) were successively added and the 
solution was stirred at room temperature for 24 h. The reaction mixture was diluted with 
CH2Cl2 and poured over 1:1 1M HCl:brine. The product was re-extracted from the 
aqueous layer 5 times using CH2Cl2. The combined organic layers were dried over 
MgSO4, filtered, and concentrated in vacuo to a volume of approximately 5 mL. The 
crude product was then precipitated out of 300 mL of cold Et2O to afford 3.2a (2.80 g, 
89%). 1H NMR (CDCl3, 600 MHz): δ 8.24 (m, 2H), 7.28 (m, 2H), 4.29-4.23 (m, 2H), 
3.83-3.40 (m, 180H), 3.65 (s, 3H), 2.92-2.85 (m, 2H), 2.81-2.74 (m, 2H). MS (MALDI-
TOF) [M+Na]+: 1904.9.  
Synthesis of Compound 3.2b. Compound 3.2b was synthesized using an identical 
procedure to 3.2a. The quantities of reagents used were 3.1b (4.08 g, 0.80 mmol, 1 
equiv), 4-nitrophenyl chloroformate (1.61 g, 8.0 mmol, 10 equiv), and pyridine (1.74 mL, 
16.0 mmol, 20 equiv).  The crude product was precipitated out of 500 mL of cold Et2O to 
afford 3.2b (3.85 g, 92%). 1H NMR (CDCl3, 600 MHz): δ 8.25 (m, 2H), 7.29 (m, 2H), 
4.28-4.26 (m, 2H), 3.77-3.48 (m, 591H), 3.36 (s, 3H), 2.92-2.88 (m, 2H), 2.81-2.76 (m, 
2H).   
Synthesis of Compound 3.4a. Compound 3.2a (2.72 g, 1.22 mmol, 1.0 equiv) was 
dissolved in 30 mL of dry CH2Cl2. NEt3 (3.40 mL, 24.4 mmol, 20 equiv) and 3.3 (2.95 g, 
12.4 mmol, 10 equiv) were successively added and the solution was stirred at room 
temperature for 24 h. The reaction mixture was diluted with CH2Cl2 and poured over 1:1 
1M HCl:brine. The product was re-extracted from the aqueous layer 5 times using CH2-
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Cl2. The combined organic layers were dried over MgSO4, filtered, and concentrated in 
vacuo to a volume of approximately 5 mL. The crude product was then precipitated out 
of 300 mL of cold Et2O to afford 3.4a (2.17 g, 77%). 1H NMR (CDCl3, 600 MHz): δ 7.28 
(m, 2H), 7.01 (m, 2H), 4.69 (s, 2H), 4.27-4.21 (m, 2H), 3.86-3.41 (m, 190H), 3.35 (s, 
3H), 2.88-2.82 (m, 2H), 2.78-2.70 (m, 2H).  MS (MALDI-TOF) [M+Na]+: 2092.2. 
Synthesis of Compound 3.4b. Compound 3.4b was synthesized using an identical 
procedure to 3.4a. The quantities of reagents used were 3.2b (4.08 g, 0.80 mmol, 1 
equiv), 3.3 (1.88 g, 7.8 mmol, 10 equiv) and NEt3 (2.20 mL, 15.7 mmol, 20 equiv).  The 
crude product was precipitated out of 400 mL of cold Et2O to afford 3.4b (3.47 g, 86%). 
1H NMR (CDCl3, 600 MHz): δ 7.30 (m, 2H), 7.03 (m, 2H), 4.70 (s, 2H), 4.28-4.24 (m, 
2H), 3.82-3.47 (m, 590H), 3.37 (s, 3H), 2.89-2.84 (m, 2H), 2.78-2.74 (m, 2H). 
Synthesis of Compound 3.5a. Compound 3.4a (2.12 g, 0.91 mmol, 1.0 equiv) was 
dissolved in 25 mL of 1% HCl in 3:1 EtOH:CH2Cl2 and stirred at room temperature for 1 
h. The reaction mixture was diluted with CH2Cl2 and poured over saturated NaHCO3. The 
product was re-extracted from the aqueous layer 5 times using CH2Cl2. The combined 
organic layers were dried over MgSO4, filtered, and concentrated in vacuo to a volume of 
approximately 5 mL. The crude product was then precipitated out of 300 mL of cold Et2O 
to afford 3.5a (1.50 g, 75%). 1H NMR (CDCl3, 600 MHz): δ 7.36 (m, 2H), 7.06 (m, 2H), 
4.65 (s, 2H), 4.29-4.23 (m, 2H), 3.83-3.40 (m, 181H), 3.36 (s, 3H), 2.90-2.83 (m, 2H), 
2.79-2.73 (m, 2H). MS (MALDI-TOF) [M+Na]+: 2066.1. 
Synthesis of Compound 3.5b. Compound 3.5b was synthesized using an identical 
procedure to 3.5a. The quantities of reagents used were 3.4b (3.54 g, 0.67 mmol, 1 
equiv).  The crude product was precipitated out of 400 mL of cold Et2O to afford 3.5b 
(2.84 g, 81%). 1H NMR (CDCl3, 600 MHz): δ 7.29 (m, 2H), 7.02 (m, 2H), 4.70 (s, 2H), 
4.28-4.23 (m, 2H), 3.81-3.45 (m, 558H), 3.36 (s, 3H), 2.89-2.83 (m, 2H), 2.79-2.72 (m, 
2H).  
Synthesis of Compound 3.6a. Compound 3.5a (0.50 g, 0.23 mmol, 1.0 equiv) was 
dissolved in 8 mL of dry CH2Cl2. Pyridine (0.40 mL, 4.6 mmol, 20 equiv) and 4-
nitrophenyl chloroformate (0.47 g, 2.3 mmol, 10 equiv) were successively added and the 
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reaction mixture was stirred at room temperature for 24 h. The reaction mixture was 
diluted with CH2Cl2 and poured over 1:1 1M HCl:brine. The product was re-extracted 
from the aqueous layer 5 times using CH2Cl2. The combined organic layers were dried 
over MgSO4, filtered, and concentrated in vacuo to a volume of approximately 3 mL. The 
crude product was then precipitated out of 80 mL of cold Et2O to afford 3.6a (0.44 g, 
86%). 1H NMR (CDCl3, 600 MHz): δ 8.26 (m, 2H), 7.45 (m, 2H), 7.37 (m, 2H), 7.14 (m, 
2H), 5.27 (s, 2H), 4.29-4.24 (m, 2H), 3.84-3.41 (m, 191H), 3.37 (s, 3H), 2.92-2.84 (m, 
2H), 2.80-2.73 (m, 2H). MS (MALDI-TOF) [M+Na]+: 2231.2. 
Synthesis of Compound 3.6b. Compound 3.6b was synthesized using an identical 
procedure to 3.6a. The quantities of reagents used were 3.5b (0.99 g, 0.19 mmol, 1 
equiv), pyridine (0.31 mL, 3.8 mmol, 20 equiv), and 4-nitrophenyl chloroformate (0.38 g, 
1.9 mmol, 10 equiv).  The crude product was precipitated out of 100 mL of cold Et2O to 
afford 3.6b (0.85 g, 83%).1H NMR (CDCl3, 600 MHz): δ 8.25 (m, 2H), 7.44 (m, 2H), 
7.36 (m, 2H), 7.13 (m, 2H), 5.26 (s, 2H), 4.28-4.23 (m, 2H), 3.84-3.41 (m, 566H), 3.35 
(s, 3H), 2.90-2.84 (m, 2H), 2.79-2.73 (m, 2H).  
Synthesis of Polymer 3.7a. Activated monomer 2.1c19 (1.02 g, 2.0 mmol, 1.0 equiv) was 
dissolved in 3 mL of 1:1 TFA:CH2Cl2 and stirred at room temperature for 2 h. The 
solvent was then removed under a stream of nitrogen in the fume hood prior to subjecting 
the reaction mixture three times to a repeat cycle of dilution with CH2Cl2 followed by 
concentration under reduced pressure to remove residual TFA and provide the 
deprotected monomer 2.5.19 End-cap 3.6a (0.22 g, 0.10 mmol, 0.05 equiv) was added and 
the resulting mixture was dissolved in 8 mL of anhydrous toluene and stirred at room 
temperature for 5 min. NEt3 (1.4 mL, 10 mmol, 5.0 equiv) and DMAP (62 mg, 0.50 
mmol, 0.25 equiv) were sequentially added and the solution was then cooled to -15˚C and 
stirred for 24 h. The solution was then warmed to room temperature and stirred for an 
additional 36 h. The reaction mixture was diluted with CH2Cl2 and poured over 1:1 1 M 
citric acid:brine and extracted from the aqueous layer 5 times with CH2Cl2. The 
combined organic layers were then washed with saturated NaHCO3 and extracted from 
the aqueous layer an additional 5 times with CH2Cl2. The combined organic layers were 
dried over MgSO4, filtered, and concentrated in vacuo. The crude polymer was dissolved 
80 
 
in 2 mL of DMF and dialyzed against DMF for 24 h (200 mL, 1 solvent change) using a 
regenerated cellulose membrane (25000 g/mol MWCO). The contents of the dialysis 
membrane were then concentrated in vacuo and lyophilized to afford polymer 3.7a (0.29 
g, 40%). 1H NMR indicated a degree of polymerization of ∼ 18 by integrating the 
benzylic peak against the PEG end-cap. 1H NMR (CDCl3, 600 MHz): δ 7.44-7.28 (br, 
36H), 7.14-7.00 (br, 35H), 5.16-5.04 (m, 35 H), 4.29-4.25 (m, 2H), 3.81-3.40 (m, 369H), 
3.38 (s, 4H), 3.21-2.84 (m, 102H), 2.80-2.74 (m, 2H). SEC: Mn=3600 g/mol, Mw=5290 
g/mol, PDI=1.47 (PEG standards). 
Synthesis of Polymer 3.7b. Activated monomer 2.1c19 (1.02 g, 2.0 mmol, 1.0 equiv) was 
dissolved in 3 mL of 1:1 TFA:CH2Cl2 and stirred at room temperature for 2 h. The 
solvent was then removed under a stream of nitrogen in the fume hood prior to subjecting 
the reaction mixture three times to a repeat cycle of dilution with CH2Cl2 followed by 
concentration under reduced pressure to remove residual TFA and provide the 
deprotected monomer 2.5.19 End-cap 3.6b (0.51 g, 0.10 mmol, 0.05 equiv) was added and 
the resulting mixture was dissolved in 8 mL of anhydrous toluene and stirred at room 
temperature for 5 min. NEt3 (1.4 mL, 10 mmol, 5.0 equiv) and DMAP (62 mg, 0.50 
mmol, 0.25 equiv) were sequentially added and the solution was stirred at -15˚C for 24 h. 
The reaction was then warmed to room temperature and stirred for an additional 36 h. 
The reaction mixture was diluted with CH2Cl2 and poured over 1:1 1M citric acid:brine 
and extracted from the aqueous layer 5 times with CH2Cl2. The combined organic layers 
were then washed with saturated NaHCO3 and extracted from the aqueous layer an 
additional 5 times with CH2Cl2. The combined organic layers were dried over MgSO4, 
filtered, and concentrated in vacuo. The crude polymer was dissolved in 2 mL of DMF 
and dialyzed against DMF for 24 h (200 mL, 1 solvent change) using a regenerated 
cellulose membrane (25000 g/mol MWCO). The contents of the dialysis membrane were 
then concentrated in vacuo and lyophilized to afford polymer 3.7b (0.55 g, 51%). 1H 
NMR indicated a degree of polymerization of ∼ 10 by integrating the benzylic peak 
against the PEG end-cap. 1H NMR (CDCl3, 600 MHz): δ 7.41-7.27 (br, 20H), 7.12-7.00 
(br, 18H), 5.15-5.04 (m, 19H), 4.29-4.25 (m, 2H), 3.80-3.41 (m, 712H), 3.37 (s, 4H), 
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3.16-2.83 (m, 56H), 2.79-2.74 (m, 2H). SEC: Mn=7170 g/mol, Mw=8650 g/mol, 
PDI=1.21 (PEG standards). 
Synthesis of Compound 3.11. Compound 3.835 (0.88 g, 2.9 mmol, 1.4 equiv)  was 
dissolved in 3 mL of 1:1 TFA:CH2Cl2 and stirred at room temperature for 2 h. The 
solvent was then removed under a stream of nitrogen in the fume hood prior to subjecting 
the reaction mixture three times to a repeat cycle of dilution with CH2Cl2 followed by 
concentration under reduced pressure to remove residual TFA and provide the Boc-
deprotected compound 3.9. Compound 3.10 (2.0 mmol, 1.0 equiv) was added and the 
resulting mixture was dissolved in 10 mL of anhydrous toluene. DIPEA (1.80 mL, 10.3 
mmol, 5.3 equiv) and DMAP (40 mg, 0.4 mmol, 0.2 equiv) were successively added to 
the reaction flask and the solution was stirred at room temperature overnight. The 
reaction mixture was diluted with CH2Cl2 and washed once with 1 M HCl, twice with 1 
M Na2CO3, and once with brine. The organic layer was then dried over MgSO4, filtered, 
and concentrated in vacuo. The resulting oil was purified through silica gel 
chromatography (1:9 EtOAc:CH2Cl2) to afford compound 3.11 as a pale yellow oil (0.65 
g, 71%). 1H NMR (CDCl3, 600 MHz): δ 8.49 (d, J=4.8, 1H), 7.74-7.59 (m, 2H), 7.29 (m, 
2H), 7.12-7.09 (m, 1H), 7.08-7.00 (m, 2H), 4.71 (s, 2H), 3.76 & 3.66 (m, rotamers, 2H), 
3.14 & 3.03 (m, rotamers, 3H), 3.10-3.03 (m, 2H), 0.93 (s, 9H), 0.09 (s, 6H). 13C NMR 
(CDCl3, 100 MHz): δ 159.8, (154.9 &154.7, rotamers), (150.2 & 149.9, rotamers), 138.5, 
137.2, 127.0, 121.5, 121.4, (121.0 & 120.9, rotamers), (120.1 & 120.0, rotamers), 64.6, 
(49.0 & 48.4, rotamers),(36.6, 36.1, & 35.9, rotamers), 26.0, 18.5, -5.1. FT-IR 
(νmax/cm−1): 2955, 2930, 2885, 2856, 1722, 1574, 1562, 1510. HRMS: calcd [M]+ 
(C22H32N2O3S2Si): 464.1624. Found (EI): 464.1619.  
Synthesis of Compound 3.12. Compound 3.11 (0.49 g, 1.1 mmol, 1 equiv) was dissolved 
in 4 mL of 1% HCl in EtOH and stirred at room temperature for 1.5 h. The reaction 
mixture was diluted with CH2Cl2 and washed with saturated NaHCO3. The organic layer 
was then dried over MgSO4, filtered, and concentrated in vacuo. The resulting oil was 
purified through silica gel chromatography (2:3 EtOAc:CH2Cl2) to afford compound 3.12 
as a pale yellow oil (0.33 g, 88%). 1H NMR (CDCl3, 600 MHz): δ 8.48 (d, J=5.0, 1H), 
7.74-7.60 (m, 2H), 7.37 (m, 2H), 7.13-7.08 (m, 2H), 7.06 (d, J=8.5, 1H), 4.66 (s, 2H), 
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3.77 & 3.67 (m, rotamers, 2H), 3.14 & 3.03 (m, rotamers, 3H), 3.09-3.03 (m, 2H). 13C 
NMR (CDCl3, 100 MHz): δ  (159.7 & 159.5, rotamers), (154.9 & 154.6, rotamers), 
(150.6 & 150.5, rotamers), 138.3, 137.2, 127.9, (121.7 &121.6, rotamers), (121.0 & 
120.9, rotamers), (120.1 & 120.0, rotamers), 64.5, (48.9 & 48.3, rotamers), (36.5 & 36.0, 
rotamers), (35.9 & 35.5). FT-IR (νmax/cm−1): 2926, 2870, 1717, 1576, 1562, 1510. 
HRMS: calcd [M]+ (C16H18N2O3S2): 350.0759. Found (EI): 350.0768.  
Synthesis of Compound 3.13. Compound 3.12 (0.25 g, 0.64 mmol, 1.0 equiv) was 
dissolved in 4 mL of dry CH2Cl2. Pyridine (0.16 mL, 1.9 mmol, 2.0 equiv) and 4-
nitrophenyl chloroformate (0.26 g, 1.3 mmol, 2.0 equiv) were successively added to the 
reaction flask and the solution was stirred for 1.5 h at room temperature until completion 
as determined by TLC. The reaction mixture was diluted with CH2Cl2 and washed with 
1M HCl followed by saturated NaHCO3. The organic layer was then dried over MgSO4, 
filtered, and concentrated in vacuo. The resulting oil was purified through silica gel 
chromatography (CH2Cl2, then 1:9 EtOAc:CH2Cl2) to afford compound 3.13 as a pale 
yellow oil (0.31 g, 92%). 1H NMR (CDCl3, 600 MHz): δ 8.46 (d, J=4.2, 1H), 7.70-7.59 
(m, 2H), 7.45-7.39 (m, 2H),  7.35 (m, 2H), 7.15 (m,  2H), 7.13-7.07 (m, 2H), 5.25 (s, 
2H), 3.77 & 3.66 (m, rotamers, 2H), 3.13 & 3.02 (m, roatmers, 3H), 3.08-3.03 (m, 2H). 
13C NMR (CDCl3, 100 MHz): (159.9 & 159.4, rotamers), 155.5, (154.5 & 154.2, 
rotamers), 152.4, 151.9, (149.9 & 149.8, rotamers), 145.5, 137.1, 131.2, 130.0, 125.3, 
(122.1 &122.0, rotamers), 121.9, (121.0 & 120.9, rotamers), (120.1 & 120.0, rotamers), 
70.4, (48.9 & 48.2, rotamers), (36.4 & 36.0, rotamers), (35.9 & 35.4, rotamers). FT-IR 
(νmax/cm−1): 3117, 3080, 3047, 2957, 2930, 1767, 1720, 1616, 1593, 1574, 1562, 1524. 
HRMS: calcd [M]+ (C23H21N3O7S2): 515.0821. Found (EI): 515.0845. 
Synthesis of Polymer 3.14. Activated monomer 2.1c19 (0.67 g, 1.3 mmol, 1.0 equiv) was 
dissolved in 3 mL of 1:1 TFA:CH2Cl2 and stirred at room temperature for 2 h. The 
solvent was then removed under a stream of nitrogen in the fume hood prior to subjecting 
the reaction mixture three times to a repeat cycle of dilution with CH2Cl2 followed by 
concentration under reduced pressure to remove residual TFA and provide the 
deprotected monomer 2.5.19 End-cap 3.13 (30 mg, 0.07 mmol, 0.05 equiv) was added and 
the resulting mixture was dissolved in 4.4 mL of anhydrous toluene and cooled to 0˚C. 
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NEt3 (0.92 mL, 6.6 mmol, 5.0 equiv) and DMAP (33 mg, 0.27 mmol, 0.2 equiv) were 
sequentially added and the solution was stirred at 0˚C for 8h, let warm to room 
temperature, and stirred an additional 16 h. The solvent was then evaporated under 
reduced pressure and the crude polymer was dissolved in 2 mL of DMF and dialyzed 
against DMF for 24 h (200, mL, 1 solvent change) using a regenerated cellulose 
membrane (12000-14000 g/mol MWCO). The contents of the dialysis membrane were 
then concentrated in vacuo and lyophilized to afford polymer 3.14 (0.21 g, 60%). 1H 
NMR indicated a degree of polymerization of ∼ 25 by integrating the benzylic peak 
against the thiopyridyl end-cap. 1H NMR (CDCl3, 400 MHz): δ 8.46 (d, J=5.3, 1H), 7.70-
7.59 (m, 2H), 7.40-7.27 (br, 48H), 7.11-6.99 (br, 50H), 5.14-5.01 (m, 48H), 3.62-3.37 (m, 
94H), 3.75 & 3.65 (m, rotamers, 2H), 3.16-2.83 (m, 209H). SEC: Mn=3150 g/mol, 
Mw=5440 g/mol, PDI=1.73 (PEG-PEO standards). Mn=5580 g/mol, Mw=9720 g/mol, 
PDI=1.74 (PEG-PEO standards). 
Synthesis of Polymer 3.16. Poly(ethylene glycol) thioacetate derivative (5000 g/mol) 
3.1736,37 (20 mg, 4 µmol, 0.6 equiv) was dissolved in 2 mL of 1:2 freshly distilled 
CH2Cl2:MeOH and cooled to 0˚C.  Polymer 3.14 (30 mg, 7 µmol, 1.0 equiv) and NaOMe 
(6 mg, 0.1 mmol, 16 equiv) were added and the solution was stirred at 0˚C for 8 h and 
then stirred an additional 8 h at room temperature. The crude reaction mixture was 
concentrated in vacuo and then dissolved in CH2Cl2 and washed with a 1:1 mixture of 1 
M HCl:brine. The product was re-extracted from the aqueous layer an additional 5 times 
with CH2Cl2. The combined organic layers were dried over MgSO4, filtered, and 
concentrated in vacuo. The crude product was dissolved in 2 mL of DMF and dialyzed 
against DMF for 24 h (200 mL, 1 solvent change) using a regenerated cellulose 
membrane (12000-14000 g/mol MWCO). The contents of the dialysis membrane were 
then concentrated in vacuo and lyophilized to afford polymer 3.16 (37 mg, 57%). 1H 
NMR indicated a degree of polymerization of ∼ 28 by integrating the benzylic peak 
against the PEG end-cap. 1H NMR (CDCl3, 600 MHz): δ 7.39-7.27 (br, 56H), 7.11-6.95 
(br, 56H), 5.16-5.02 (m, 57H), 3.78-3.41 (m, 644H), 3.37 (s, 3H), 3.16-2.84 (m, 179H). 
SEC: Mn=5200 g/mol, Mw=7330 g/mol, PDI=1.41 (PEG-PEO standards). 
84 
 
Synthesis of Compound 3.18. Compound 3.1738 (0.40 g, 2.9 mmol, 1.0 equiv) and NEt3 
(0.70 mL, 9.5 mmol , 3.3 equiv) were added to 10 mL of dry CH2Cl2 cooled to 0˚C. 4-
Nitrophenyl chloroformate (0.65 g, 3.2 mmol, 1.1 equiv) dissolved in 5 mL of CH2Cl2 
was added dropwise to the reaction mixture over 20 min. The solution was warmed to 
room temperature and stirred an additional 1.5 h until completion as determined by TLC. 
Freshly distilled triethylene glycol monomethyl ether (0.36 mL, 1.3 mmol, 0.45 equiv) 
was added and the reaction was stirred for 30 min to quench the remaining 4-nitrophenyl 
chloroformate. The reaction mixture was diluted with CH2Cl2 and washed with 1 M HCl. 
The organic layer was dried over MgSO4, filtered, and concentrated in vacuo. The crude 
solid was purified through silica gel chromatography (1:49 EtOAc:CH2Cl2) to afford 3.18 
as a white solid (0.71 g, 80%). 1H NMR (CDCl3, 600 MHz): δ 8.28 (m, 2H), 7.45 (m, 
2H), 7.37 (m, 2H), 7.23 (m, 2H), 4.44 (s, 2H), 3.37 (s, 3H). 13C NMR (CDCl3, 100 MHz): 
δ 155.3,151.0,150.1,145.6,128.9, 125.4, 121.8, 120.7, 73.9, 58.3. FT-IR (νmax/cm−1): 
2928, 2854, 1763, 1726, 1618, 1595, 1526. HRMS: calcd [M]+ (C15H13NO6): 303.0743. 
Found (EI): 303.0749. 
Synthesis of Compound 3.19. Compound 3.9 was synthesized using the same procedure 
outlined above. Compound 3.9 (0.24 g, 0.77 mmol, 1.5 equiv) and compound 3.18 (0.16 
g, 0.51 mmol, 1.0 equiv) were dissolved in 5 mL of dry toluene. DIPEA (0.42 mL, 3.9 
mmol, 5.0 equiv) and DMAP (20 mg, 0.15 mmol, 0.30 equiv) were successively added to 
the reaction flask and the solution was stirred at room temperature overnight. The 
reaction mixture was then diluted with CH2Cl2 and washed with 1M HCl, followed by 1 
M Na2CO3 and brine. The organic layer was dried over MgSO4, filtered, and concentrated 
in vacuo. The resulting oil was purified through silica gel chromatography (3:20 
EtOAc:CH2Cl2) to afford 3.19 as a pale yellow oil (0.13 g, 70%).  1H NMR (CDCl3, 600 
MHz): δ 8.48 (d, J=5.3, 1H), 7.72-7.59 (m, 2H), 7.33-7.28 (m, 2H), 7.13-7.06 (m, 2H), 
7.06-7.02 (d, J=8.0, 1H), 4.43 (s, 2H), 3.76 & 3.66 (m, rotamers, 2H), 3.36 (s, 3H), 3.14 
& 3.02 (rotamers, 3H), 3.09-3.03 (m, 2H).13C NMR (CDCl3, 100 MHz): δ (159.7 & 
159.4, rotamers), (154.7 & 154.5, rotamers), 150.7, (149.8, & 149.7, rotamers), 137.1, 
135.3, 128.6, 121.6, (121.0 & 120.9, rotamers), (120.0 & 119.9, rotamers), 74.1, (48.9 & 
48.3, rotamers), (36.5 & 36.0, rotamers), (35.8, & 35.5, rotamers). FT-IR (νmax/cm−1): 
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2926, 2854, 2822, 1722, 1574, 1562, 1510. HRMS: calcd [M]+ (C17H20N2O3S2): 
364.0915. Found (EI): 364.0916. 
Synthesis of Compound 3.21. Compound 3.20 (0.14 g, 0.76 mmol, 1.5 equiv) and 
compound 3.18 (0.15 g, 0.50 mmol, 1.0 equiv) were dissolved in 3 mL of dry toluene. 
DIPEA (0.26 mL, 1.5 mmol, 3.0 equiv) and DMAP (13 mg, 0.11 mmol, 0.21 equiv) were 
successively added to the reaction flask and the solution was stirred at room temperature 
overnight. The reaction mixture was then diluted with CH2Cl2 and washed with 1M HCl, 
followed by 1 M Na2CO3 and brine. The organic layer was dried over MgSO4, filtered, 
and concentrated in vacuo. The resulting oil was purified through silica gel 
chromatography (3:20 EtOAc:CH2Cl2) to afford 3.20 as a pale yellow oil (0.16 g, 92%).  
1H NMR (CDCl3, 600 MHz): 7.32-7.28 (m, 2H), 7.10-7.05 (m, 2H), 4.42 (s, 2H), 3.61-
3.39 (m, methylenes, rotamers, 4H), 3.37-3.34 (m, 3H), 3.11 & 3.02 (rotamers, 3H), 2.94-
2.86 (m, rotamers, 3H), 1.50-1.40 (m, 9H).13C NMR (CDCl3, 100 MHz): δ (155.9, 155.7, 
& 155.5, rotamers), (154.9 & 154.6, rotamers), (150.9 & 150.8, rotamers), (135.2 & 
135.1, rotamers), 128.6, (121.8 & 121.6, rotamers), (79.9, 79.7, 79.6, & 79.5, rotamers), 
74.1, 58.0, (47.4, 47.2, 47.0, 46.8, 46.6, 46.5, CH2 rotamers), (35.4 & 35.2, rotamers), 
(34.7 & 34.6, rotamers), 28.4. FT-IR (νmax/cm−1): 2976, 2930, 1722, 1693, 1510. HRMS: 
calcd [M]+ (C18H28N2O5): 352.1998. Found (EI): 352.1996. 
3.2.3 Degradation Studies 
Degradation of Compounds 3.19. Compound 3.19 (10 mg) was dissolved in 1 mL of 0.1 
M phosphate buffer (D2O):acetone-d6 (3:2) and sparged under argon for 10 minutes. The 
solution was then heated to 37˚C using an INOVA variable temperature controller 
calibrated using ethylene glycol and maintained at 37˚C for 3 hours while 1H NMR 
spectra were recorded at 15-minute intervals. Following the control period, DTT (20 mg, 
5 equiv) was added to the NMR tube and the solution was incubated at 37˚C for 48 hours. 
Following complete degradation, the pH of the solution was tested to ensure that the 
sample did not fall outside of the buffer region during the degradation process. The extent 
of cyclization was quantified by integrating the aromatic peak of the 4-
(methoxymethyl)phenol degradation product relative to the corresponding aromatic peak 
in the undegraded sample. The plateau region corresponding to 100% degradation was 
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defined as the region in which the mean fluctuation between successive integral values 
was less than or equal to 3%. Degradation data was treated by non-linear regression and 
fit to a first-order degradation model.  
Degradation of Compounds 3.22. Compound 3.21 (10 mg) was dissolved in 1 mL of 1:1 
TFA:CH2Cl2 and stirred at room temperature for 2 h. The solvent was blown off and the 
product was taken up in CH2Cl2 and washed with a 1:1 mixture of brine:1 M citric acid. 
The deprotected polymer was then re-extracted from the aqueous layer 5 times with 
CH2Cl2. The combined organic layers were dried over MgSO4, filtered, and concentrated 
in vacuo to afford the deprotected compound 3.22. Compound 3.22 was then taken up in 
1 mL of 0.1 M pH 7.4 phosphate buffer (D2O):acetone-d6 (3:2) preheated to 37˚C and 
filtered through a Promax® PTFE membrane (0.22 µm). The filtered solution was then 
incubated at 37˚C using an INOVA variable temperature controller calibrated using 
ethylene glycol. 1H NMR spectra were recorded at 5 min intervals over a period of 2 
hours. Following complete degradation, the pH of the solution was tested to ensure that 
the sample did not fall outside of the buffer region during the degradation process. The 
extent of cyclization was quantified by integrating the methyl peak of the N,N’- 
dimethylimidazolidinone degradation product relative to the (CHD2)(CD3)CO in the 
sample. The plateau region corresponding to 100% degradation was defined as the region 
in which the mean fluctuation between successive integral values was less than or equal 
to 3%. Degradation data was treated by non-linear regression and fit to a first-order 
degradation model.  
Degradation of Polymers 3.7a and 3.7b. Polymer (10 mg) was dissolved in 1 mL of 0.1 
M pH 7.4 phosphate buffer (D2O) and sonicated for 10 minutes. The nanoparticle 
solution was then incubated at 37˚C over a 30-day period with 1H NMR spectra taken at 
roughly 2-day intervals throughout the degradation process. Following complete 
degradation, the pH of the solution was tested to ensure that the sample did not fall 
outside of the buffer region during degradation. The extent of degradation was quantified 
by integrating the methyl peak of the N,N’-dimethylimidazolidinone degradation product 
relative to residual solvent in the sample. The plateau region corresponding to 100% 
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degradation was defined as the region in which the mean fluctuation between successive 
integral values was less than or equal to 3%.  
Degradation of Polymer 3.14. Polymer 3.14 (12 mg, 3 µmol, 1 equiv) was dissolved in 
1.0 mL of 0.1 M pH 7.4 phosphate buffer (D2O):acetone-d6 (3:2) preheated to 37˚C. DTT 
(7.5 mg, 50 µmol, 17 equiv) was added and the degradation mixture was incubated at 
37˚C over a period of 30 d with 1H NMR spectra taken throughout the degradation 
process. Following complete degradation, the pH of the solution was tested to ensure that 
the sample did not fall outside of the buffer region during degradation. The extent of 
degradation was quantified by integrating the methyl peak of the N,N’- 
dimethylimidazolidinone degradation product relative to residual DMF in the sample. 
The plateau region corresponding to 100% degradation was defined as the region in 
which the mean fluctuation between successive integral values was less than or equal to 
3%. 
3.2.4 General Procedure for Nanoparticle Assembly 
Self-immolative block copolymer (5 mg) was dissolved in 0.5 mL of THF and stirred 
vigorously while 2 mL of deionized water was added dropwise to the stirred solution over 
a period of 10 minutes. Following the addition of water, the nanoparticle suspension was 
dialyzed against distilled water for 36 h (2 L, 2 changes) using a 12000-14000 g/mol 
MWCO regenerated cellulose membrane to remove THF.  
3.2.5 Transmission Electron Microscopy 
The suspension of nanoparticles (20 µL, 0.1 mg mL-1) was placed on a carbon formvar 
grid and was dried in air overnight before imaging. Imaging was performed using a 
Phillips CM10 microscope operating at 80 kV with a 40 lm aperture. 
3.3 Results and Discussion 
3.3.1 Motivation and Design 
Two designs were proposed to investigate different aspects of the amphiphilic PEG-self-
immolative block copolymer system based on our previously reported polycarbamate 
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backbone derived from alternating 1,6-elimination and cyclization spacers (Figure 3.1b). 
The first proposed design, depicted in Figure 3.2a, involves the use of a PEG succinic 
acid end-cap in place of the PEG acetic-acid version utilized in our initial report. Our 
attempts to synthesize PEG acetic acids were plagued by incomplete conversions and 
PEG-dimerizations. Furthermore, commercial sources of PEG acetic acid are relatively 
expensive, making our initial system costly to investigate. As a result, this alteration was 
proposed to provide a low-cost, efficient method of incorporating PEG derivatives, while 
at the same time bypassing any issues associated with the synthesis of PEG acetic acid. 
Overall, this system was designed to probe the self-assembly characteristics of the 
amphiphilic block copolymer system and investigate the morphological effect of varying 
the size fraction of either block.  
 
Figure 3.2: Chemical structures, proposed depolymerization mechanisms, and 
expected depolymerization products of (a) target PEG succinic acid based self-
immolative block copolymer and (b) target PEG disulfide based self-immolative 
block copolymer.  
The second proposed design was aimed to address the lack of stimuli-responsive 
degradation in the initial system by introducing a disulfide linkage between the 
hydrophilic PEG block and hydrophobic polycarbamate backbone. This target polymer, 
shown in Figure 3.2b, involves the use of a N-methylaminoethanethiol spacer to 
conjugate PEG through a disulfide linkage. This linker has been previously explored in 
the development of self-immolative prodrugs, but never incorporated into a polymeric 
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framework.35 It was envisioned that the use of N-methylaminoethanethiol instead of 2-
mercaptoethanol would permit an enhanced stability of the block copolymer system due 
to end-cap incorporation through a carbamate linkage instead of the hydrolytically labile 
carbonate. This enhanced stability should limit unwanted end-cap hydrolysis and restrict 
the degradation of these block copolymers to a single pathway involving a reduction 
sensitive trigger.  In this design, reduction of the disulfide linkage between the two blocks 
reveals an active thiol terminus that then cyclizes to initiate degradation of the 
polycarbamate backbone through alternating 1,6-elimination and cyclization reactions.  
This strategy also marks the first time a heterogeneous cyclization spacer has been used 
in an end-cap design to influence the overall kinetics of polymer degradation.  
3.3.2 Synthesis 
3.3.2.1 PEG Succinic Acid Block Copolymer Model System 
 
Scheme 3.1: Synthesis of a PEG succinic acid based end cap 
Synthesis of the hydrolytically sensitive linear self-immolative block copolymer was 
carried out using a macromolecular PEG end-cap during polymerization of the 
polycarbamate backbone. As shown in Scheme 3.1, a modified synthetic route to that 
used in our previously reported system was adopted to allow for incorporation of PEG 
succinic acid. Monofunctional PEG succinic acids (3.1a & 3.1b) were prepared through a 
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ring-opening of succinic anhydride using commercial PEG monomethylether alcohols 
having molecular weights of approximately 2000 and 5000 g/mol in the presence of 
DMAP and NEt3.  This ring-opening reaction provided a facile means to generate PEG 
acids that resulted in high conversion of the alcohol as measured by NMR spectroscopy 
in a moderate yield following purification. These PEG succinic acids were then reacted 
with 4-nitrophenyl chloroformate to generate the highly electrophilic 4-nitrophenyl ester 
species 3.2a and 3.2b, which were subsequently substituted with the TBS-protected 
phenol 3.3 to yield the TBS-protected esters 3.4a and 3.4b. The TBS groups of these 
esters were removed by treatment with HCl in 3:1 EtOH:CH2Cl2, and the resulting 
alcohols 3.5a and 3.5b were then activated with 4-nitrophenyl chloroformate to afford the 
PEG end-caps 3.6a and 3.6b.  
 
Scheme 3.2: Polymerization of linear self-immolative block copolymers 3.7a and 
3.7b using a PEG end capping agent 
As shown in Scheme 3.2, the amphiphilic block copolymers 3.7a and 3.7b were 
synthesized by polymerizing the activated carbonate monomer 2.5 in the presence of 
DMAP and NEt3, while using PEG end-caps 3.6a and 3.6b, respectively. Our initial 
report utilized preparative size exclusion chromatography to purify the analogous block 
copolymer. However, in this work it was sought to improve the scalability of this design 
by purifying these compounds through dialysis. Self-immolative polymer systems 
synthesized through polycondensations are often hindered by poor end-cap incorporation. 
This is only a minor limitation when using small molecule end caps, as unreacted end 
caps and low molecular weight, non-end capped species can be removed by dialysis. On 
the other hand, this can be problematic when using macromolecular end caps due to the 
increased difficulty separating heterogeneous polymer species from one another.  
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Polymers 3.7a and 3.7b were purified by dialysis in DMF against a 25000 g/mol MWCO 
membrane to yield polymers with number average molecular weights of 3600 and 7170 
g/mol and PDIs of 1.37 and 1.21, respectively, as measured by SEC relative to PEG-PEO 
standards. (Figure 3.3). Analysis by 1H NMR spectroscopy revealed monomer to end cap 
ratios of 18:1 for polymer 3.7a and 10:1 for polymer 3.7b (Figures A21 and A22). This 
underestimation of the ratio for polymer 3.7b is indicative of residual unreacted 5000 
g/mol PEG end cap, which can be clearly seen in the bimodal SEC chromatogram (Figure 
3.3). Conversely, dialysis was an effective means to remove the unreacted 2000 g/mol 
PEG end cap for polymer 3.7a, leaving only a slight shoulder in the SEC chromatogram. 
Future attempts to purify these polymers will focus on alternate techniques such as gel 
filtration or precipitation in MeOH to remove any unreacted PEG species.  
 
Figure 3.3. Size exclusion chromatograms of block copolymers 3.7a (Mn = 3600 
g/mol, PDI=1.47) (grey) and 3.7b (Mn = 7170 g/mol, PDI=1.21) (black). All 
chromatograms obtained a concentration of 5 mg/mL and calibrated against PEG in 
THF.  
3.3.2.2 Redox Sensitive Linear Self-Immolative Block Copolymer 
An alternate synthetic strategy was employed for the synthesis of the redox sensitive self-
immolative block copolymer due to the issues encountered in the removal of unreacted 
macromolecular end caps following polymerization. It was envisioned that use of a 
modular design in which polymerization is separated from PEG incorporation would 
alleviate any purification issues and reduce the overall number of synthetic steps 
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necessary to generate amphiphilic self-immoaltive block copolymers. Such a strategy 
also allows for a higher degree of control over the size fraction of both blocks in the 
design due to the decoupling between polymerization and block copolymer formation.  
A small molecule disulfide end cap bearing a thiopyridyl group for subsequent reaction 
with PEG thiol was synthesized as shown in Scheme 3.3. Boc-protected N-
methylaminoethanethiopyridine 3.835 was deprotected using trifluoroacetic acid (TFA) 
and subsequently reacted with the 4-nitrophenyl activated carbonate 3.10 to yield the 
TBS-protected carbamate 3.11. The TBS group on 3.11 was removed by treatment with 
HCl in EtOH, and the alcohol 3.12 was reacted with 4-nitrophenyl chloroformate to 
generate the thiopyridyl end cap 3.13.  
 
Scheme 3.3: Synthesis of a redox sensitive end cap incorporating a N-
methylaminoethanethiol cyclization spacer 
Synthesis of the thiopyridyl disulfide polymer 3.14 was carried out using a similar 
strategy to that described for polymer 3.7 with the use of the small molecule end cap 
3.13. Purification of this polymer through dialysis in DMF against a 12000-14000 g/mol 
MWCO membrane yielded a polymer with a Mn of 3150 g/mol and a PDI of 1.73 as 
measured by SEC relative to PEG-PEO standards (Figure 3.4). Analysis by 1H NMR 
spectroscopy revealed a monomer to end cap ratio of 24, which was similar to the feed 
ratio of 20:1 (Figure A29). Our attempts to react this polymer with PEG thiol were 
unsuccessful due to the tendency of PEG thiol to dimerize in storage. To address this 
issue, this polymer was reacted with monofunctional PEG thioacetate 3.15 derived from 
commercial PEG monomethylether alcohol with a molecular weight of approximately 
5000 g/mol, in the presence of NaOMe.  This strategy for block copolymer formation 
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through a thiol/disulfide reaction does not suffer PEG dimerization issues as PEG thiol is 
generated in situ through the hydrolysis of PEG thioacetate under basic conditions. 
Purification of this polymer by dialysis in DMF against a 12000-14000 g/mol MWCO 
membrane yielded copolymer 3.16 with a Mn of 5200 g/mol and a PDI of 1.41 as 
measured by SEC relative to PEG-PEO standards (Figure 3.4). Analysis by 1H NMR 
spectroscopy revealed a monomer to end cap ratio of 28, which was similar to the ratio 
observed for the homopolymer 3.14 (Figure A30).  
 
Scheme 3.4: Synthesis of a redox sensitive block copolymer using a thiol/disulfide 
exchange reaction 
Another benefit to the generation of self-immolative block copolymers through a modular 
approach is the tracking of the molecular weight evolution through SEC. As shown in 
Figure 3.4, the peak molecular weight of 3.16 is approximately equal to the cumulative 
contribution of polymers 3.14 and 3.15, therefore supporting the successful conjugation 
of the PEG block through the thiol/disulfide exchange reaction. A small shoulder is 
evident in the SEC chromatogram of copolymer 3.16 that appears to correspond to a 
residual amount of homopolymer 3.14 that was not detected in the 1H NMR spectrum. In 
the absence of absolute molecular weight data, the equivalents of PEG thioacetate to be 
added were determined by end group analysis through 1H NMR spectroscopy. It is likely 
that the conjugation efficiency of this design can be further improved with the use of 
absolute molecular weight data for the self-immolative homopolymer. Interestingly, the 
PDI of the block copolymer was significantly less than that observed for the self-
immolative homopolymer. This narrowing of the polymer distribution is due to the 
degradation of non-end-capped species of polymer 3.14 under the basic/polar conditions 
encountered during block copolymer formation.  1H NMR of the crude copolymer 
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revealed the presence of 4-hydroxybenzyl alcohol and N,N’- dimethylimidazolidinone, 
which are formed during the degradation of the polycarbamate backbone. This backbone 
degradation lowered the overall yield during block copolymer formation, but removed 
any non-end-capped homopolymer species that could potential interfere with the 
subsequent generation of nanoparticles.  
 
Figure 3.4: Size exclusion chromatograms of polymers 3.14 (Mn = 3150 g/mol, 
PDI=1.73) (grey), 3.15 (Mn = 4300 g/mol, PDI=1.01)  (- - -), and 3.16 (Mn = 5200 
g/mol, PDI=1.41) (dark grey). All chromatograms obtained a concentration of 5 
mg/mL and calibrated against PEG-PEO in THF. 
3.3.3 Probing the Solution Degradation Kinetics 
The solution phase degradation kinetics of N,N’-dimethylethylenediamine and the 
corresponding polymer derived from alternating 4-hydroxybenzyl alcohol and N,N’-
dimethylethylenediamine spacers have been previously explored in our group.19 
However, the cyclization kinetics of N-methylaminoethanethiol have yet to be 
investigated and its rate of degradation is currently unknown relative to the more 
conventional N,N’-dimethylethylenediamine cyclization spacer. To this end, a model N-
methylaminoethanethiol compound 3.19 was prepared by reacting 3.9 with the 4-
nitrophenyl-activated carbonate species 3.18 derived from 4-hydroxybenzyl methylether 
3.1738 (Scheme 3.5). Our previous experimental findings have suggested that unwanted 
reactivity of benzylic alcohols can adversely influence kinetic experiments26 so a 
benzylmethylether compound was selected to alleviate such effects. For an accurate 
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comparison, an analogous N,N’-dimethylethylenediamine model compound 3.22 was 
prepared by reacting 3.20 with the 4-nitrophenyl-activated carbonate species 3.18 
followed by treatment with TFA to remove the Boc group (Scheme 3.6).  
 
Scheme 3.5: Synthesis of model N-methylaminoethane thiol compound 3.19 and its 
cyclization to form 3-methylthiazolidinone  
 
Scheme 3.6: Synthesis of model N,N’-dimethylethylenediamine compound 3.22 and 
its cyclization to form N,N′-dimethylimidazolidinone 
The cyclization kinetics of model compounds 3.19 and 3.22 were investigated by 1H 
NMR spectroscopy under pseudo-physiological conditions in a 3:2 mixture of 0.1 M pH 
7.4 phosphate buffer (D2O):acetone-d6 maintained at 37˚C. Compound 3.22 displayed a 
first-order rate constant of 6.48 ± 0.16 × 10−2 min-1 and a half-life of 10.7 ± 0.3 min 
following dissolution in the buffer/acetone mixture, as determined through triplicate 
measurement (Figure 3.5a). Since end cap removal cannot be studied independently of 
cyclization for compound 3.19, the rate of end cap removal had to be increased such that 
its influence on the overall kinetics could be neglected. Under normal conditions, 
disulfide cleavage is a second order bimolecular reaction that is dependent on the 
concentrations of the reducing agent and the compound bearing the disulfide bond.39 
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Hence in our design, using a large excess of reducing agent can therefore increase the rate 
of disulfide cleavage to point where the subsequent cyclization is largely rate limiting. As 
shown in Figure 3.7, a complete removal of the thiopyridyl end cap on compound 3.19 
was observed by the time of the first NMR reading following the addition of DTT to a 
concentration of 0.1 M. Subsequent cyclization of the N-methylaminoethanethiol linker 
required an additional 24 hours to reach completion (Figure 3.5b). A first-order model 
was fit to the experimental data to yield a rate constant of 1.56 ± 0.16 × 10−1 h-1 and a 
half-life of 4.5 ± 0.4 h for compound 3.19, thereby indicating that the N-
methylaminoethanethiol spacer cyclizes approximately 25 times slower than N,N’-
dimethylethylenediamine under the conditions examined.  
 
Figure 3.5: Kinetics of cyclization in 0.1 M phosphate buffered D2O:acetone-d6 as 
measured by 1H NMR spectroscopy for (a) compound 3.19 and (b) compound 3.21  
and (c) polymer 3.14 after reduction of the thiopyridyl disulfide moeity in a highly 
reducing environment (0. 1 M DTT). Dashed lines correspond to the first-order fits 
for compounds 3.19 and 3.21 and the modified Avrami fit for polymer 3.14.  
The large difference in the rate of cyclization for two spacers prompted an additional 
degradation study to investigate the overall influence of incorporating the slower N-
methylaminoethanethiol end cap on the kinetics of polymer degradation. Polymer 3.14 
was investigated under similar conditions to that used for compound 3.19 in order to 
minimize the effects of disulfide cleavage on the observed rate of polymer 
depolymerization (Figure 3.7). Under these conditions, the degradation of polymer 3.14 
required approximately 5.9 h to reach 50% degradation and 24 h to reach complete 
degradation. Consequently, the kinetics of end cap cyclization were rate limiting in this 
design, with the overall rate of depolymerization roughly mirroring that of the N-
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methylaminoethanethiol cyclization spacer (Figure 3.5c). Such an observation is 
interesting in the context of tuning the rate of polymer degradation, as the use of a slower 
cyclization spacer in the end cap design can be used a means of gated rate control. 
Varying the electrophilic character of the carbamate cyclization center in the end cap 
through the incorporation of different electron withdrawing or donating groups should 
allow for an additional means of depolymerization rate control in future designs. It should 
be noted that the preliminary investigation of the degradation kinetics of polymer 3.14 
were not performed in triplicate.  Consequently, the modified Avrami equation fit was 
prone to significant leverage effects related to the location of the final time point 
measurement.  
 
 
 
Figure 3.6: 1H NMR spectra of compound 3.19: (a) immediately following 
dissolution in 0.1 M pH 7.4 phosphate buffered D2O:acetone-d6 (3:2) at 37˚C; (b) 5 
min and (c) 5 h following DTT addition; and (d) following 40 h in a reducing 
environment.  
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Figure 3.7: 1H NMR spectra of polymer 3.14: (a) immediately following dissolution 
in 0.1 M pH 7.4 phosphate buffered D2O:acetone-d6 (3:2) at 37˚C; (b) after complete 
disulfide reduction 5 min after DTT addition; and (c) following complete 
degradation after 40 h in a highly reducing environment (0.1 M DTT).  
3.3.4 Self-Assembly of Self-Immolative Block Copolymers 
The formation of PEG-self-immolative nanoparticles in our group was initially 
accomplished through sonication of the amphiphilic block copolymers in aqueous 
solution over a prolonged period of time.19 Although effective in generating micelles, this 
method resulted in a broad size distribution and suffered from a lack of reproducibility. 
Our more recent attempts have focused on the use of nanoprecipitation techniques to 
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generate functional nanoparticles with controllable diameters and uniform size 
distributions.40,41 In this work, the use of a nanoprecipitation technique involving 
dissolution of copolymers 3.7a, 3.7b, and 3.16 in THF followed by a gradual addition of 
H2O led to the reproducible formation of different nanoparticles. Copolymer 3.7a was 
found to assemble into micelles with an average diameter of approximately 80 nm, while 
copolymer 3.7b assembled into larger, non-spherical nanoparticles with an average 
diameter of approximately 330 nm as determined by dynamic light scattering (DLS) 
(Figure 3.8a) and transmission electron microscopy (TEM) (Figure 3.9a & b). It was 
originally anticipated that the incorporation of the smaller 2000 g/mol PEG end cap in 
copolymer 3.7a could lead to the formation of polymer vesicles by reducing the fraction 
of the hydrophilic block to within 25 to 45%, as required for vesicle formation.  Although 
vesicles were not observed in this preliminary study, further investigation of the PEG-
self-immolative system may still yield such assemblies. In particular, further increases to 
the fraction of the polycarbamate backbone, incorporation of smaller PEG end caps, a 
reduction to the PDI of the copolymer, or an alternate method of preparation, such as thin 
film hydration, may promote the assembly of polymer vesicles.42-44  
 
Figure 3.8: Dynamic light scattering traces of nanoparticles derived from (a) PEG 
succinic acid based block copolymers 3.7a (d=78.5 ± 1.4 nm, PDI=1.51 ± 0.17 × 10−1) 
(grey) and 3.7b (d=332 ± 8.1 nm, PDI=1.84 ± 0.14 × 10−1) (black) or (b) PEG thiol 
based block copolymer 3.16 (d=499 ± 22 nm, PDI=2.81 ± 0.27 × 10−1) (dark grey). 
All traces obtained at a concentration of 0.1 mg/mL.   
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Nanoprecipitation of copolymer 3.16 led to the formation of spherical nanoparticles with 
an average diameter of approximately 500 nm as measured by DLS (Figure 3.8b) and 
TEM (Figure 3.9c). Notably, the nanoparticles derived from this amphiphilic block 
copolymer displayed a narrower size distribution compared to that of either 3.7a or the 
more closely related 3.7b, bearing a 5000 g/mol PEG end cap. The narrowing of the 
particle size distribution is attributed to the differences in the molecular weight 
distributions and the presence of unreacted PEG end caps in 3.7a and 3.7b. It has been 
previously shown that the presence of homopolymers and surfactants has a strong 
influence on nanoparticle size and polydispersity.42,45 Therefore, the inefficient 
macromolecular end cap incorporation method utilized for 3.7a and 3.7b may have 
adverse effects on the polydispersity of the resultant nanoparticles.  
 
Figure 3.9: Transmission electron microscopy images of the nanoparticles formed 
from copolymers 3.7a (a), 3.7b (b), and 3.16 (c).   
Collectively, the results observed for 3.7b and 3.16 indicate that the incorporation of the 
larger 5000 g/mol PEG chain results in the formation of large nanoparticles with 
diameters in the range of 200 nm to 1 µm. In theory, the incorporation of larger PEG 
chains should increase the curvature and reduce the diameter of the resultant 
nanoparticles. The failure of the two systems investigated in this work to assemble into 
smaller nanoparticles may be indicative of a substantial amount of unconjugated 
homopolymer chains that promote the aggregation of the amphiphilic copolymers into 
larger, non-spherical assemblies. Since the optimum particle size to maximize blood 
circulation time is around 80-150 nm,43 further modification of this system is necessary to 
improve the biomedical utility of self-immolative nanoparticles involving 5000 g/mol 
PEG chains. Based on the preliminary results observed in this study, incorporation of 
A) B) C) 
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PEG chains smaller than 5000 g/mol may be more ideal for the formation of 
nanoparticles for biomedical applications.  
3.4 Self-Immolative Nanoparticle Degradation 
The degradation of the nanoparticles derived from 3.7a and 3.7b were studied under 
pseudo-physiological conditions in 0.1 M pH 7.4 phosphate buffer (D2O) by NMR 
spectroscopy. Our initial study suggested that the degradation of PEG-self-immolative 
copolymers is diffusion controlled in aqueous conditions due to the shielding of the ester 
linkage between the hydrophilic and hydrophobic blocks on the interior of the 
hydrophilic corona and that the depolymerization of the polycarbamate block was slowed 
due to the increased hydrophobicity in the interior of the nanoparticle core. As a result, 
the PEG-self-immolative nanoparticles display a much slower rate of degradation than 
that dictated by their solution phase degradation kinetics. It was originally envisioned that 
the incorporation of a smaller PEG chain to reduce the overall size of the hydrophilic 
layer would reduce the degradation time of these nanoparticles by decreasing the path 
over which diffusion must occur. Interestingly, our preliminary, single run data suggests 
that the size of the PEG chain has no effect on the degradation kinetics of the 
nanoparticles, as the degradation profile of 3.7a roughly mirrored that of 3.7b. However, 
further investigation of this system is necessary to verify such an observation. In 
particular, the nanoparticles derived for these NMR degradation studies should be formed 
by a nanoprecipitation method instead of the currently employed sonication method to 
exert a higher degree of control over the self-assembly process. More comprehensive 
studies are also required to investigate diffusion effects since the use of 1H NMR 
spectroscopy to monitor byproduct formation only offers limited insight into the 
controlling processes behind nanoparticle degradation.   
A preliminary investigation of the degradation kinetics for copolymer 3.16 was not 
carried out due to the amount of material and the time required for a NMR degradation 
study. The degradation and release kinetics of this system will be the subject of ongoing 
investigation in our laboratory due to its potential to form stimuli-responsive self-
immolative nanoparticles for the controlled release of hydrophobic molecules under 
redox conditions.   
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Figure 3.10: Kinetics of self-immolative nanoparticle degradation in 0.1 M pH 7.4 
phosphate buffer (D2O) for copolymer 3.7a () and 3.7b (p) as measured by 1H 
NMR spectroscopy.  
3.5 Conclusion 
In conclusion, significant advancements have been made in the development of self-
immolative nanoparticles incorporating cyclization spacers for controlled release 
applications. In this work we presented an alternate low-cost method of generating self-
immolative amphiphilic block copolymers using our previously reported linear self-
immolative polymer backbone derived from alternating 4-hydroxybenzyl alcohol and 
N,N’-dimethylethylenediamine spacers. This method involved the use of PEG succinic 
acid-based macromolecular end capping agents during polymerization of the 
polycarbamate backbone. Although this system provided a versatile means of evaluating 
the self-assembly characteristics of the amphiphilic block copolymers, it lacks a stimuli-
responsive trigger to initiate self-immolative degradation. A redox-sensitive variant of 
this design was developed to address this limitation by incorporating a disulfide linkage 
between the hydrophilic and hydrophobic blocks. This redox-sensitive amphiphilic block 
copolymer was synthesized through an improved modular approach in which backbone 
polymerization and PEG incorporation are decoupled from one another. It is expected 
that this modular approach will be more widely utilized than the macromolecular end cap 
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strategy due to an increased control over the characteristics and purity of the amphiphilic 
block copolymers. The self-assembly characteristics of both copolymers were 
investigated using a nanoprecipitation technique, however, vesicles could not be formed 
by reducing the size of the incorporated PEG end cap from 5000 g/mol to 2000 g/mol. 
Despite the immense promise, further investigation of the self-assembly characteristics as 
well as the degradation and release kinetics of these self-immolative nanoparticles is 
required before they can receive widespread biomedical application as drug delivery 
vehicles.  
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Chapter 4  
4 Conclusions and Future Perspectives 
The work described in this thesis focused on two currently underexplored areas in the 
field of linear self-immolative polymers: degradation kinetics and functional designs. In 
the first section (Chapter 2), the degradation kinetics of linear self-immolative polymers 
involving cyclization spacers were investigated with the overall goal of developing a 
generalized model to relate the kinetics of polymer degradation to monomer cyclization. 
In addition, it was sought to demonstrate chain length as an alternate means to tune the 
degradation time in linear self-immolative polymer systems. This was accomplished 
using the previously reported linear self-immolative polycarbamate backbone derived 
from alternating 4-hydroxybenzyl alcohol and N,N’-dimethylethylenediamine spacers. A 
degradation model was first derived from first principles by treating backbone 
degradation as a series of first-order intramolecular reactions. This model was then 
applied to the degradation of a set of monodisperse oligomers synthesized through a new 
iterative, convergent method to validate the assumptions used during model development. 
These results were then extended to the polydisperse case by applying the self-
immolative degradation model to the degradation of a set of polymers synthesized to 
display varying molecular weights.  
The experimental findings and computer simulations explored in the first section give 
proof that linear self-immolative polymer systems exhibit mixed-mode degradation 
kinetics with an initial pseudo zero-order domain that gradually transitions towards first 
order behaviour. This particular mechanism of degradation is highly controlled by the 
kinetics of monomer self-immolation and results in a proportional dependence of 
degradation time on chain length. Hence, the results presented in the first section 
demonstrate that varying chain length is a viable means to control and tune the 
degradation time in linear self-immolative polymer systems. Such a finding has 
significant implications on the use of linear self-immolative polymers for biomedical 
applications as the degradation time of these polymers can now effectively be tuned two-
dimensionally through rational monomer design and molecular weight control.  
107 
 
The second section of this work (Chapter 3) was geared towards the development of self-
immolative amphiphilic block copolymers involving cyclization spacers for controlled 
release applications. A modified procedure was proposed for the fabrication of self-
immolative block copolymers using low-cost PEG succinic acid-based end caps. This 
method was demonstrated to be a versatile means of generating model compounds to 
investigate the self-assembly characteristics of self-immolative copolymers. However, the 
incorporation of the PEG block through an ester linkage failed to exploit the potential for 
stimuli-responsive degradation in self-immolative systems. As a result, a modified variant 
of the initial design was developed to incorporate a reduction sensitive disulfide linkage 
between the hydrophilic PEG block and hydrophobic self-immolative block.  This new 
design was synthesized through an improved modular approach in which PEG 
incorporation was decoupled from polymerization of the self-immolative backbone. Such 
an approach allowed for an increased control over the composition and purity of the self-
immolative block copolymers compared to the incorporation of the PEG block during 
backbone polymerization. Despite the promise of this system, additional work is required 
to optimize the fabrication of functional redox-sensitive nanoparticles and to study the 
degradation and release kinetics of this system under physiological conditions.  
Collectively, the work presented in this thesis serves to expand the utility of linear self-
immolative polymers for biomedical applications. The kinetic model describing linear 
self-immolative degradation and subsequent model validation offers the first conclusive 
proof of the proportional relationship between degradation time and chain length. In 
conjunction with rational monomer design, this property can be used to fine-tune the 
degradation time of these polymers with a level of precision that greatly surpasses that 
available in traditional biodegradable systems. It is expected that this model will serve as 
an initial point of reference in the design and tailoring of future linear self-immolative 
polymer systems with controllable degradation times. This model also offers new insight 
into the mixed-mode, pseudo zero- and first-order kinetic phenomenon observed in the 
degradation of linear self-immolative polymer systems. This property has yet to be 
explored in the context of controlled release and should greatly increase the usefulness of 
these materials relative to their dendrimer counterparts. A number of different 
macromolecular prodrug strategies can be envisioned to exploit this effect in order to 
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achieve an initial period of pseudo zero-order release, which is highly desirable in the 
field of drug delivery.  
The functional linear self-immolative block copolymer designs presented in this thesis 
demonstrate the inherent flexibility of such materials. With much of the synthetic 
groundwork laid in the design of linear self-immolative polymer backbones, a shift in 
focus needs to be geared towards the application of these materials through controlled 
design.  The two systems explored in this work are promising examples of the ease at 
which linear self-immolative polymers can be incorporated into amphiphilic block 
copolymers capable of self-assembly in aqueous solution. Future work in the 
development of these materials should also focus on the incorporation of different 
stimuli-responsive linkages to initiate block separation and self-immolative backbone 
degradation under a variety of conditions for programmable release. The ideal design for 
these systems would involve an entirely self-immolative block copolymer system in 
which triggering groups are contained at the terminus of the hydrophilic block, directly 
exposed to the external environment. To this end, additional work should be conducted 
into developing hydrophilic self-immolative homopolymers by modifying the currently 
available backbones with pendent solubilizing groups such as triethylene glycol. Upon 
further optimization of the self-immolative block copolymer design, it is presumable 
these materials will receive widespread application in the field of drug delivery due their 
ability to form functional nanoparticles with a highly controlled mechanism of 
degradation.  
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Appendices 
Appendix A: NMR Characterization Data 
 
Figure A1: 1H NMR spectrum of compound 2.1a (600 MHz, CDCl3) 
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Figure A2: 13C NMR spectrum of compound 2.1a (100 MHz, CDCl3) 
 
Figure A3: 1H NMR spectrum of compound 2.2a (600 MHz, CDCl3) 
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Figure A4: 1H NMR spectrum of compound 2.2b (600 MHz, CDCl3) 
 
Figure A5: 1H NMR spectrum of compound 2.2c (600 MHz, CDCl3) 
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Figure A6: 1H NMR spectrum of compound 2.3a (600 MHz, CDCl3) 
 
Figure A7: 1H NMR spectrum of compound 2.3b (600 MHz, CDCl3) 
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Figure A8: 1H NMR spectrum of compound 2.3c (600 MHz, CDCl3) 
 
Figure A9: 1H NMR spectrum of compound 2.4a (600 MHz, CDCl3) 
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Figure A10: 1H NMR spectrum of polymer 2.6 (600 MHz, CDCl3) 
 
Figure A11: 1H NMR spectrum of polymer 2.7 (600 MHz, CDCl3) 
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Figure A12: 1H NMR spectrum of compound 3.1a (600 MHz, CDCl3) 
 
Figure A13: 1H NMR spectrum of compound 3.1b (600 MHz, CDCl3) 
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Figure A14: 1H NMR spectrum of compound 3.2a (600 MHz, CDCl3) 
 
Figure A15: 1H NMR spectrum of compound 3.2b (600 MHz, CDCl3) 
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Figure A16: 1H NMR spectrum of compound 3.4a (600 MHz, CDCl3) 
 
Figure A17: 1H NMR spectrum of compound 3.5a (600 MHz, CDCl3) 
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Figure A18: 1H NMR spectrum of compound 3.5b (600 MHz, CDCl3) 
 
Figure A19: 1H NMR spectrum of compound 3.6a (600 MHz, CDCl3) 
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Figure A20: 1H NMR spectrum of compound 3.6b (600 MHz, CDCl3) 
 
Figure A21: 1H NMR spectrum of polymer 3.7a (600 MHz, CDCl3) 
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Figure A22: 1H NMR spectrum of polymer 3.7b (600 MHz, CDCl3) 
 
Figure A23: 1H NMR spectrum of compound 3.11 (600 MHz, CDCl3) 
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Figure A24: 13C NMR spectrum of compound 3.11 (100 MHz, CDCl3) 
 
Figure A25: 1H NMR spectrum of compound 3.12 (600 MHz, CDCl3) 
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Figure A26: 13C NMR spectrum of compound 3.12 (100 MHz, CDCl3) 
 
Figure A27: 1H NMR spectrum of compound 3.13 (600 MHz, CDCl3) 
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Figure A28: 13C NMR spectrum of compound 3.13 (100 MHz, CDCl3) 
 
Figure A29: 1H NMR spectrum of polymer 3.14 (400 MHz, CDCl3) 
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Figure A30: 1H NMR spectrum of polymer 3.16 (600 MHz, CDCl3) 
 
Figure A31: 1H NMR spectrum of compound 3.18 (600 MHz, CDCl3) 
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Figure A32: 13C NMR spectrum of compound 3.18 (600 MHz, CDCl3) 
 
Figure A33: 1H NMR spectrum of compound 3.19 (600 MHz, CDCl3) 
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Figure A34: 13C NMR spectrum of compound 3.19 (100 MHz, CDCl3) 
 
Figure A35: 1H NMR spectrum of compound 3.21 (600 MHz, CDCl3) 
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Figure A36: 13C NMR spectrum of compound 3.21 (100 MHz, CDCl3) 
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Appendix B: HPLC Chromatograms 
 
Figure B1. HPLC chromatogram of compound 2.1a 
 
Figure B2. HPLC chromatogram of compound 2.2a 
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Figure B3. HPLC chromatogram of compound 2.2b 
 
Figure B4. HPLC chromatogram of compound 2.2c 
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Figure B5. HPLC chromatogram of compound 2.3a 
 
Figure B6. HPLC chromatogram of compound 2.3b 
 
3 4 5 6 7 8 9 10 11 12 130
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
Retention Time (min)
Ab
so
rb
an
ce
, 2
25
 n
m
 (a
.u
.)
   Rp=6.84 min,  Purity=97 %
3 4 5 6 7 8 9 10 11 12 130
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
Retention Time (min)
Ab
so
rb
an
ce
, 2
25
 n
m
 (a
.u
.)
   Rp=5.45 min,  Purity=99.8 %
O
O
O N
O
N
O
O
O
O
N
NBoc
3
HO
O N
O
N
O
O
O
O
N
NBoc
3
131 
 
 
Figure B7. HPLC chromatogram of compound 2.3c 
 
Figure B8. HPLC chromatogram of compound 2.4a 
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Appendix C: Supplemental Degradation Study Spectra 
 
Figure C1: 1H NMR spectrum of compound 2.1d: a) prior to and b) timmediately 
following a 1:1 1 M citric acid:brine wash (600 MHz, CDCl3)  
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Figure C2: 1H NMR spectrum of Boc-deprotected polymer 2.7: a) prior to and b) 
immediately following a 1:1 1 M citric acid:brine wash (400 MHz, CDCl3)  
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Figure C3: 1H NMR spectra of compound 2.1d (a) following end-cap removal in 0.1 
M pH 7.4 phosphate buffer (D2O):acetone-d6 (3:2) at the first time point reading in 
the degradation process; (b) following complete cyclization after 2 h at 37˚C; and (c) 
following hydrolysis of all acetate end-groups 
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Figure C4: 1H NMR spectra of compound 2.2d (a) following end-cap removal in 0.1 
M pH 7.4 phosphate buffer (D2O):acetone-d6 (3:2) at the first time point reading in 
the degradation process; (b) following complete cyclization after 2 h at 37˚C; and (c) 
following hydrolysis of all acetate end-groups 
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Figure C5: 1H NMR spectra of compound 2.3d (a) following end-cap removal in 0.1 
M pH 7.4 phosphate buffer (D2O):acetone-d6 (3:2) at the first time point reading 
(t=5 min) in the degradation process; (b) following complete cyclization after 2 h at 
37˚C; and (c) following hydrolysis of all acetate end-groups 
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Figure C6: 1H NMR spectra of compound 2.4d (a) following end-cap removal in 0.1 
M pH 7.4 phosphate buffer (D2O):acetone-d6 (3:2) at the first time point reading 
(t=5 min) in the degradation process; (b) following complete cyclization after 2 h at 
37˚C; and (c) following hydrolysis of all acetate end-groups 
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Figure C7: 1H NMR spectra of polymer 2.6 (a) following end-cap removal in 0.1 M 
pH 7.4 phosphate buffer (D2O):acetone-d6 (3:2) at the first time point reading (t=5 
min) in the degradation process; and (b) following complete cyclization after 4 h at 
37˚C 
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Figure C8: 1H NMR spectra of polymer 2.7 (a) following end-cap removal in 0.1 M 
pH 7.4 phosphate buffer (D2O):acetone-d6 (3:2) at the first time point reading (t=5 
min) in the degradation process; and (b) following complete cyclization after 4 h at 
37˚C.  
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Figure C9: Control 1H NMR study of compound 3.19 in 0.1 M pH 7.4 phosphate 
buffer (D2O) :acetone-d6 (3:2) in the absence of DTT at (a) the first time point 
reading (t=5 min) and (b) following incubation for 2 h.  
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Figure C10: 1H NMR spectra of compound 3.21 (a) following Boc-group removal in 
0.1 M pH 7.4 phosphate buffer (D2O):acetone-d6 (3:2) at the first time point reading 
(t=5 min) in the degradation process; and (b) following complete cyclization after 1 
h at 37˚C.  
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Figure C11: 1H NMR spectra of polymer 3.7a (a) following dissolution and 
sonication in 0.1 M pH 7.4 phosphate buffer (D2O) at the first time point reading 
(t=15 min) in the degradation process; and (b) following complete cyclization after 
32 d at 37˚C.  
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Figure C12: 1H NMR spectra of polymer 3.7b (a) following dissolution and 
sonication in 0.1 M pH 7.4 phosphate buffer (D2O) at the first time point reading 
(t=15 min) in the degradation process; and (b) following complete cyclization after 
32 d at 37˚C. 
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Appendix D: Factorial DOE Experiments 
D1. Factorial Design: Varying the Molecular Weight Obtained from the 
Polymerization of Compound 2.5 
3 Factor, 2 Level Design with Blocking:  
Factor Low Level (-) High Level (+) 
1. Reaction Duration 6 h 24 h 
2. Temperature 0˚C Room Temperature 
3. Equivalents of End-Cap 0.025 0.05 
4. Amine Base (Blocked 
Variable) 
NEt3 DIPEA 
 
DOE Structure: 
Experiment Duration 
(xD) 
Temperature 
(xT) 
End Cap 
(xEC) 
Blocking 
Pattern (xB) 
MP (g/mol) 
1 - - - - 30,558 
2 + - - + 25,453 
3 - + - + 29,096 
4 + + - - 28,743 
5 - - + + 17,770 
6 + - + - 23,962 
7 - + + - 21,507 
8 + + + + 18,416 
MP – Peak molecular weight (g/mol) relative to polystyrene standards 
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Experimental Details: Activated monomer 2.1c (1 equiv) was dissolved in 6 mL of 1:1 
TFA:CH2Cl2 and stirred at room temperature for 2 h. The solvent was then blown off 
prior to subjecting the reaction mixture three times to a repeat cycle of dilution with 
CH2Cl2 followed by concentration under reduced pressure to remove residual TFA and 
provide the deprotected monomer 2.5. End-cap 2.1c  (0.025 or 0.05 equiv) was added and 
the resulting mixture was dissolved in 12 mL of anhydrous toluene and cooled to 0˚C or 
maintained at room temperature. The amine base (NEt3 or DIPEA) and DMAP (0.066 g, 
0.54 mmol, 0.22 equiv) were sequentially added and the solution was stirred at 0˚C or 
room temperature for 6 or 24 h. The  solvent was then evaporated under reduced pressure 
and the crude polymer was dissolved in 2 mL of DMF and dialyzed against DMF for 24 h 
(200, mL, 1 solvent change) using a regenerated cellulose membrane (6000-8000 g/mol 
MWCO). The contents of the dialysis membrane were then concentrated in vacuo and 
lyophilized to afford the purified polymers.  
 
 
Figure D1. SEC chromatograms of DOE polymers 1-8 (DMF, PS standards) 
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Appendix E: Regression Fits 
 
 
 
Figure E1. Degradation plots for monomer compound 2.1d. a) Run 1: k=1.52×10-1 
min-1, h1/2=4.56 min , SE= 5.7%; b) Run 2: k=2.03×10-1 min-1, h1/2=3.41 min , SE= 
1.2%; and  c) Run 3: k=1.35×10-1 min-1, h1/2=5.14 min , SE= 2.9%.  
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Figure E2. Degradation plots for dimer compound 2.2d. a) Run 1: k=1.52×10-1 min-
1, h1/2=4.56 min , SE= 2.4%; b) Run 2: k=1.55×10-1 min-1, h1/2=4.46 min , SE= 1.8%; 
and  c) Run 3: k=1.36×10-1 min-1, h1/2=5.10 min , SE= 3.0%. 
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Figure E3. Degradation plots for tetramer compound 2.3d. a) Run 1: k=1.28×10-1 
min-1, h1/2=5.43 min , SE= 5.4%; b) Run 2: k=1.50×10-1 min-1, h1/2=4.62 min , SE= 
1.9%; and  c) Run 3: k=2.01×10-1 min-1, h1/2=3.44 min , SE= 5.1%. 
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Figure E4. Degradation plots for octamer compound 2.4d. a) Run 1: k=1.53×10-1 
min-1, h1/2=4.52 min , SE= 1.1%; b) Run 2: k=1.52×10-1 min-1, h1/2=4.54 min , SE= 
2.0%; and  c) Run 3: k=2.12×10-1 min-1, h1/2=3.26 min , SE= 2.5%. 
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Table E1. Regression statistics for compounds 2.1d-2.4d 
Compound Run 
First-Order Model Self-Immolative Model 
SE AIC BIC SE AIC BIC 
2.1d 1 5.65 / /    
 2 1.20 / /    
 3 2.91 / /    
2.2d 1 2.5 129.9 133.8 2.4 126.8 130.7 
 2 2.2 127.8 131.8 1.8 117.6 121.6 
 3 3.5 186.5 191.1 3.0 175.1 179.7 
2.3d 1 2.3 174.3 179.2 2.4 179.6 184.5 
 2 2.0 144.5 149.0 1.9 141.1 145.6 
 3 6.4 180.7 184.6 5.1 168.2 172.1 
2.4d 1 1.1 178.3 184.5 1.1 181.1 184.5 
 2 4.1 220.0 224.9 2.0 162.8 167.7 
 3 2.9 183.1 187.9 2.5 173.2 178.0 
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Figure E5: Numerical regression of the self-immolative degradation model applied 
to polymer 2.6   
 
Figure E6: Numerical regression of the self-immolative degradation model applied 
to polymer 2.7.  
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Figure E7. Degradation plots for model compound 3.19. a) Run 1: k=1.74×10-1 h-1, 
h1/2=3.97 h, SE= 1.0%; b) Run 2: k=1.44×10-1 h-1, h1/2=4.81 h , SE= 0.7%; and  c) 
Run 3: k=1.49×10-1 h-1, h1/2=4.65 h , SE= 0.8%. 
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Figure E8. Degradation plots for model compound 3.21. a) Run 1: k=6.59×10-2 min-
1, h1/2=10.5 min , SE= 1.3%; b) Run 2: k=6.30×10-2 min-1, h1/2=11.0 min , SE= 2.3%; 
and  c) Run 3: k=6.54×10-1 min-1, h1/2=10.6 min , SE= 3.3%. 
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Appendix F: Permission to Reuse Copyrighted Material 
 
American Chemical Society’s Policy on Theses and Dissertations  
 
If your university requires you to obtain permission, you must use the RightsLink 
permission system.   
See RightsLink instructions at http://pubs.acs.org/page/copyright/permissions.html. 
 
This is regarding request for permission to include your paper(s) or portions of text from your 
paper(s) in your thesis. Permission is now automatically granted; please pay special attention to 
the implications paragraph below. The Copyright Subcommittee of the Joint Board/Council 
Committees on Publications approved the following:  
 
Copyright permission for published and submitted material from theses and dissertations  
ACS extends blanket permission to students to include in their theses and dissertations their 
own articles, or portions thereof, that have been published in ACS journals or submitted to 
ACS journals for publication, provided that the ACS copyright credit line is noted on the 
appropriate page(s).  
Publishing implications of electronic publication of theses and dissertation material  
Students and their mentors should be aware that posting of theses and dissertation material 
on the Web prior to submission of material from that thesis or dissertation to an ACS 
journal may affect publication in that journal. Whether Web posting is considered prior 
publication may be evaluated on a case-by-case basis by the journal’s editor. If an ACS 
journal editor considers Web posting to be “prior publication”, the paper will not be 
accepted for publication in that journal. If you intend to submit your unpublished paper to 
ACS for publication, check with the appropriate editor prior to posting your manuscript 
electronically.  
 
Reuse/Republication of the Entire Work in Theses or Collections: Authors may reuse all or 
part of the Submitted, Accepted or Published Work in a thesis or dissertation that the author 
writes and is required to submit to satisfy the criteria of degree-granting institutions. Such reuse is 
permitted subject to the ACS’ “Ethical Guidelines to Publication of Chemical Research” 
(http://pubs.acs.org/page/policy/ethics/index.html); the author should secure written confirmation  
(via letter or email) from the respective ACS journal editor(s) to avoid potential conflicts with 
journal prior publication*/embargo policies. Appropriate citation of the Published Work must be 
made. If the thesis or dissertation to be published is in electronic format, a direct link to the 
Published Work must also be included using the ACS Articles on Request author-directed link − 
see http://pubs.acs.org/page/policy/articlesonrequest/index.html  
 
* Prior publication policies of ACS journals are posted on the ACS website at  
http://pubs.acs.org/page/policy/prior/index.html  
 
If your paper has not yet been published by ACS, please print the following credit line on the first 
page of your article: "Reproduced (or 'Reproduced in part') with permission from [JOURNAL 
NAME], in press (or 'submitted for publication'). Unpublished work copyright [CURRENT 
YEAR] American Chemical Society." Include appropriate information.  
 
If your paper has already been published by ACS and you want to include the text or portions of 
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the text in your thesis/dissertation, please print the ACS copyright credit line on the first page of 
your article: “Reproduced (or 'Reproduced in part') with permission from [FULL REFERENCE 
CITATION.] Copyright [YEAR] American Chemical Society." Include appropriate information.  
 
Submission to a Dissertation Distributor: If you plan to submit your thesis to UMI or to 
another dissertation distributor, you should not include the unpublished ACS paper in your thesis 
if the thesis will be disseminated electronically, until ACS has published your paper. After 
publication of the paper by ACS, you may release the entire thesis (not the individual ACS 
article by itself) for electronic dissemination through the distributor; ACS’s copyright credit line 
should be printed on the first page of the ACS paper.  
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